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Sulfated polysaccharides are widespread in nature. These compounds are implicated in a 
wide variety of important biological processes such as blood clotting, cell adhesion, and 
cell–cell communication. However, detailed characterization of their specific biological 
roles has proved to be very challenging. One reason for this is that the synthesis of even 
relatively small sulfated oligosaccharides still remains a considerable challenge. A 
general approach to the synthesis of sulfated carbohydrates was examined in which the 
sulfate group is incorporated at the beginning of the syntheses as a protected sulfodiester. 
Towards this end, a series of modified sulfuryl imidazolium salts were prepared and 
examined as reagents for incorporating 2,2,2-trichloroethyl-protected sulfate esters into 
monosaccharides.. A more efficient sulfating agent was obtained by incorporating a 
methyl group at the 2-position of the imidazolium ring. O-Sulfations that required 
prolonged reaction times and a large excess of the original sulfuryl imidazolium salt 
(SIS) which bears no alkyl groups on the imidazolium ring, were more readily achieved 
using the new reagent.  Direct regioselective incorporation of TCE-protected sulfates into 
monosaccharides was achieved using the new imidazolium salt. We have also shown that 
the new SIS can also be used for the direct disulfation of monosaccharides and that 
trisulfated monosaccharides can also be prepared from the disulfated compounds. SIS’s 
bearing the TFE and phenyl groups, were readily prepared.  In most instances, both TFE- 
and phenyl protected sulfated carbohydrates were easily prepared in good yields using 
SIS’s. Deprotection of the TFE group from secondary sulfates in carbohydrates and aryl 
sulfates was achieved in excellent yields using NaN3 in DMF. We applied the sulfate 
protecting group strategy towards the total synthesis of the tetrasaccharide portion of a 
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disulfated glycosphingolipid called SB1a. Efficient routes were developed for the 
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Chapter 1.  Sulfated Carbohydrates: their biological functions, roles in 
drug development and chemical synthesis 
________________________________________________________________________ 
1.1 Sulfated Carbohydrates 
 Carbohydrates encompass the most abundant group of natural products. They 
represent a unique family of polyfunctional compounds which can be chemically 
manipulated in a large number of ways.  Carbohydrates form the major constituents of 
shells of insects, lobsters, crabs, and the supporting tissue of the plants and also they are 
found as parts of all cell walls. Oligosaccharides have many biological functions which 
include bacterial and viral adhesion to host tissues, tumor cell metastasis, leukocyte 
trafficking and associated inflammatory responses, clearance of materials from the blood 
stream, determination of blood group specificity, and regulation of hormone and enzyme 
activities.  
 The presence of negatively charged sulfate groups on a wide variety of 
carbohydrates from simple monosaccharides to complex polysaccharides provides many 
interesting and important compounds.  The diversity of carbohydrate sulfates is attributed 
to the position(s) of the sulfate group(s) on the sugar ring, the nature of the carbohydrate 
and the presence of other functional groups, such as amines or uronic acids.  An 
important consequence of this structural diversity is that each unique structure has the 
potential to be recognized by an individual receptor or enzyme, making sulfated 
oligosaccharides ideal for carrying information in complex biological systems. There are 
many important sulfated carbohydrates.1  A handful of them, as well as recent  
developments in carbohydrate drug design, are presented below. 
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 An important class of polysaccharides found in connective tissue and the 
extracellular matrix are the glycosaminoglycans (GAG’s). GAG’s are a large family of 
polydisperse anionic polysaccharides that bind numerous proteins of biological interest 
including antithrombin III and fibroblast growth factor. They are classified into seven 
structural groups, heparin, heparan sulfate, keratan sulfate, dermatan sulfate, hyaluronate 
and chondroitin 4- and 6-sulfates.  Heparin and heparan sulfate are made essentially by 
the same process, but whereas heparin is only synthesised in mast cells, heparan sulfate is 
widely distributed through epithelial tissues. Heparan sulphate and heparin consist of 
alternating units of glucosamine (GlcN) with glucuronic acid (GlcA) or iduronic acid 
(IdoA). Heparan sulphate contains a greater proportion of GlcA, whereas heparin 
contains more IdoA. Both molecules are sulphated, but heparin is more highly N-sulfated 















































X= H or SO3
Y= Ac, SO3 , or H
 
Figure 1.1.  Major and minor disaccharide repeating units in heparin and heparan sulfate 
 
 Heparan sulphate GAG chains tend to exist as proteoglycan components — that 
is, tethered to a protein core. In this way, they are expressed on the surfaces of cells, 
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including those of the vascular endothelium and of circulating leukocytes, which provides 
a general net negative charge to these surfaces. Heparin, by contrast, is co-released with 
histamine from degranulating mast cells, and can dissociate from its protein core to exist 
as free GAG chains.5-7 
 More than 94 years ago, a medical student at Johns Hopkins University found that 
an extract of dog liver prolonged the time required for plasma to clot.8 The extract, which 
was named heparin, remains the most important anticoagulant drug in current clinical 
use. The coagulation cascade is defined by Rosenberg and coworkers9 as a series of 
linked, proteolytic reactions ultimately leading to the generation of thrombin. Once 
thrombin is formed, two pairs of fibrinopeptides are released from fibrinogen, and 
polymerization of the resulting fibrin leads to an insoluble clot. 
 After the understanding of the structure and properties of heparin, many efforts 
were made to demonstrate the structure-activity relationship of heparin. In the early 
1980’s, the studies of Lindahl and coworkers10 on the identification of the consensus 
sequence of hexa- and octasaccharides, which were isolated by heparin degradation and 
affinity chromatography on immobilized AT-III, led to the structural elucidation of the 
unique pentasaccharide domain (1.1 Figure 1.2), which now called the antithrombin III 











































































Figure 1.2.  Heparin pentasaccharide and its synthetic analogs. 
Interaction of heparin with antithrombin III (AT-III) led to a conformational change in 
the serine protease inhibitor, which allowed the loop with the reactive center to interact 
with coagulation enzymes, such as thrombin and factor Xa. The unique pentasaccharide 
domain—also called the antithrombin III binding domain (ABD)—should be present in 
the heparin chain to induce the conformational change in AT-III. The pentasaccharide 
stimulates exclusively the AT-III-mediated inactivation of factor Xa (anti-Xa activity), 
whereas longer heparin fragments comprising both the pentasaccharide domain (ABD) 




Figure 1.3  Interaction of heparin with antithrombin III (AT-III). 
This Figure is taken from a review published by Petitou, M. and van Boeckel, C. A. A. Angew. Chem.Int. 
Ed. 2004, 43, 3118-3133. 
 
 In 1985, Petitou et al. ,11 synthesized the first pentasaccharides 1.2 as analogues of 
the active domain 1.1, which contain an N-sulfate group instead of an N-acetyl group on 
the non-reducing end of the pentasaccharide. (Figure 1.2).   More than 60 steps were 
required in the chemical synthesis of the first pentasaccharide 1.2, which was isolated in 
extremely low yield and insufficient purity for use as a synthetic drug. The 
pentasaccharide showed anti-Xa activity but no antithrombin activity was observed.  
 In early 1987, the pentasaccharide 1.3 (Figure 1.2), which is closely related to the 
natural sequence and had been prepared by both Sanofi (now Sanofi-Synthelabo) and 
Organon companies was selected for further development.12,13 The analogue 1.3 with a 
methyl group at the anomeric center was expected to be easier to synthesize and purify 
than the pentasaccharide 1.2. In 1989 over 20 g of highly purified pentasaccharide 1.3 
was prepared; and in 2001 after successes in toxicology testing and clinical studies, 1.6 
was registered in the USA and Europe as a new antithrombotic drug under the name 
Arixtra (fondaparinux).14 Arixtra is currently used for the prevention of venous 
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thromboembolic events following knee- or hip replacement surgery and after hip 
fractures. Arixtra is superior to natural heparin in that it requires a lower dosage, has a 
much longer half life (t1/2 = 17 h, the half life of heparin is 1 h).14 The synthesis of Arixtra 
is summarized in Scheme 1.1, where the orthogonal protecting group strategy was 
applied in which hydroxy groups to be sulfated are masked with acetyl groups, whereas 
those corresponding to the free hydroxy groups in the pentasaccharide are protected as 
benzyl ethers.3  The fully protected pentasaccharide 1.6 is prepared by coupling 
trisaccharide donor 1.4 with disaccharide 1.5 (prepared in over 50 combined synthetic 
steps).3,12 The locations that bear the sulfates are deprotected and then O-sulfated. The 
remaining benzyl and azido groups are removed by hydrogenolysis, and then selective N-














































































































contributing groups  
Figure 1.4. Essential sulfate groups in Arixtra 
Many synthetic analogues of the unique pentasaccharide were prepared to help in 
understanding of the heparin-mediated activation of AT- III.12 The results of the structural 
activity relationship of these analogues showed that, the heterogeneous pentasaccharide 
domain of heparin is the only polyanion identified so far that is able to trigger the 
conformational change in AT-III. There are two N-sulfate groups, and two essential 
carboxylate groups. Removal of one of these key sulfate or carboxylate groups leads to a 
nearly complete loss of activity, while the presence of two to three more sulfate groups in 
the pentasaccharide domain help to increase its biological activity. Moreover, the 
persulfated pentasaccharide displays no significant activity. The orientation of the key 
charged groups in space is important, since epimers display reduced activity. The activity 
was decreased when an essential sulfate group was replaced by a phosphate group, which 
means the type of charge is crucial. These results suggest that the essential charged 
groups of heparin interact with the complementary residues of AT- III through ordered 
hydrogen bonds. In addition, the hydroxyl groups of the pentasaccharide are not used as 
hydrogen bond donors in the interaction process, since methylation of the hydroxyl 
groups does not reduce the activity. The hydrogen atoms of the sulfated amino groups are 
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not important hydrogen bond donors, because N-sulfate can be replaced by sulfate 
without changing the activity. 12 
 Among the synthetic analogues of the unique pentasaccharide are the two O-


























































Figure 1.5. Idraparinux and Idrabiotaparinux 
Idraparinux showed higher activity and higher bio-availability than both heparin 
and Arixtra, (t1/2 = 120 h), and by 2003 had reached phase III clinical trials.  Due to the 
high activity of Idraparinux, major bleeding was observed in greater than 18% of the 
clinical trials.15 To overcome this problem, a biotin moiety was tethered to the non-
reducing end of 1.7 to give Idrabiotaparinux 1.8 (Figure 1.5). It is expected that the 
activity of Idrabiotaparinux can be controlled by the addition of avidin, and this process 
is currently in phase III clinical trials.15 The development of Arixtra, Idraparinux and 
Idrabiotaparinux is considered to be one of the most exceptional achievements of modern 
drug design and development. 
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 Another important class of naturally occurring sulfated oligosaccharides is 
chondroitin sulfate family of glycosaminoglycans. Chondroitin sulfates occur in many 
tissues as side chains of proteoglycans. They are found at the cell surface or 
intracellularly in secretory granules, as well as in various body fluids.16,17 Chondroitin 
sulfates are linear copolymers formed from dimeric units composed of D-glucuronic acid 
(GlcA) and 2-acetamido-2- deoxy-D-galactose (GalNAc). In the major variants, the 4- 
and 6-O-positions of the Gal-NAc residues are found sulfonated. Chondroitin sulfates 
have many biological roles, such as cell recognition, 18 development of osteoarthritis,19 
inhibition of human C1q factor,20 and AT-III-mediated anticoagulant activity.21 
 Hsieh-Wilson and coworkers, reported that tetrasaccharide 1.9 (Figure 1.6), a 
fragment of a chondroitin sulfate glycoaminoglycan, stimulates neuronal growth.22 The 
authors mentioned that, the presence of the four sulfate residues was absolutely essential 





















Figure 1.6. Chondroitin 4,6-O-sulfates 
The discovery of the selectins in the 1980`s has generated intense interest in 
therapeutic potential of carbohydrates as anti-inflammatory agents. Selectins (E-, P-, and 
L-) are a family of adhesion molecules that mediates the interaction of circulating 
leukocytes with endothelial cells, a key step in their recruitment to sites of 
inflammation.23 Potential ligands for these selectins include sialyl Lewis x,  sialyl Lewis 
a,  6`-sulfo Lewis x,  and 3`-sulfo Lewis x. 23b-e  The structure of 6`-sulfated sialyl Lewis x, 
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1.10 which is a main capping group24 of the high endothelial venules (HEV) associated 
























Figure 1.7. 6`-Sulfated sialyl Lewis x 
 Another example of a biologically active sulfated carbohydrate is the 
glycosphingolipid SB1A (1.11, Figure 1.8). SB1A is a glycosphingolipid carbohydrate 
antigen with a disulfated tetrasaccharide moiety that has shown to accumulate in both 
cultured and tissue-extracted human hepatocellular carcinoma (HCC) cell lines. 
Carbohydrate antigens are often expressed specifically to a certain type of tumor, and are 
not overexpressed or recognized by the immune system in normal tissues; thus 
oligosaccharide based antigens show a great deal of potential for application towards 
tumor immunotherapy.25 It has been suggested that SB1A is one of the most important 
cancer-associated carbohydrate antigens for HCC.25 SB1A will be covered in more detail 
























Figure 1.8. Structure of SB1A  
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1.2 Synthesis of Sulfated Carbohydrates 
 Although sulfated carbohydrates are widespread, a clear comprehension of their 
specific roles is limited. These compounds are commonly isolated as complex mixtures 
from natural sources, which makes it difficult to determine the precise structure-activity 
relationships responsible for their biological functions and hence there is a need to 
synthesize deliberate portions of their structures.   
 In the current approach, the synthesis of sulphated oligosaccharides typically 
involves first constructing a fully protected precursor in which the hydroxyl groups that 
ultimately bear the sulfate group(s) are protected in a manner orthogonal to those that will 
not be sulfated. The protecting groups on the hydroxyls that are to be sulfated are then 
removed, and the resulting free hydroxyl groups are sulfated, usually with a sulfur 
trioxide-amine or amide complex, and then all other protecting groups are removed to 





























































Scheme 1.2. Orthogonal protection strategy for the synthesis of sulphated sugars 
 
Despite the success of the direct sulfation strategy, however, there are some drawbacks 
especially during the synthesis of complex molecules.  First, good yields of the sulfation 
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reactions can be difficult to attain especially when multiple sulfations are necessary.26 
Second, the sulfated products are highly polar and can be difficult to purify for 
subsequent manipulations.  Finally, additional protecting group manipulations are 
required at later stages of the synthesis.  Due to these shortcomings, another strategy for 
the synthesis of sulfated carbohydrates appeared some time ago where the sulfate groups 
are introduced at the monosaccharide stage as a protected sulfate diester. Once the fully 
protected oligosaccharide is assembled, the hydroxyl and sulfate protecting groups are 
removed, and the desired sulfopolysaccharide is obtained (Scheme 1.3). This is an 
attractive approach because the initial products are uncharged, can be purified by the 
traditional chromatographic methods, and may be amenable to subsequent chemical 
manipulations.  The key to this approach is finding a sulfate protecting group that is 
readily introduced, is compatible with the diverse conditions that are encountered during 











































1.3 Protecting Groups for the Sulfate Moiety 
 Sulfate esters can react with nucleophiles by S-O bond cleavage (pathway (c) in 
Figure 1.9) or C-O bond cleavage (pathways (a) and (b) in Figure 1.9).27,28  Nucleophilic 
substitution by pathway (c) is usually slow unless the leaving group is good.  A 
protecting group that would be removed by pathway (c) would probably have to be too 
good a leaving group to be practical for complex syntheses.  Hence, the design of sulfate 
protecting groups has focused mainly on disfavouring attack by route (a) where R = 
carbohydrate (Figure 1.9), and favoring attack by route (b) where R’ is the protecting 
group.  Substitution by pathway (a) is also generally slow when R is a carbohydrate 
especially with the sulfate esters of secondary alcohols.  Acid-labile protecting groups 
cannot be used as the deprotected products are also acid labile.  Benzylic moieties, which 
are typically removed by hydrogenolysis, cannot be used as they are very labile to C-O 
bond cleavage (pathway (b)).  Base labile protecting groups that are removed by basic 
hydrolysis (route (c)) are unlikely candidates for the reasons mentioned above.  If a β-
proton is available then elimination (route (d)) also occurs very readily under basic 
conditions so the absence of a β-proton is important.  Taken together, these factors 
severely limit the number of protecting groups which can be used for the sulfate moiety. 
In the next section a survey of the different sulfate protecting groups that have been 
developed to date is presented. 











Figure 1.9.  Possible routes for reactions of sulfate esters. 
 14
1.3.1 Phenyl Protection for Sulfate Monoesters 
 Penney and Perlin29 were the first to explore the possibility of using a protecting 
group strategy for the synthesis of sulfated carbohydrates.  They examined the phenyl 
group as a sulfate protecting group.  The phenyl sulfate was introduced using phenyl 
chlorosulfate.  Two simple monosaccharides were used as model systems, where the 
partially protected monosaccharides were treated with sodium hydride in oxalane 
followed by phenyl chlorosulfate to afford the corresponding phenyl sulfocarbohydrates 

























OHO3SO O NaH, 1.3 eq, 1h     rt, oxolane then
 PhOSO2Cl,1eq, 
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Scheme 1.4.  Incorporation and deprotection of phenyl sulfates. 
 
 Stability studies of the phenyl-protected sulfate esters showed that, the phenyl 
sulfates were stable to variety of conditions including NaOMe at room temperature; 2:1 
NH4OH in pyridine; CsF in acetonitrile or methanol; KF and 18-crown-6.  In addition, 
the 5,6-isopropylidine group in 1.16 could be hydrolyzed without affecting the phenyl 
group using mild acidic conditions such as TFA in CHCl3 or cationic resin in 
water/oxolane at room temperature but not at elevated temperature.  The authors also 
reported that the acetals could be removed using 1:1 Ac2O/H2SO4 without affecting the 
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phenyl sulfate. On the other hand, unidentifiable products were formed upon treatment of 
1.13 with TBAF in oxolane. 
 To remove the phenyl group, Penney and Perlin subjected the protected sulfates to 
a solution of potassium carbonate (3 eq.) and 12 wt. % platinum oxide/H2 (Parr 
hydrogenator, 37 lb. in -2) in ethanol-water for 20 h (Scheme 1.4).  These conditions 
resulted in the hydrogenation of the phenyl ring to the cyclohexyl group, which was 
removed under the basic conditions to give the desired sulfated carbohydrates 1.14 and 
1.17.29 A rather tedious purification then followed and the resulting sulfated products 
were obtained in low yields (< 50%).  It was noted that 10 % desulfation had also taken 
place.  Perlin and coworkers also examined selective sulfations with this 
methodology.30,31 These studies will be discussed in more detail in chapter 3.  
Nevertheless, due to the low yields obtained during deprotection and the fact that partial 
desulfation occurs this protecting group has never been used in the synthesis of complex 
sulfated carbohydrates. 
1.3.2. Trifluoroethyl Protection for Sulfate Monoesters 
 Due to the limitations of the phenyl protecting group, Proud et al.28 offered an 
alternative.  For both steric and electronic reasons, the authors expected trihaloethyl 
sulfate esters, to be stable to nucleophilic attack at the methylene carbon.  They initially 
focused on the trichloroethyl (TCE) group, since it had previously been used for 
phosphate and carboxyl protection and can be removed selectively with Zn/AcOH.32 The 
authors tried many conditions for the reaction of 2,2,2-trichloroethyl chlorosulfate with 
partially protected carbohydrates, but the reactions yields were too low to be of use, 
attributing this to steric reasons.  Proud et al. 28 therefore switched to the trifluoroethyl 
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group as a protecting group. They started by treating the carbohydrates with 2,2,2-
trifluoroethyl chlorosulfate, but the yields were poor. However, the authors were able to 
introduce the TFE-protected sulfates into the sugars using a two step approach in which 
the sulfate-unprotected sugar was prepared using sulfur trioxide-amine complexes 
followed by treatment with 2,2,2-trifluorodiazoethane to give the desired TFE-protected 
sulfocarbohydrates (Scheme 1.5).  Other sulfated carbohydrates prepared by Proud et are 




































 b) Me3N.SO3.complex, 
     2.2 eq., THF, rt, 15 h
a) Bu2SnO, 1eq,   











































93% 80%  
Figure 1.10.  Trifluoroethyl esters of carbohydrate sulfates prepared by Proud et al.28 
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 Stability studies by Proud et al. revealed that the TFE-protected sulfates are stable 
to a variety of conditions commonly used in carbohydrate chemistry such as TFA in 
EtOH, TBAF, hydrogenation, and NaOMe in MeOH at room temperature and apparently, 
at reflux.  On the other hand, the TFE-group was removed by using potassium t-butoxide 
in refluxing t-butanol with the yields of deprotected products ranging from 82-96% 




































t-BuOK, 5 eq, t-butanol, reflux, 1-2 h
1.27
82%
t-BuOK, 5 eq, t-butanol, reflux, 1-2 h
1.23 1.28
96%
t-BuOK, 5 eq, t-butanol, reflux, 1-2 h
1.29
88%  
Scheme 1.6.  Deprotection of the TFE-group. 
The next stage in the development of TFE-group as a protecting group for 
sulfated carbohydrates started in 2003 by Linhardt and coworkers33 where they reported 
the use of the TFE group in the synthesis of fully differentiated hexosamine 
monosaccharides for the synthesis of GAG’s.  The TFE-protected sulfate was introduced 
into the monosaccharides in the same manner used by Proud et al.  
 The Linhardt group studied the preparation of some monosaccharides donors 
bearing the TFE sulfate moiety at the C-6 or C-4 position of the sugar. Both fluoride and 



























a) TBAF, 1.1 eq
AcOH, 1.5 eq,
THF, -25 oC
b) Cl3CCN, 10 eq,
DBU, 0.25 eq, 0oC 1.33
59%
1.30
a) 3HF,Et3N, 10 eq





Scheme 1.7.  Synthesis of monosaccharides donors bearing TFE sulfates. 
The authors mentioned that, when TBAF was used to remove the anomeric thexyldisilyl 
(TDS) group on monosaccharides, the TFE-sulfate moiety at the 6-position acted as a 
good leaving group and 1,6-anhydro sugars was recovered as a side product. To 
overcome this problem, excess acetic acid was added to TBAF, or a milder reagent such 
as triethylamine trihydrofluoride was used.  In addition, partial loss of the sulphate 
protecting group was observed under the basic conditions required to prepare 
trichloroacetimidate 1.33 (Scheme 1.7).  Fluoride 1.31 and imidate 1.33 were used in the 
glycosylation reactions with simple donors having primary hydroxyl groups (Scheme 






























































 Scheme 1.8. Glycosylation with TFE-sulfated donors 
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In 2004, a second paper was published by the Linhardt group where more sulfo-
protected monosaccharide donors (Scheme 1.9) and acceptors were prepared and 






































Scheme 1.9. Synthesis of glycosyl imidate donors 
  
 A wide variety of glycosylation reactions were studied, demonstrating the TFE 
sulfate group was compatible with a range of activation conditions commonly used with 
fluoride, imidate, and sulfoxide donors.  Reaction of imidate donor 1.40 with galactose 
acceptor 1.34 in DCM in presence of TMSOTf as promoter afforded the disaccharide 
1.43 in 91% yield as a mixture of α and β in 1.2:1 ratio indicating that there is probably 
no anchimeric assistance by the TFE-protected sulfate during the glycosidation reaction 
(Scheme 1.10).  Less reactive acceptors such as 1.44 gave the disaccharide product 1.45 





























































































Scheme 1.10.  Synthesis of the disaccharides 
  
Linhardt et al.34 used the conditions of Proud et al (t-BuOK in refluxing t-
BuOH)28 for TFE-sulfate deprotection.28  Although the TFE-group was deprotected from 
the monosaccharide 1.37 in 82% yield, disaccharide 1.36 decomposed under the same 
conditions.  The authors found that NaOMe/MeOH could sometimes remove the TFE-
group, such as in the synthesis of disaccharide 1.47 which was isolated in a 70 % yield 
(Scheme 1.11).  This is in contrast to the report by Proud et al28 that TFE-protected 
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Scheme 1.11. Deprotection of TFE-protected sulfates 
 In some cases it was found that the TFE protecting group could be removed under 
the standard conditions (t-BuOK/t-BuOH) only after the complete removal of the ester 
groups with NaOMe/MeOH such as with 1.48 (Scheme 1.11). They applied stepwise 
deprotection for the 2,4-disulfate 1.45, where the 4-O-sulfate was removed with 
NaOMe/MeOH to give the mono protected sulphate 1.50, which was then subjected to t-
BuOK/t-BuOH to deprotect the 2-O-position sulfate, providing the disaccharides 1.51 in 
only a 45% overall yield, with loss of the 6-OTBDMS and anomeric OMP protecting 
groups (Scheme 1.11).34 
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 As we see from the above studies, the TFE protecting group has been used for the 
synthesis of variety of protected carbohydrate sulfate diesters, and has proved to be stable 
to a number of conditions commonly used in carbohydrates synthesis.  On the other hand, 
this protecting group has some strong limitations.  Introducing the TFE group involves 
the use of trifluorodiazoethane, a reagent that must be prepared fresh and is highly toxic 
and potentially explosive, and often the yields are inconsistent. Moreover, the harsh 
conditions that are usually employed for its removal, KOt-Bu in refluxing t-BuOH, can 
result in substrate decomposition and consequently low or moderate sulfate deprotection 
yields.  Alternative protecting groups are required to overcome these limitations. 
 
1.3.3. Neopentyl and Isobutyl Protection for Sulfate Monoesters 
 Widlanski et al.35 described the synthesis of sulfate esters employing the 
neopentyl and isobutyl protecting groups.  The selection of these two protecting groups 
was based on the fact that the neopentyl (nP) and isobutyl (i-Bu) groups are known to 
serve as good protecting groups for sulfonates.35 The authors reported the synthesis of 
various neopentyl- and isobutyl-protected sulfate monoesters by treating alcohols and 
phenols with a slight excess of sodium bis (trimethylsilyl)amide (NaHMDS) in THF 
(20% DMPU present for nP, no DMPU for i-Bu) at –75 oC (for nP) or -15 oC (for i-Bu), 
followed by the addition of neopentyl chlorosulfate (1.1 eq.) or isobutyl chlorosulfate (5-
10 eq.) then warming to rt and stirring for several hours.  Under these conditions, a 
variety of sulfo-protected compounds including protected estrone sulfate (1.56 and 1.57) 
protected tyrosine sulfate 1.58, and sulfocarbohydrates 1.59-1.61 were readily prepared in 
excellent yields (Table 1.1).  The neopentyl esters were stable at room temperature for 
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several months while the isobutyl esters degraded at room temperature and had to be 
stored at – 20 oC.  
Table 1.1.  Preparation of neopentyl and isobutyl sulfate diesters. 
ROH
1. NaHMDS or NaH
2. ClSO2OR`
ROSO3R`
1.52, R`= nP   



















1.54 R= nP 













1.56 R= nP 






























1.59 R= nP 

















1.61 R= iBu 
 
86 
* E= Estrone; nP= neopentyl; iBu= isobutyl 
 
 Simpson and Widlanski35 examined the stability of the neopentyl and isobutyl 
protected sulfate esters to acid and base by subjecting protected phenyl sulfates 1.54 and 
1.55 to different concentrations of TFA and piperidine using NMR assays. The studies 
showed that both the isobutyl and neopentyl sulfate esters were stable to 50% TFA, with 
 24
less than 10% degradation observed after 48 h.  In addition, the neopentyl sulfate ester 
was stable to 20% piperidine in chloroform. On the other hand, the isobutyl sulfate ester 
was less tolerant, showing evidence of nucleophilic cleavage, even at 6% piperidine 
solution. From the stability studies, the authors concluded that both the neopentyl and 
isobutyl groups offer viable protection under highly acidic conditions, while the isobutyl 
protecting group was much less effective under basic or nucleophilic conditions. The 
stability of the alkyl sulfates was not investigated with TFA or piperidine; however, 
carbohydrate sulfates 1.59, 1.60, and 1.61 were subjected to H2SO4 in THF/H2O to 

















































Scheme 1.12. Stability of alkyl protected carbohydrate sulfates 
 The authors studied the conditions required to cleave the neopentyl moiety by 
subjecting the protected sulfate esters to nucleophiles in polar solvents. Treating 
neopentyl sulfate 1.54 with sodium iodide in acetone yielded the desulfated phenol rather 
than cleavage of the neopentyl group (Scheme 1.13a), and no reaction was observed with 
the neopentyl protected glucose sulfate 1.59 (Scheme 1.13b). On the other hand, small 
nucleophiles such as azide and cyanide in warm DMF (60-70 oC) were reported to be 
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effective for removing the neopentyl protecting group in protected aryl sulfates 1.54, 
1.56, and 1.58, as well as the protected sulfate of diacetone-D-glucose 1.59 (Scheme 
1.13c) in near quantitative yields.  Treating the unprotected glucopyranose neopentyl 
diester 1.62 with sodium azide in DMF, however, led to the displacement of the entire 


















































Scheme 1.13. Deprotection of neopentyl protected sulfate groups 
 The inconsistencies found during the deprotection of the neopentyl group 
prompted the authors to suggest that the neopentyl group is not useful for the protection 
for sulfates of primary or secondary alcohols of carbohydrates. On the other hand, as 
nucleophilic substitution is significantly faster at isobutyl centers than at the more 
hindered neopentyl counterpart, a variety of nucleophiles were expected to cleave the 
isobutyl protecting group. Subjecting the isobutyl protected sulfate esters of unprotected 
hexoses 1.63 and 1.64 to sodium iodide in acetone at 55 °C provide the target sulfates 






































Scheme 1.14. Deprotection of isobutyl protected sulfate groups 
 On the basis of the above studies, Simpson and Widlanski suggest that the 
neopentyl group is more suited as a protecting group for aryl sulfates.  Since the i-Bu 
group is more readily removed than the nP group they suggested that it could be useful 
for the protection of alkyl sulfates though its lack of robustness would limit its use in 
complex syntheses.  There are other issues with the i-Bu group.  Its introduction required 
5-10 equivalents of isobutyl chlorosulfate and the isobutyl esters degraded at room 
temperature and had to be stored at – 20 oC.   Moreover, neither isobutyl chlorosulfate 
nor neopentyl chlorosulfate are particularly stable:  they slowly decompose over several 
weeks to months even when stored under Ar at – 20 oC.36 Moreover, no studies have been 
performed to test the isobutyl esters stability to many of the conditions encountered 
during carbohydrate syntheses nor has its introduction into carbohydrates been examined 
in the presence of other protecting groups other than ether and acetal protecting groups.  
The authors also suggested that isobutyl chlorosulfate would be effective for introducing 
sulfate monoesters at the last step in a synthesis and would be superiour to using sulfur 
trioxide complexes.  This would probably not be the case for carbohydrates as it is 
introduced using a very strong base (NaHMDS) at -15 oC to rt, conditions where 
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protecting groups such as acyl groups (the most commonly used protecting groups in 
carbohydrate chemistry) could isomerize and other side reactions could occur.  Thus, 
although this group might be useful in certain cases, it does not provide a significant 
alternative to the conventional sulfation methods.  No further reports on the use of this 
group for the synthesis of sulfated carbohydrates has appeared since Widlanski and 
Simpson’s initial report.  
 
1.3.4 Trichloroethyl Protection for Sulfate Monoesters 
 In 1997, Proud et al.28 attempted to use the trichloroethyl (TCE) group as a 
sulfate protecting group for sulfated carbohydrates.  The authors claimed they were 
unable to incorporate the TCE-protected sulfates into carbohydrates using 2,2,2-
trichloroethyl chlorosulfate (TCEOSO2Cl) in good yield so they switched to the TFE 
group as mentioned earlier.  The TCE group has been used extensively for the protection 
of carboxylic acids.  It is typically removed using Zn/AcOH.  However, in order for it to 
be practical for sulfate protection new methodology would have to be developed for both 
its introduction (without using toxic and explosive diazo derivatives) and its removal as 
sulfate monoesters are acid labile. 
 In 2004 and 2006, the Taylor group came up with solutions to the above 
problems.37,38 The authors demonstrated that trichloroethyl chlorosulfate (1.71) can 
























74-95% 81-94%  
Scheme 1.15. Preparation of aryl sulfates 
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Most significantly, they demonstrated that the TCE group could be easily removed in 
excellent yields under mild conditions using Pd/C and ammonium formate, or using Zn 
and ammonium formate in methanol.37 The success achieved in introducing and 
removing TCE-group into aryl sulfates encouraged the Taylor group to investigate the 
use of the TCE group for protecting alkyl sulfates, specifically carbohydrate sulfates.  
The authors reported that reagent 1.71 can be reacted with diacetone glucose 1.15 to give 
the sulfated product 1.74 in 82% yield (Scheme 1.16). This was an important 
development, since it contradicted Proud’s previous conclusions that incorporation of the 




















Scheme 1.16. TCE-protected sulfate moiety 
 
When the authors attempted to extend their methodology to other carbohydrates 
containing a primary hydroxyl group, some problems appeared. For example treating 
1,2:3,4-di-O-isopropylidene galactose  1.34 with the TCE chlorosulfate 1.71 gave 
carbohydrate 1.75 in only a 51% yield (Scheme 1.17a).  Analysis of the reaction products 
revealed that displacement of the TCE sulfate moiety by the liberated chloride ion to give 
chlorosugar 1.76 was a competing reaction.  The chlorosugar by-products were also 
observed when the authors applied their methodology to benzyl-protected carbohydrates 
1.77 and 1.79 (Scheme 1.17b,c) where the reactions proceeded very slowly, and the 
chlorosugars 1.78 and 1.80 were formed in varying amounts. Nevertheless, these results 
suggest that the desired compounds could be formed in good yield if a highly reactive 
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Scheme 1.17.  Formation of chlorosugar by-products. 
  
In 2006, Ingram and Taylor reported a new type of sulfating agent capable of 
introducing TCE-protected sulfates into monosaccharide building blocks. 38 The authors 
prepared the sulfuryl imidazolium triflate salt 1.83, according to Scheme 1.18.  Reagent 
1.71 was added to an excess of imidazole in THF at 0 oC to afford TCE sulfuryl 
imidazole 1.82 in 86% yield. Treatment of TCE sulfuryl imidazole 1.82 with methyl 
triflate (1.0 eq.) in dry diethyl ether provided the imidazolium triflate salt 1.83 as a white 
precipitate which was obtained by simple filtration in 96% yield. No further purification 
was required. This was the first report describing the synthesis of a sulfuryl imidazolium 
salt. Compound 1.83 is a stable compound and can be stored indefinitely at 4 oC or – 20 
oC. It has been stored at room temperature for months without any detectable 























86% 96%  
Scheme 1.18. Synthesis of TCE-sulfuryl imidazolium triflate reagent 
  
Taylor and Ingram treated a variety of monosaccharide building blocks with 
reagent 1.83 (2.0–10.5 equiv) in the presence of N-methylimidazole (NMI) (2.5–11.6 
equiv) in THF at room temperature for 16-48 h.  The corresponding TCE-protected 
sulfocarbohydrates were isolated in yields ranging from 81 to 94% (Table 1.2).  The 
authors found that, the presence of NMI was essential for all the reactions. Other bases 

































































































































































































































Further manipulations of the sulfated carbohydrates indicated that the TCE-
protected sulfates are stable to many of the conditions commonly encountered in 
carbohydrate chemistry (Table 1.3) such as selective 6-O-debenzylation and acetylation  
 
Table 1.3.  Manipulations of TCE-protected carbohydrate sulfates38 












ZnCl2 (3.7 eq.), 






















NaOMe (0.16 eq.) 






















CH3COCl (3M in MeOH) 


















PhBCl2 (3.4 eq.), Et3SiH 
(3.0 eq.), 4A MS,  -78 °C, 




















TfOH (3.4 eq.), Et3SiH 
(3.0 eq), 4A MS,  -78 °C, 





















TsOH (0.1 eq.), 
CH2Cl2/MeOH, 


















NBS (3.0 eq.), acetone, 




















DBU (0.2 eq.), Cl3CCN 
(16 eq.), -40 to -10 °C, 

















NBS (3.5 eq.), CaCO3 (5 

























with ZnCl2/AcOH/Ac2O, deacetylation with NaOMe in MeOH, benzylidene ring opening 
with either TfOH or PhBCl2 in the presence of Et3SiH, cleavage of the benzylidene group 
with TsOH, deprotection of the anomeric  thiotolyl using N-bromosuccinimide (NBS) in 
acetone/water, formation of  trichloroacetimidate with a free anomeric OH group using 
trichloroacetonitrile in the presence of catalytic 1,8-diazabicyclo[5.4.0]undec-7-ene 
(DBU). Although the ester group in 1.96 was deacetylated in 85% yield using catalytic 
NaOMe in MeOH, attempts to deacetylate 1.95, which bears secondary acetate groups, 
under the same Zemplén conditions resulted in both deacetylation and loss of the TCE-
sulfate. To overcome this issue, carbohydrate 1.95 was stirred in an acidic methanol to 
afford the corresponding deacetylated compound 1.100 in good yields (Table 1.3). On the 
other hand, attempts to remove the benzyl group in 1.93 selectively with H2 and Pd 
catalyst, without affecting the TCE-protected sulfate group, were unsuccessful. However, 
the benzyl group in 1.93 was selectively cleaved to give 1.105 in 91% yield by irradiation 
with a 250-W lamp in the presence of NBS and CaCO3.39 
 The TCE group was removed in very good yields by employing zinc–ammonium 
formate in methanol (Table 1.4). The side products were easily removed by passing the 
carbohydrate through a short column of silica with CH2Cl2/MeOH/NH4OH (20:4:1) as 
eluent. The authors also performed deprotection studies with Pd/C–ammonium formate; 



































































































































































 As mentioned in the beginning of this chapter, Karst et al. removed the TFE 
moiety from sulfate groups in fully protected disaccharides in low to moderate yields.34 
Taylor et al. anticipated that this would not be an issue with the TCE group as it is 
removed under very mild conditions.38  To illustrate this, the authors synthesised the 
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disaccharide 1.113 by coupling the trichloroacetimidate donor 1.104 with glycosyl 
acceptor 1.101 in the presence of TMSOTf to give disaccharide 1.113 in 81 % yield 
(Scheme 1.19). Subjecting the disaccharide 1.113 to zinc and ammonium formate in 
methanol gave the sulfodeprotected disaccharide 1.114 in 92 % isolated yield (Scheme 




























































 Scheme 1.19. Synthesis of the disulfated disaccharide 1.113 
  
From the results obtained by Taylor et al.38 it is clear that, reagent 1.83 represents 
a new class of highly potent sulfating agents and is the first new type of sulfating agent to 
appear in almost 50 years.   
 
1.4 Summary and Thesis Outline 
 It is now well established that many distinct sulfated oligosaccharides have 
important biological roles.  Moreover, of the few carbohydrate-based drugs that have 
been developed several are sulfated oligosaccharides and their activity depends mainly on 
the presence of the sulfate groups at specific locations within the oligosaccharides.  There 
are no simple and efficient routes to obtain pure, well-defined fragments from naturally 
occurring sulfated oligosaccharides.  Hence chemical synthesis of complex sulfated 
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carbohydrates is extremely important for studying and understanding their biological 
roles. This thesis focuses on my research contributions to the synthesis of sulfated 
carbohydrates.  The ultimate goal is to devise a more efficient and reliable method by 
which such compounds can be prepared. Chapter 2 describes the development of a 
second generation sulfuryl imidazolium salt and its application to the synthesis of TCE-
protected sulfated monosaccharides.  This new reagent allows for the incorporation of a 
protected sulfodiester into monosaccharides in higher yields than our previous first 
generation reagent. Chapter 3 describes our investigations into the use of TCE sulfuryl 
imidazolium salts as reagents for the regioselective incorporation of trichloroethyl-
protected sulfate esters into monosaccharides.  We also examine the use of TCE sulfuryl 
imidazolium salts for the synthesis of multiply-sulfated monosaccharides.  Chapter 4 
covers the synthesis of sulfuryl imidazolium salts bearing the phenyl and TFE groups and 
the use of these salts in the synthesis of both phenyl- and TFE-protected sulfates. This 
chapter also includes a search for finding milder conditions for the removal of the TFE 
group.  Finally, in chapter 5, we applied the methodology that we developed in chapters 2 
and 3 to the synthesis of a complex disulfated tetrasaccharide that corresponds to the 














Chapter 2   The Second Generation of 2,2,2- Trichloroethoxy-Sulfuryl 
Imidazolium Salts. 
______________________________________________________ 
2.1 Introduction and Objectives 
 As mentioned in Chapter 1, in 2004, Taylor et al. described the use of the 2,2,2-
trichloroethyl (TCE) group as the first protecting group developed for aryl and alkyl 
sulfates.37,38 The TCE-protected sulfate esters were prepared in a single step by the 
reaction of phenols or carbohydrates with 2,2,2-trichloroethyl chlorosulfate 1.71 or the 
corresponding imidazolium salt 1.83 (Figure 2.1) in the presence of triethylamine or N-
methylimidazole.  The resulting protected sulfates were stable to a variety of conditions, 
but were readily deprotected in excellent yields under neutral conditions with Pd/C–







Figure 2.1.  Imidazolium salt 1.83. 
Although imidazolium salt 1.83 works well for most sulfations it does have some 
limitations. The sulfations must be carried out in THF as the triflate salt is poorly soluble 
in less polar solvents such as CH2Cl2 and chloroform.  In THF its stability is limited and 
it is assumed that for the slower reactions, reagent 1.83 begins to break down in THF 
before the sulfation occurs, thus the addition of aliquots over extended periods of time is 
required for high yields. As a result, reactions involving poorly nucleophilic substrates 
require excess of reagent 1.83 and longer reactions time.38 The objective of this work is 
to design sulfurylimidazolium sats (SIS’s) with stability, solubility and sulfating 
properties that are superior to reagent 1.83.  
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2.2 Results and Discussion 
2.2.1 Synthesis of Derivatives of 2,2,2-Trichloroethoxysulfuryl Imidazolium Triflate `
 (1.83) 
 This work was done in conjunction with Laura J. Ingram and Ahmed M. Ali 
former graduate students in the Taylor group. We anticipated that the solubility, stability 
and sulfating properties of SIS 1.83 could be improved by introducing alkyl groups on 
the imidazolium ring.  Towards this end we prepared a series of SIS’s all of which 
contained the TCE group yet had different alkyl groups at the 2- and 3-positions of the 
imidazolium ring.40 In addition, the tetrafluoroborate counterion was also examined.  The 
synthesis of the TCE-sulfurylimidazole derivatives was readily achieved by reacting 
reagent 1.71 with the appropriate imidazole derivative to give compounds 2.1-2.3. 
Reaction of 2.1-2.3 with methyltriflate or trimethyl- or triethyloxonium tetrafluoroborate 
gave the SIS’s (Table 2.1).  When the product precipitated out of the reaction mixture 
pure SIS’s were obtained in good yield simply by filtration. It is likely that the 
precipitation of the product is required to drive the formation of the sulfuryl imidazolium 
salts. Compounds 2.9, 2.11, and 2.12 did not precipitate out of the reaction mixture 
irrespective of the solvent used (diethyl ether, THF, CH2Cl2), and the reaction did not go 
to completion even with extended reaction times.  Attempts to selectively precipitate the 
products using non-polar solvents such as hexane or pentane were not successful, and 
semisolids consisting of both the starting material and product were obtained. In general, 
SIS’s having the triflate counterion were obtained in higher yields than those having a 
tetrafluoroborate counterion (Table 2.1).   
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2.4-2.12 (See Table 2.1)
X-
+
2.1, R1 = Me (88%)
2.2, R1 = Et (84%)
2.3, R1 = i-Pr (68%)










Product R R’ X- Yield (%) 
2.4 Me Me TfO- 99 
2.5 Et Me TfO- 98 
2.6 iPr Me TfO- 85 
2.7 Me Me BF4- 85 
2.8 Et Me BF4- 79 
2.9 iPr Me BF4- ND 
2.10 Me Et BF4- 81 
2.11 Et Et BF4- ND 
2.12 iPr Et BF4- ND 
 
We were unable to obtain the BF4- salt 2.9 which did not precipitate during the reaction 
while the corresponding TfO- salt 2.6 was readily isolated in 85% yield (Table 2.1).  
Several of us encountered strong allergic reactions when we attempted to prepare and 
isolate the TfO- analogues of compounds 2.10-2.12 and so these triflate salts were not 
pursued any further. All of the SIS’s that were obtained in pure form were white powders 
and could be stored at 4 oC for years without any detectable decomposition. At the same 
time, SIS’s were stable in a solution of CDCl3 for several days as no detectable 
decomposition was observed by 1H NMR analysis. As we expected, all of these SIS’s 
exhibited good solubility in less polar solvents such as methylene chloride and 
chloroform which supports our assumptions.   
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 Carbohydrate 2.13 was selected as a model substrate to test the sulfating ability of 
the new SIS’s.  Previously we found that sulfation of the 4-OH in carbohydrate 2.13 in 
THF requires 8.0 equiv of the original imidazolium salt 1.83, and 8.5 equiv 1-
methylimidazole (1-MeIm) added over a 72 hour period to obtain a 76% yield of 
carbohydrate 2.14.  The yield (56%) was even poorer in CH2Cl2 possibly due to the very 
limited solubility of 1.83 in this solvent.  To evaluate the new SIS’s compound 2.13 was 
treated with 2 equiv SIS in the presence of 2.5 equiv base in various solvents for 20 h 
after which the reaction was stopped and the yield of 2.14 was determined after 
purification (Table 2.2). Higher yields of 2.14 were obtained in CH2Cl2 as a solvent using 
SIS’s 2.4-2.6 compared to THF (for example, table 2.2 entry 4 vs. 5).  Due to their 
limited solubility in THF, we were unable to evaluate the sulfating ability of SIS’s 2.7-
2.10 in THF as a solvent. Good yields were obtained with SIS’s 2.4 and 2.7, which bear a 
1,2-dimethylimidazolium group, using 1,2-dimethylimidazole (1,2-dMeIm) as the base 
(entries 5 and 16).  The results showed that there is no significant effect of the counter ion 
(TfO- or BF4-) on the yield.  Low yields were obtained when the SIS contained an ethyl or 
isopropyl moiety at the 2-position of the imidazole ring (SIS’s 2.5, 2.6 and 2.10) if these 
reactions were performed in which the base was the same as the leaving group of the 
respective SIS’s (1-methyl-2-isopropylimidazole (1-Me-2-iPrIm), 1-methyl-2-
ethylimidazole (1-Me-2-EtIm) (entries 8, 10, 12, 14, and 17).  However, the yields were 























2.5 equiv base, solvent
0 oC to rt, 20h
2 equiv sulfating agent
 
Entry Reagent Base Solvent Yield (%) 
1 1.83 1-MeIm THF 70 
2 1.83 1-MeIm CH2Cl2 56 
3 1.83 1-MeIm DMF 35 
4 2.4 1,2-DiMeIm THF 65 
5 2.4 1,2-DiMeIm CH2Cl2 80 
6 2.4 1-Me-2-iPrIM CH2Cl2 53 
7 2.4 1,2-DiMeIm DMF 40 
8 2.5 1-Me-2-EtIm THF 18 
9 2.5 1,2-DiMeIm THF 58 
10 2.5 1-Me-2-EtIm CH2Cl2 21 
11 2.5 1,2-DiMeIm CH2Cl2 68 
12 2.6 1-Me-2-iPrIm THF 18 
13 2.6 1,2-DiMeIm THF 54 
14 2.6 1-Me-2-iPrIm CH2Cl2 30 
15 2.6 1,2-DiMeIm CH2Cl2 60 
16 2.7 1,2-DiMeIm CH2Cl2 79 
17 2.8 1-Me-2-Et CH2Cl2 38 
18 2.8 1,2-DiMeIm CH2Cl2 78 
19 2.10 1-Et-2-MeIm CH2Cl2 45 
20 2.10 1,2-DiMeIm CH2Cl2 75 
 
1H NMR studies by Laura Ingram- a former PhD candidate in Taylor group- in CDCl3 
revealed that just one equiv of 1,2-dMeIm rapidly displaced the 1-Me-2-EtIm, or 1-Me-2-
iPrIm from SIS’s 2.5 and 2.6 within minutes thus forming in situ SIS 2.4 which is a better 
sulfating agent (Scheme 2.1). Even after several hours, 1H NMR provided no evidence 
that the reverse reaction to the original compound was occurring, which indicates that  
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reagent 2.4 is more stable than 2.5 and 2.6. This is possibly due to steric hindrance 
between the ethyl or isopropyl group at the 2-position of the imidazole ring, and the 









































Scheme 2.1. In situ imidazolium exchange in SIS’s 2.5 and 2.6. 
 
 
We also found that a reduced yield of 2.14 was obtained using SIS 2.4 and 1-Me-2-iPrIm 
in CH2Cl2 as the base (entry 6) revealing that the low yields encountered with SIS’s 2.5, 
2.6 and 2.10 with 1-Me-2-iPrIm or 1-Me-2-EtIm may in part be due to the added 
imidazole derivative itself which may be acting as a general base during the reaction.  It 
is possible that there is greater steric crowding at the transition state of the reaction with 
SIS’s 2.5, 2.6 and 2.10 and 1-Me-2- iPrIm or 1-Me-2-EtIm than with SIS’s 2.4 or 2.7 and 
1,2-dMeIm.  SIS 2.10, which differs from SIS 2.7 only by the presence of an ethyl rather 
than methyl group on one of the nitrogens gave lower yields than SIS 2.7 (entry 16) when 
1-ethyl-2-methyl imidazole (1-Et-2-MeIm) was used as base but almost the same yield 
when 1,2-dMeIm was used as base (entries 17 and 18) again suggesting that the 1-Et-2-
MeIm group in SIS 2.10 was exchanging with 1,2-dMeIm.  DMF was also examined as a 
solvent for SIS’s 1.83 and 2.4 but low yields were obtained (entries 3 and 7).  However, 
we found that DMF can be used as a solvent for less challenging sulfations.  For example, 
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1:2,3:4-di-O-isopropylidene galactose 1.34 is sulfated with 2 equiv reagent 1.83 and 2 
equiv 1-MeIm in very good yields in either THF or DMF (Scheme 2.2). 
 
1.75
2 equiv 1-MeIm solvent
















Scheme 2.2.  Sulfation of carbohydrate 1.34 in DMF and THF 
 
 
In general, SIS 2.4 can be readily prepared in very high yield and the best yields 
in Table 2.2 were obtained with this compound. We decided to use this reagent for 
subsequent studies.  Further studies with SIS 2.4 and carbohydrate 2.13 revealed that an 
88% yield of 2.14 could be obtained in 24 h using just 3 equiv reagent 2.4, 4.3 equiv 1,2-
dMeIm in CH2Cl2 (Scheme 2.3).  Carbohydrate 2.16 was previously prepared in a 90% 
yield after subjecting compound 2.15 to 10.5 equiv SIS 1.83 and 11.6 equiv 1-MeIm for 
28 h in THF.38 However, using just 4 equiv SIS 2.4 and 4.6 equiv 1,2-dMeIm in CH2Cl2, 
carbohydrate 2.16 was obtained in a 96% yield after just 24 h.  On the other hand, 
performing the reaction under the same conditions in THF gave a 40% yield of 2.16 with 
unreacted 2.15 still remaining after 24 h demonstrating that these reactions can be subject 
to a significant solvent effect. A complex mixture of products were obtained when we 
attempted to sulfate compound 2.17 which is the STol analogue of 2.15, with either SIS 
1.83 or 2.4 and we were unable to isolate the desired sulfated compound 2.18.  This was 
unexpected since the sulfation of the 4-OH of p-tolyl 2,3-di-O-benzoyl-6-O-benzyl-1-
thio-β-D-glucopyranoside was previously reported in high yield using reagent 1.83.38  
one possible explanation is that, upon sulfation of compound 2.17 intramolecular 
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displacement of the TCE sulfate group by the sulfur atom occurs resulting in the 















































oC to rt, 24h
3 equiv  2.4
96%
 base, solvent






 Scheme 2.3. Improved sulfation reactions using reagent 2.4 
  
Laura Ingram has shown that reagent 2.4 is superiour to our previous sulfating 
agents 1.71 and 1.83 for performing N-sulfations.40 For example, reaction of 2.21 with 
reagent 1.71 in the presence of 4 equiv 1,2-dMeIm gave product 2.24 in only a 60% yield 
(Scheme 2.4a).  Sulfation of 2.21 using imidazolium salt 1.83 and 1-MeIm was 
unsuccessful in that a complex mixture of products were formed (as determined by TLC) 
and only a 9% yield of product 2.22 was isolated (Scheme 2.4b).  The same was found 
for substrate 2.23 in that only a trace amount of product was obtained using reagent 1.83.  








































2.21 2.22, R1 = H, R2 = allyl, 60%
1.83, R3 =  H (6 eq)





2.21, R1 = H, R2 = allyl
2.23, R1 = STol, R2 = H
2.22, R1 = H, R2 = allyl: 9% using 1.83
                                       94% using 2.4
2.24, R1 = STol, R2 = H: trace amounts using  1.83






Scheme 2.4.  Sulfation of glucose amine derivatives with reagents 1.71, 1.83 and 2.4.40 
2.3 Summary and Future Work 
 A series of modified sulfuryl imidazolium salts was prepared and studied to 
overcome some of the limitations of reagent 1.83. A more efficient sulfating agent 2.4, 
was obtained by incorporating a methyl group at the 2-position of the imidazolium ring of 
1.83. O-Sulfations that required prolonged reaction times and a large excess of the 
original reagent 1.83, were more readily achieved using reagent 2.4. It is expected that 
this next generation of sulfating agent will find widespread use in the preparation of 
sulfated carbohydrates and other organosulfates.  The next step in this work is the 
application of our sulfate protecting group strategy to the total synthesis of a 
multisulfated oligosaccharide and an example of such a synthesis will be given in 
Chapters 5. 
2.4 Experimental 
2.4.1 General Information 
All reactions were carried out using freshly distilled solvents unless otherwise 
noted.  Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled from sodium metal 
 46
in the presence of benzophenone under argon. CH2Cl2 was distilled from calcium hydride 
under nitrogen.  Flash chromatography was performed using silica gel 60 Å (234-400 
mesh).  Chemical shifts (δ) for 1H NMR spectra are reported in parts per million (ppm) 
relative to Me4Si (0.0 ppm) or DMSO-d6 (2.49 ppm) and are reported as follows: 
chemical shift (ppm), multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; 
br, broadened), integration, coupling constant in Hz, and assignment.   Chemical shifts 
(δ) for 13C spectra are reported in ppm relative to CDCl3 (δ 77.0, central peak) or DMSO-
d6 (δ 39.5, central peak).  Chemical shifts (δ) for 19F spectra are reported in ppm relative 
to an external standard (δ 0.0, CFCl3).  All peak assignments were confirmed using 2D-
NMR (COSY, HMQC) techniques. Optical rotations were measured at the sodium D line 
at ambient temperature in cells with 1 dm path length. All melting points are uncorrected. 
High resolution mass spectra were obtained at the University of Waterloo Mass 
Spectrometry Facility.  HRMS data for chlorine containing compounds is reported for 
35Cl.  







2,2,2-Trichloroethoxysulfuryl chloride (1.71). Procedure modified from the original 
synthesis.41 Distilled sulfuryl chloride (20.0 mL, 0.250 mol) was added dropwise via 
syringe pump over 1 h to a solution of pyridine (20.5 mL, 0.250 mol) and 2,2,2-
trichloroethanol (24.0 mL, 0.250 mol) in distilled Et2O at –78 °C.  The resulting slurry 
was stirred for an additional 1 h at –78 °C, and then stirred for 3 h at room temperature.  
The precipitate was removed by suction filtration and the filtrate was concentrated to a 
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crude oil.  Purification by vacuum distillation afforded 1.71 as a clear colourless oil (54.4 
g, 88%). Boiling point 71 °C/ 8 mm Hg. 1H NMR (300 MHz, CDCl3) δ 4.90 (s, 2H, 
CH2). 
General procedure for the preparation of compounds 2.1-2.3 (Table 2.1). To a 
solution of appropriately 2-substituted imidazole (0.072 mol, 3.60 eq.) in dry THF (40 
mL) at 0 oC was added dropwise a solution of 2,2,2-trichloroethoxysulfuryl chloride 
(1.71) (5.0 g, 0.02 mol, 1.00 eq.) in THF (50 mL). The reaction was stirred at 0 oC for 1 
h, warmed to room temperature and stirred for an additional hour. The reaction mixture 
was filtered; residue washed with THF and the combined filtrate was concentrated under 







2,2,2-Trichloroethoxysulfuryl-(2-methyl)imidazole (2.1). To a solution of 2-methyl 
imidazole (5.9 g, 0.072 mol, 3.60 equiv) in dry THF (40 mL) at 0 oC was added dropwise 
a solution of reagent 1.71 (5.0 g, 0.02 mol, 1.00 equiv) in THF (50 mL). The reaction was 
stirred at 0 oC for 1 h, warmed to room temperature and stirred for an additional hour. 
The reaction mixture was filtered, the residue was washed with THF and the filtrate was 
concentrated under vacuum. The crude residue was purified by flash chromatography 
using (33:67 EtOAc/hexanes) to give 2.1 as a white solid (5.2 g, 88 %); Mp 53-55 oC; 1H 
NMR (300 MHz, CDCl3) δ 7.32 (s, 1H, Himi), 6.94 (s, 1H, Himi), 4.65 (s, 2H, CH2), 2.67 
(s, 3H, CH3-imi); 13C NMR (75 MHz, CDCl3) δ 146.4, 128.2, 120.1, 91.7, 80.0, 14.9; 









1-(2,2,2-Trichloroethoxysulfuryl) 2-ethyl imidazole (2.2).  Prepared according to the 
general procedure.  White solid (5.1 g, 84%). Mp 56-57 °C; 1H NMR (300 MHz, CDCl3) 
δ 7.29 (d, 1H, J = 1.8 Hz, Himi), 6.95 (d, 1H, J = 1.5 Hz, Himi), 4.61 (s, 2H, CH2), 2.99 (q, 
2H, J = 7.5 Hz, CH2-imi), 1.36 (t, 3H, J = 7.5 Hz, CH3-imi); 13C NMR (75 MHz, CDCl3) δ 
151.2, 128.1, 120.0, 91.7, 80.0, 21.7, 11.3; HRMS (EI+): Calculate for C7H9Cl3N2O3S 










1-(2,2,2-Trichloroethoxysulfuryl) 2-isopropyl imidazole (2.3).  Prepared according to 
the general procedure. White solid (4.4 g, 68%). Mp 67-69 °C; 1H NMR (300 MHz, 
CDCl3) δ 7.27 (d, 1H, J = 1.5 Hz, Himi), 6.98 (s, 1H, Himi), 4.64 (s, 2H, CH2), 3.51 (sept, 
1H, J = 6.8 Hz, CHimi), 1.36 (d, 6H, J = 6.8 Hz, 2xCH3-imi); 13C NMR (75 MHz, CDCl3) δ 
155.4, 128.1, 119.6, 91.7, 80.0, 27.5, 21.9; HRMS (EI+): Calculate for C8H11Cl3N2O3S 
(M)+ 319.9556, found 319.9555. 
 
General procedure for the preparation of sulfuryl imidazolium triflate salts (Table 
2.2, compounds 2.4-2.6).  To a solution of the appropriate TCE-sulfurylimidazole  (15 
mmol, 1.0 equiv) in dry Et2O (70 mL) at 0 oC was added methyltriflate (1.8 mL, 15 
mmol, 1.0 equiv) dropwise.  The reaction was stirred for 3 h at 0 oC during which time a 
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white precipitate formed. The mixture was filtered.  The filter cake was washed with cold 
ether and the filtrate was cooled to – 20 oC and filtered.  This second precipitate was 
washed with cold ether and then combined with the first precipitate which afforded 






ClCl OTf  
2,2,2-Trichloroethoxysulfuryl-(2-methyl)-N-methylimidazolium triflate (2.4). 
Prepared according to the general procedure. A fluffy white solid (6.8 g) in 99 % yield. 
We have prepared compound 2.4 in batches up to 75 g in excellent yield.  We typically 
store compound 2.4 at 4 or –20 oC and have never detected any decomposition even after 
6 months.  We have also stored reagent 2.4 on the benchtop at room temperature for a 
month and not detected any decomposition.  1H NMR (300 MHz, CD3OD) δ 8.09 (d, 1H, 
J = 2.1 Hz, Himi), 7.74 (d, 1H, J = 1.8 Hz, Himi), 5.35 (s, 2H, CH2), 3.92 (s, 3H, CH3-imi), 
2.91 (s, 3H, CH3-imi); 13C NMR (75 MHz, CD3OD) δ 148.6, 123.52, 120.8, 120.4 (q, JCF 
= 316.5 Hz, CF3), 91.6, 82.0, 35.3, 10.5; 19F NMR (282 MHz, CD3OD) δ -79.8; HRMS 
















1-(2,2,2-trichloroethoxysulfuryl) 2-ethyl 3-methylimidazolium triflate  (2.5).  
Prepared according to the general procedure. White solid (6.9 g, 98%). 1H NMR (300 
MHz, CD3OD) δ 8.10 (s, 1H, Himi), 7.75 (s, 1H, Himi), 5.37 (s, 2H, CH2), 3.96 (s, 3H, 
CH3-imi), 3.35 (q, 2H, J = 7.5 Hz, CH2-imi), 1.39 (t, 3H, J = 7.5, Hz, CH3-imi); 13C NMR (75 
MHz, CD3OD) δ 151.7, 123.8, 121.0, 120.3 (q, JCF = 317.25 Hz, CF3), 91.6, 82.1, 35.3, 
18.4, 9.2; 19F NMR (282 MHz, CD3OD) δ -79.8; HRMS (+ESI): Calculate for 











1-(2,2,2-trichloroethoxysulfuryl) 2- isopropyl 3-methylimidazolium triflate  (2.6).  
Prepared according to the general procedure. White powder (6.2 g, 85%). 1H NMR (300 
MHz, CD3OD) δ 8.04 (s, 1H, Himi), 7.69 (s, 1H, Himi), 5.39 (s, 2H, CH2), 4.09-4.00 
(m,4H, CHimi & CH3-imi), 1.56 (d, 6H, J = 7.2 Hz, 2xCH3-imi); 13C NMR (75 MHz, 
CD3OD) δ 152.9, 124.7, 121.4, 120.3 (q, JCF = 315 Hz, CF3), 91.6, 82.4, 37.1, 26.7, 17.0; 
19F NMR (282 MHz, CD3OD) δ -79.7; HRMS (+ESI): Calculate for C9H14Cl3N2O3S+ 
(M-OTf)+ 334.9791, found 334.9786. 
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General procedure for the synthesis of substituted imidazolium tetraflouroborate 
salts 2.7 and 2.8.   
A solution of compounds 2.1 or 2.2 (3.4 mmol, 1.00 equiv) in THF (12 mL) was added 
dropwise to an ice cooled suspension of trimethyloxonium tetrafluoroborate (0.5 g, 3.4 
mmol, , 1.00 equiv) in 6 mL of THF. The reaction mixture was then allowed to come to 
room temperature and stirred O/N. The solvent then removed under vacuum and the 
resulting residue was triturated with a mixture of CH2Cl2:Et2O (1:4) and resulting 











1-(2,2,2-trichloroethoxysulfuryl) 2,3-dimethylimidazolium tetrafluoroborate  (2.7).  
Prepared according to the general procedure. White powder (1.1 g, 85%). 1H NMR (300 
MHz, CD3OD) δ 8.07 (d, 1H, J = 2.2 Hz, Himi), 7.73 (d, 1H, J = 2.2 Hz, Himi), 5.33 (s, 
2H, CH2), 3.91 (s, 3H, CH3-imi) , 2.90 (s, 3H, CH3-imi); 13C NMR (75 MHz, CD3OD) δ 
148.6, 123.6, 120.6, 91.7, 81.9, 35.3, 10.4; 19F NMR (282 MHz, CD3OD) δ -154.4; 










 1-(2,2,2-trichloroethoxysulfuryl) 2-ethyl 3-methylimidazolium tetrafluoroborate  
(2.8).  White powder (1.1 g, 79%). 1H NMR (300 MHz, CD3OD) δ 8.19 (d, 1H, J = 1.9 
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Hz, Himi), 7.93 (d, 1H, J = 2.0 Hz, Himi), 5.51 (s, 2H, CH2), 3.88 (s, 3H, CH3-imi), 3.22 (q, 
2H, J = 7.5 Hz, CH2-imi), 1.25 (t, 3H, J = 7.5, Hz, CH3-imi); 13C NMR (75 MHz, CD3OD) 
δ 151.8, 124.5, 121.7, 92.2, 82.1, 36.2, 18.8, 10.9; 19F NMR (282 MHz, CD3OD) δ -












1-(2,2,2-trichloroethoxysulfuryl) 3-ethyl 2-methylimidazolium tetrafluoroborate 
(2.10). A solution of compound 2.34 (0.5 g, 1.7 mmol, 1.00 equiv) in CH2Cl2 (6 mL) was 
added dropwise to a suspension of triethyloxonium tetrafluoroborate (0.32 g, 1.7 mmol, 
1.00 equiv) in CH2Cl2 (3 mL).  The reaction mixture was then heated at reflux for 1 hour, 
cooled to room temperature then solvent was removed under vacuum.  The resulting 
residue was triturated with 5 mL of CH2Cl2:Et2O (5:1) and the resulting precipitate was 
filtered, and dried to yield tetrafuoroborate salt 2.10 as a white powder (0.56 g, 81%). 1H 
NMR (300 MHz, CD3OD) δ 8.25 (s, 1H, Himi), 8.03 (s, 1H, Himi), 5.54 (s, 2H, CH2), 4.27 
(q, 2H, J = 7.2 Hz, CH2-imi), 2.88 (s, 3H, CH3-imi), 1.42 (t, 3H, J = 7.2, Hz, CH3-imi); 13C 
NMR (75 MHz, CD3OD) δ 148.4, 122.5, 121.8, 92.4, 81.9, 44.8, 14.4, 11.9; 19F NMR 
(282 MHz, CD3OD) δ -154.0; HRMS (+ESI): Calculate for  (M-BF4)+ C8H12Cl3N2O3S+ 












General procedure for O-sulfation using reagent 1.98, 2.37-2.41 and 2.43 (Table 2.5, 
compound 2.14). To carbohydrate 2.13 (0.25 g, 0.54 mmol) in solvent (2.2 mL, 0.25 M) 
at 0 oC was added 1,2-dialkylimidazole (1.35 mmol) followed by the SIS (1.83, 2.4-2.8 or 
2.10, 1.08 mmol). The reaction was stirred at 0 oC, allowed to warm to room temperature 
by allowing the ice bath to melt, and then stirred for 18 h at room temperature. The 
reaction was diluted with CH2Cl2, (in case of using CH2Cl2 as a solvent) or the solvent 
was removed under vacuum (in case of using THF or DMF as a solvent) then the residue 
was dissolved in CH2Cl2, washed with brine, and dried over MgSO4 and condensed to 
brown crude oil. Flash chromatography (1:5 EtOAc/hexanes) yielded 2.14 as a white 
amorphous solid.  See Table 2.5 for yields. 1H NMR (300 MHz, CDCl3) δ 2.06 (s, 3H, 
CH3), 2.11 (s, 3H, CH3), 3.81 (m, 6H, OCH3, H5, H6, H6`), 4.58 (dd, 2H, J = 13.7, 12.2 
Hz, CH2Ph), 4.69 (AB system, 2H, J = 11.1 Hz , CH2CCl3), 4.98 (m, 2H, H1, H4), 5.21 
(t, 1H, J = 9.2, 8.1 Hz, H3), 5.42 (t, 1H, J = 9.3 Hz, H2), 6.77 (d, 2H, J = 8.9 Hz,  ArH), 
6.93(d, 2H, J = 8.9 Hz, ArH), 7.31(m, 5H, ArH); 13C NMR (75 MHz, CDCl3) δ 20.6, 
20.7, 55.6, 67.8, 71.4, 72.1, 73.1, 73.7, 79.3, 80.2, 92.5, 100.1, 114.6, 118.7, 127.8, 
127.81, 128.4, 137.5, 150.8, 155.8, 169.3, 169.35; [α]D25 =-40.7 (c 1.0, CHCl3); HRMS 









Chapter 3  Multiple and Regioselective Introduction of Protected 
Sulfates into Carbohydrates  Using Sulfuryl Imidazolium Salts 
________________________________________________________________________ 
3.1 Introduction 
 In chapters one and two we demonstrated that trichloroethyl-protected sulfates 
could be introduced into monosaccharides in good yield using sulfuryl imidazolium salts.  
In this chapter we present our studies on the direct regioselective incorporation of 
trichloroethyl-protected sulphate groups into monosaccharides using 
trichloroethoxysulfuryl-(2-methyl)-N-methylimidazolium triflate. We also present the 
synthesis of multiply sulfated monosaccharides using the TCE-protected sulfate strategy. 
 Regioselectivity is a major issue in carbohydrate chemistry as sugars contain 
several hydroxyl groups and it is often desirable to specifically functionalize or protect 
one or only selected ones during their synthesis.  The hydroxyl groups in each 
carbohydrate differ in their reactivity depending on whether the hydroxyl groups are 
anomeric, primary, secondary, axial or equatorial. These differences in reactivity can 
sometimes be significant enough to achieve the desired product in one step without 
additional manipulations.  Selective functionalization or protection of hydroxyl groups in 
carbohydrates can significantly reduce the number of steps in a synthesis.   
 Regioselective incorporation of sulfate groups into the sugars is usually achieved 
either by treating the sugar derivatives directly with sulfur trioxide-amines complex or 
more commonly, by reacting preformed stannanediyl acetals or stannyl ethers of 
carbohydrates with sulfur trioxide-amines complex. There are only a few examples in the 
literature in which protected sulfates were used for the regioselective incorporation of the 
sulfate groups into the monosaccharides. In the following section we present some 
 55
examples from the literature for the regioselective incorporation of the sulfate group into 
the carbohydrates. 
3.1.1 Direct Regioselective Incorporation of Sulfate Groups into Carbohydrates  
 In 1961, Guiseley and Ruoff 42 reported the direct regioselective sulfation of 
glucose. They prepared glucose-6-sulfate 3.2 in 54% yield by treating anhydrous glucose 
in dry DMF with SO3-pyridine complex (1 equiv.) dropwise as a solution in DMF over 













 SO3-Pyr.complex, 1 eq.
 DMF, 2.5 h, rt
3.1 3.2
54%  
Scheme 3.1.  Selective incorporation of a sulfate group into D-glucose. 
 
These workers also reported the selective sulfation of methyl 4,6-O-benzylidene-α-D-
glucopyranoside 3.3 at the 2-OH under the same conditions except the SO3-pyridine 











O SO3-Pyr.complex, 1 eq.
 DMF, 24 h, rt
3.3 3.4
67%  
Scheme 3.2.  Regioselective sulfation of methyl-α-glucopyranoside 3.3.  
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 Since this initial report a number of groups have described the direct 
regioselective incorporation of sulfate groups into carbohydrates.  Some examples are 
given below. 
Although the secondary axial hydroxyl groups of carbohydrates usually undergo 
acylation less rapidly than the equatorial isomers, the 4-OH of the methyl 2-acetamido-2-
deoxy-α-D-galactopyranoside 3.5 was selectively sulfated by Hirano with sulfur trioxide-
pyridine complex in pyridine at room temperature in the presence of the free 3-OH in 68 


















Scheme 3.3. Regioselective sulfation of galactose amine derivative 3.5. 
 
 Several impressive examples of selective sulfations have been reported by 
Jacquinet and coworkers.  In 1998, Jacquinet and coworkers45 attempted to synthesise the 
disaccharide repeating units of chondroitin 6-sulfate using tin-mediated (see section 3.1.2 
for a discussion on the use of tin–mediatedd selective sulfations) regioselective sulfation 
of the diol 3.7, but low yields were obtained due to the difficulties they faced in removing 
the tin salts from the reaction mixture. By treating diol 3.7 with 3 equiv. sulphur trioxide-
trimethyl amine complex in DMF at 50 oC for 4 hours, they were able to separate the 6-
O-sulfo disaccharide 3.8 in an outstanding 90% yield. Traces of the 4,6-disulfated 


































   1)  SO3.NMe3complex, 3 eq.




1) H2O2, 30%, 
     THF-water; 7:3,
     LiOH (1M), -5 oC,2h
      rt, 15 h                 
2) NaOH (4M), rt, 6 h
82%
3.9






Scheme 3.4.  Regioselective sulfation of disaccharide 3.5. 
  
 Belot and Jacquinet46 applied the same procedure used in the synthesis of 
disaccharide 3.8 to the synthesis the chondroitin 6-sulfate trisaccharide 3.12. The primary 
6-OH was selectively sulfated over the axial 4-OH of the galactose amine moiety in 72% 































DMF, 50 oC, 4h
72%  
 
Scheme 3.5. Regioselective sulfation of trisaccharide 3.11. 
 
 
 In 2000, Belot and Jaquinet47 reported the total synthesis of chondroitin 
pentasaccharide derivatives O-sulfated at the C-4 or C-6 of the amino sugar moieties and 
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having a methyl β-D-glucopyranosiduronic acid at the reducing end, which represent 
structural elements of chondroitin 4- and 6- sulfate proteoglycans. The tetraol 3.13 was 
selectively sulfated with 6.6 equiv. sulfur trioxide-trimethyl amine complex in DMF at 50 

































































1) H2O2, 30%,THF-water; 7:3,
    LiOH (1M), -5 oC,2h, rt, 16 h                 
2) NaOH (4M), MeOH, rt, 8 h
3.13
3.14
SO3.NMe3, 6.6 eq, 




Scheme 3.6. Regioselective sulfation of pentasaccharide 3.11. 
 
 Bovin et al.48 described the synthesis of some mono-, di- and tri-O-sulfated N-
acetyl lactosamines using sulfur trioxide-pyrinde complex in pyridine. The selective 
sulfation reactions were carried out at -10 to -20 oC, while the multiple sulfations were 




































































a) pyr.SO3, 3 eq
pyridine,-10 to -20 oC, 3 h
3.17






a) pyr.SO3, 3 eq
pyridine,-10 to -20 oC, 2 h
3.20
b) H2, 10% Pd/C
73%a) pyr.SO3, 3 eq
pyridine, 22 oC, 2 h







Scheme 3.7.  Multiple and regioselective sulfation of disaccharides 3.16 and 3.19. 
 
 
 SiaLex with a sulfate group at 6-OH of the galactose moiety has the highest-
affinity ligand for siglec-8,49 ( siglec-8 is a sialic acid-binding immunoglobulin-like lectin 
that is expressed specifically by eosinophils) while SiaLex derivative with a sulfate group 
at the 6-OH of GlcNAc is known to be a specific receptor for the avian influenza 
viruses.50 In 2009, Bovin and coworkers 51 used sulfur trioxide-pyridine complex in 

















































-10 to -20 oC, 5 h
3.23; R1= SO3Na, R2=H           51%















































-10 to -20 oC, 1.5 h
3.26; R1= SO3Na,  R2= H         32%
3.27; R1=R2= SO3Na,               23%
3.28; R1= H,    R2=SO3Na,        3%  
 





3.1.2 Tin Mediated Selective Sulfation of Carbohydrates 
 Organotin derivatives are widely used as intermediates in the regioselective 
substitution of the hydroxyl groups of sugars.52 The reactions of electrophiles with 
organotin intermediates proceed much faster than with the parent diols and the reactions 
can be carried out under milder conditions. These reactions are commonly used in 
carbohydrate chemistry, as they give monosubstituted products with high 
regioselectivetiy.52 The most common organotin (IV) carbohydrate derivatives are 
dialkylstannylene acetals which normally are formed by the reaction of dibutyltin oxide 
with the free diols (Scheme 3.9), and tributyltin ethers which can be formed by the 



























Scheme 3.9. Formation and reaction of dialkylstannylene acetals with electrophiles 
 
Although the two reagents give similar products, the dialkyltin reagents are 
usually preferred because of their lower toxicity.53 The organotin derivatives of 
carbohydrates are normally prepared by heating a mixture of the bis(tributyltin) oxide or 
dibutyltin oxide and the sugar in toluene or benzene, with azeotropic removal of the 
water formed, or in methanol.54 There are numerous examples in the literature describing 
tin-mediated regioselective sulfation of carbohydrates.  A select few examples of this 




 In 1994, Lubineau and Lemoine55 reported that the stannylene derived from free 
or 6-protected β-D-galactopyranosides, gave the 3-O-sulfate in high yields upon 
treatment with sulfur trioxide-trimethyl amine complex in a one pot reaction, with 
excellent regioselectivity.  When 3.31 or 3.32 was treated with Bu2SnO in refluxing 
toluene, and the formed stannylene acetal was treated in situ with SO3-NMe3 complex in 
DMF at room temperature followed by acetylation with acetic anhydride-pyridine, the 3-
O-sulfate derivatives 3.33 and 3.34 were obtained in 92% and 81% yield respectively 
(Scheme 3.10).   In contrast, treatment of triol 3.31 with SO3-NMe3 complex in pyridine 






































1. a) Bu2SnO ,1.1 eq, toluene
         reflux, 16 h
    b) SO3.NMe3complex, 1.2 eq.
         DMF, 5 h, rt
3.31 3.35 3.36
3.31, R = TBDMS
3.32, R = H
3.33; R= TBDMS    92%
3.34; R= Ac             81%
 
 
Scheme 3.10.  Tin-mediated regioselective sulfation of galactoside 3.31 and 3.32.   
 
 Lubineau applied this to the synthesis of a trisaccharide derived from Lewisa, 
which is a sulfated oligosaccharide that has a high ligand affinity for E- and L-
selectins.55,56 By applying the tin-mediated regioselective sulfation methodology, 
Lubineau and Lemoine55 were able to synthesis the 3`-O-sulfated Lewisa trisaccharide 

















































1. a) Bu2SnO ,1.1 eq, toluene
         reflux, 16 h
    b) SO3.NMe3-complex, 1.2 eq.
         DMF, 5 h, rt
3.38; R= TBDMS     94%
3.39; R= H               69%







Scheme 3.11. Synthesis of Lewisa trisaccharide 3.40 via tin-mediated regioselective 
sulfation. 
 
 Flitsch et al.57 reported the selective sulfation of thiophenylactoside 3.41 by 
treating it with dibutyltin oxide, followed by SO3.NMe3 complex in dioxane to give the 
3`-sulfated lactoside 3.42 in 76% yield and 10% of the 3`,6`-disulfated lactoside as a side 
product. By stirring lactoside 3.41 with SO3. NMe3 complex in dioxane without dibutyltin 
oxide, no product was observed due to the poor solubility of 3.41. This confirms that the 






















OH   a) Bu2SnO ,1 eq, MeOH
         reflux, 16 h
b) SO3.NMe3complex, 2 eq.
         dioxane, 30 h, rt3.41 3.42
76%  
Scheme 3.12.  Tin-mediated regioselective sulfation of lactoside 3.41 
 
 The 3`-sulfo-N-acetyllactosaminide 3.44 is useful in detecting high levels of 
serum α−1,3-L-fucosyltransferase in ovarian cancer patients,58 as it is a selective 
substrate for this enzyme. Flitsch et al.57  prepared the 3`-sulfo-N-acetyllactosaminide 
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3.44 in 83% yield from compound 3.43  using the same methodology without detecting 






















OH   a) Bu2SnO ,1 eq, MeOH
         reflux, 16 h
b) SO3.NMe3complex, 2 eq.
         dioxane, 30 h, rt3.43 3.44
83%  
Scheme 3.13.  Tin-mediated regioselective sulfation of lactosaminide 3.44. 
 
When Flitsch et al.58 tried to apply the same regioselective sulfation procedure on 
maltosides (which contain no cis diols), they got mixtures of mono- and di-6- and 6`-
sulfate esters. By protecting both primary hydroxyl groups as in compounds 3.45 and 
3.46, selective sulfation of the 2`-hydroxyl group was the major isolated product (Scheme 




















O   a) Bu2SnO ,1 eq, 
        MeOH, reflux, 16 h
b) SO3.NMe3complex,





tBu,           54%
3.48; R= CH2OTBDMS  56%  
 
Scheme 3.14.  Tin-mediated regioselective sulfation of maltosides 3.45 and 3.46. 
 
  
In 1994, Andrea Vasella and coworkers59 reported the regioselective sulfation of 
dibutylstannanediyl acetals of partially protected hexoses. Treatment of methyl 4,6-O-
benzylidene-α-D-glucopyranoside 3.49 with sulfur trioxide-triethyl amine complex in 
DMF at 25 oC for 48 hour, gave a mixture of mono- and disulfated derivatives. On the 
other hand treating glucopyranoside 3.49 with 1 equivalent of dibutyltin oxide in 
refluxing toluene, followed by sulfur trioxide-triethyl amine complex in DMF at room 





























 b) Et3N.SO3.complex, 
     1.2 eq., DMF, rt, 1 h3.49 3.50
84%
a) Bu2SnO, 1eq,   
    toluene, reflux, 16 h
  Et3N.SO3.complex, 1.5 eq,  












Scheme 3.15.  Tin-mediated regioselective sulfation of glucopyranoside 3.49  
 
  
Vasella et al.59 applied the same conditions to methyl 4,6-O-isopropylidene-β-D-
galactcopyranoside 3.53 and methyl 4,6-O-isopropylidene-α-D-mannopyranoside 3.57. 
They isolated the 3-O-sulfated galactopyranoside 3.54 and 2-O-sulfated 
mannopyranoside 3.58 in 89% and 70% yields respectively (Schemes 3.16 and 3.17). 
Good regioselectivity was achieved, when Vasella et.al.59 applied the tin mediated 
regioselective sulfation procedure on the lactoside 3.61, where the 3`-O-sulfated lactoside 
3.62 was isolated as the only monosulfated product in 83% yield. In the absence of 
dibutyltin oxide, the reaction is slower and the 3`-O-sulfated lactoside 3.62 was isolated 
































 b) Et3N.SO3.complex, 
     1.2 eq., DMF, 0 oC,4 h
3.54
89%
a) Bu2SnO, 1eq,   
    toluene, reflux, 16 h
  Et3N.SO3.complex, 1.5 eq,  



























































 b) Et3N.SO3.complex, 
     1.2 eq., DMF, rt, 2 h3.57 3.59
10%
a) Bu2SnO, 1eq,   
    toluene, reflux, 16 h
  Et3N.SO3.complex, 1.25 eq, 











































 b) Et3N.SO3.complex, 
    1.2 eq., DMF, 25 oC,2 h
a) Bu2SnO, 1eq,   
    toluene, reflux, 16 h
3.61 3.62
89%
  Et3N.SO3.complex, 1.5 eq,  

















Scheme 3.18.  Direct and tin-mediated regioselective sulfation of lactoside 3.61. 
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 In 1995, Kiessling et al.60 used the tin mediated regioselective sulfation in the 
synthesis of three sulfated derivatives of Lewis a to test their binding affinity towards 
selectin (E, L and P-selectin). In the synthesis of compound 3.65, sulfur trioxide-pyridine 
complex was added dropwise to a solution of 3.64 in DMF over 20 minutes at -60 oC 
(Scheme 3.19). Sulfation of compound 3.66 using (Bu3Sn)2O followed by SO3.pyr. 
complex in benzene at room temperature give the 6`-sulfated trisaccharide 3.67. The 
3`,6`-disulfate 3.68 was obtained when the sulfation reaction was carried out in pyridine 








































































1. a) Bu2SnO ,1 eq, PhH
         reflux, 2h
    b) SO3.pyr.complex, 1 eq.
         DMF, 12 h, -60oC
2. H2, Pd(OH)2/ C, 
    (MeOH/H2O, 2:1), 12 h
3.65
57% (over the three steps)
3.66
1. a) (Bu3Sn)2O ,1 eq, PhH
         reflux, 2 h
    b) SO3.pyr.complex, 2 eq.
       PhH, 20 min, rt
2. H2, Pd(OH)2/ C,       
   (MeOH, 10 h, rt
3.67
59% (over the three steps)1. a) (Bu3Sn)2O ,1 eq, PhH, reflux, 2 h
    b) SO3.pyr.complex, 3 eq., pyridine, 20 min, rt
2. H2, Pd(OH)2/ C, (MeOH/H2O; 2:1), 3 days, rt
3.68





Scheme 3.19.  Tin-mediated regioselective sulfation of Lewis a derivatives 
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 Sinay and coworkers61 used the stannylene procedure to synthesize some mono-, 
di- and trisulfated Lewis x trisaccharide derivatives (Scheme 3.20). Treatment of the 
stannylene acetal of 3.69 with 2 equivalents of SO3.NMe3 complex in THF for 40 hours 
at room temperature give the 3`-sulfated trisaccharide 3.70 in 79% yield in addition to 
13% of the 3`,6`-disulfated derivative 3.71. Different patterns of sulfation were obtained 
on subsequent sulfation of 3.74. Compound 3.74 was treated with 1 equivalent of 
Bu2SnO in refluxing methanol for 2 hours. After removing the solvent, the residue was 
treated with 2 equivalents of SO3.NMe3 complex in THF at room temperature for 40 
hours. Then the solvent was evaporated and the residue was treated again with 2 
equivalents of SO3.NMe3 complex in DMF at room temperature for 60 hours to give a 
mixture of sulfated products 3.75 (26%), 3.76 (11%), 3.77 (52%) and 3.78 (7%) (Scheme 
3.20). Subjecting the sulfated product mixture (3.75-3.78) to 6 equivalents of sulfur 
trioxide-pyridine complex in DMF for 5 days at room temperature, afford the trisulfated 








































































1. a) Bu2SnO ,1 eq, MeOH
         reflux, 2 h
3.70; R= H            79%
3.71; R=SO3Na    13%
H2, 10% Pd/C
MeOH, 15 h, rt
3.69
b) SO3.NMe3complex, 2 eq.




1. a) Bu2SnO ,1 eq, MeOH
         reflux, 2 h
b) SO3.NMe3complex, 4-10 eq.
         THF, 40 h, rt
3.75;   R1=R2=R4=H, R3= SO3Na,  26%
3.76;   R1=R3=SO3Na, R2=R4= H,  11%
3.77;   R1=R2=H, R3=R4= SO3Na,  52%











































MeOH, 16-20 h, rt
3.76; R1=R3=SO3Na, R2=R4= H
3.78; R1=R3=R4= SO3Na, R2=H
3.79;    R= H          97%
3.80;  R= SO3Na,  90%  
 
Scheme 3.20.  Tin-mediated regioselective sulfation of Lewis x derivatives 3.69 and 
3.74. 
 
 Sulfatide, which is a mixture of 3-sulfated β-D-galactopyranosylceramides with 
different fatty acids attached to the ceramide moiety, is an antigen presented by CD1a 
protein.  In 2002, Panza and coworkers62 reported the tin-mediated regioselective 
sulfation synthesis of four different 3-O-sulfated galactosylceramides. The synthesized 


























1. a) Bu2SnO ,1 eq, 
        MeOH, reflux, 2h
b) SO3NMe3complex, 
    2 eq.,THF, rt, 2-20 h3.81a-d 3.82a-d
70-75%
a;  R= C15H31        b;  R= C17H35
c;  R= C21H43        d;  R=  
 
Scheme 3.21.  Tin-mediated regioselective sulfation of sulfatide derivatives 3.81a-d. 
 
 The stannylene procedure was used by Narvor et.al.63 for the regioselective 
sulfation of the 3-OH of the terminal galactose during the chemoenzymatic synthesis of 







































b) SO3.NMe3, 1.1 eq, 
     DMF, rt, 28 h
54%
a) Bu2SnO ,1.1 eq, DMF-PhH
      reflux, 16 h
 
 
Scheme 3.22.  Tin-mediated regioselective sulfation of Lewis a tetrasaccharide 3.83. 
 
  
 α-L-Iduronate glycosides containing a sulfate group at the 2-position are used for 
assaying iduronate-2-sulfatase, whose deficiency results in Hunter syndrome 
(mucopolysaccharidosis-II).  Gelb and coworkers64 applied the stannylene procedure in 



































1. a) Bu2SnO ,1.5 eq, MeOH
         reflux, 40 min
3.85
b) SO3.NMe3complex, 1.5eq.






61% overall yield from 3.85  
 
Scheme 3.23.  Tin-mediated regioselective sulfation of α-L-iduronate glycoside 3.85. 
 
 
3.1.3 Selective Sulfation of Carbohydrates with Protected Sulfate Diesters  
 As discussed in Chapter 1, the phenyl group has been used by Perlin and 
coworkers as a sulfate protecting group for the synthesis of sulfated carbohydrates.29  It is 
introduced using phenyl chlorosulfate (PhOSO2Cl).29  In 1989, Abdel-Malik and Perlin30 
reported the reaction of methyl 2,3-di-O-benzyl-α-D-glucopyranoside 3.88 with phenyl 
chlorosulfate (1.4 eq.) in dioxane in the presence of NaH at -30 oC, which gave a mixture 
of the 6-sulfate product 3.89 and the 4,6-bis-phenylsulfate product 3.90 in 77% and 8% 
yield respectively. When the reaction was carried out at room temperature, the 4,6-cyclic 
sulfate 3.91 was formed in 60% yield as the major product, in addition to 11% of the 4,6-




































 b) -30 oC, PhOSO2Cl, 1.4 eq, 












a) NaH, 3 eq, 10 min,
    rt, oxolane
 b) PhOSO2Cl,1.4 eq, 
      rt, 24 h
a) NaH, 3 eq, 10 min,
    rt, oxolane
 
 
Scheme 3.24. Introduction of a phenyl-protected sulfate into α-glucopyranoside 3.88. 
 
 
Similar results were obtained in the reaction of methyl 2,3-di-O-benzyl-β-D-



































 b) -30 oC, PhOSO2Cl,
     1.4 eq,  60 h
a) NaH, 3 eq, 10 min,






 b) PhOSO2Cl,1.4 eq, 
      rt, 60 h
a) NaH, 3 eq, 10 min,










The galactopyranosyl 4,6-diol 3.96 showed good regioselectivity upon treatment 
with phenyl chlorosulfate at -30 oC, where the 6-(phenylsulfate) was formed in 80% yield 
in addition to 15% of the disulfated derivatives. At room temperature, the 4,6-cyclic 
sulfate derivative was formed in 52% yield as well as 30% of the 4,6-di-(phenylsulfate) 


































 b) -30 oC, PhOSO2Cl,
     2 eq,  60 h
a) NaH, 3 eq, 10 min,




 b) PhOSO2Cl,1.4 eq, 
      rt, 60 h
a) NaH, 3 eq, 10 min,





Scheme 3.26. Regioselective introduction of a phenyl-protected sulfate into α-
glactopyranoside 3.96. 
 
 Perlin et al.31 reported that phenylchlorosulfonate is more selective for the 2-OH 
than the 3-OH of methyl 4,6-O-benzylidene-α-D-glucopyranoside 3.100, when the 
reactions were carried out over the temperature range of -25 to 0 oC.  The 2-O-Phenyl 
sulfate was isolated in 68% yield at -25 oC. At higher temperatures (25 to 50 oC), the 2,3-
cyclic sulfate was formed in yields ranging from 25 to 77%.   2,3-Diphenylsulfate 3.102 
was formed as one of the products especially at high temperatures (10% yield at 25 or 50 
oC), in addition to methyl 2,3-anhydro-4,6-O-benzylidene-α-D-allopyranoside which was 
isolated in 4 to 15% yield and its yield was increased with increasing reaction time  



































 b) PhOSO2Cl, 2 eq, 
      0.5-2 h
a) NaH, 2-3 eq, 
    rt, oxolane


















Scheme 3.27. Temperature-dependent introduction of phenyl-protected sulfates into 
3.100. 
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 Perlin also treated different methyl 4,6-O-benzylidene-D-pyranosyl derivatives (β-
D-glucopyranosyl (3.105), α- and β-D-galactopyranosyl (3.108 and 3.111) and α-D-
mannopyranosyl (3.115)) with phenyl chlorosulfate and sodium hydride at different 
temperatures. The main products were mono-, di-sulfated and anhydro monosaccharides, 
depending on the temperature of the reaction (Scheme 3.28).  Decent selectivity was 







































 b) PhOSO2Cl, 2 eq, 
      -10 oC, 320 h
a) NaH, 3 eq, 





 b) PhOSO2Cl, 2 eq, 
      -25 oC, 24 h
a) NaH, 3 eq, 





a) NaH, 3 eq, 
    rt, oxolane
 b) PhOSO2Cl, 2 eq, 
























































 b) PhOSO2Cl, 2 eq, 
      -10 oC, 2 h
a) NaH, 3 eq, 





 b) PhOSO2Cl, 2 eq, 
      -20 oC, 96 h
a) NaH, 3 eq, 











Scheme 3.28. Incorporation phenyl-protected sulfates into benzylidene 2,3-diols 3.105, 
3.108, 3.11 and 3.115.   
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 As discussed in Chapter 1, the trifluoroethyl group has been used as a sulfate 
protecting group for the synthesis of sulfated carbohydrates.28 It is introduced by reacting 
suflated carbohydrates with trifluorodiazoethane. In 2003, Linhardt and coworkers33 
reported the use of the TFE group in the synthesis of fully differentiated hexosamine 
monosaccharides. When diols 3.118 and 3.120 were submitted to selective 6-O-sulfation 
with sulfur trioxide-trimethyl amine complex followed by treatment with 
trifluorodiazoethane the TFE-protected sulfocarbohydrates 3.119 and 3.121 were 















a) SO3.NMe3complex, 1.5 eq., DMF, 50 
oC

























Scheme 3.29.  Selective incorporation of a TFE-protected sulfate into carbohydrates 
3.118 and 3.120. 
 
3.2 Objectives 
 It is clear from the above discussion that regioselective sulfation, either directly or 
using the tin-mediated approach, is a means by which sulfated carbohydrates can be 
prepared more efficiently.  As discussed in chapters 1 and 2, the Taylor group has 
developed new sulfating agents based on sulfuryl imidazolium salts, such as reagent 2.4, 
and shown that they can be used to prepare sulfated carbohydrates.  However, 
regioselective sulfation of carbohydrates using these reagents had yet to be investigated. 
The primary objective of the work described in this chapter is to examine whether 
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trichloroethyl-protected sulfate esters could be regioselectively introduced directly into 
monosaccharides using reagent 2.4.  An additional objective is to examine whether 
reagent 2.4 can also be used to prepare multiply sulfated monosaccharides. 
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3.3 Results and Discussion 
3.3.1 Regioselective Incorporation of TCE-Protected Sulfate into Monosaccharides  
 Our studies began with selective sulfations of 4,6-O-benzylidene acetals of 
galactosides and glucosides (2-OH versus 3-OH sulfations, Table 3.1).  Adding 1.2 equiv 
of imiazolium salt 2.4 and 1.5 equiv of 1,2-dimethylimidazole (1,2-DiMeIm) in a single 
batch to a solution of α-glucoside 3.122 in methylene chloride gave the 2-sulfated 
product 3.127 as the major product in a 58% yield (entry 1). The 2,3-disulfated product 
was isolated in a 5% yield.  Increasing the amount of reagent 2.4 and 1,2-DiMeIm to 2.0 
and 2.5 equiv, respectively, and adding them as separate solutions in CH2Cl2 dropwise 
slowly to a solution of 3.122  in methylene chloride increased the yield of 3.127 to 68% 
(entry 1) and disulfated product to 15%. None of the 3-sulfated product was produced in 
either case. Alternatively, we found that a similar yield of 3.127 and disulfated product 
could be obtained by adding reagent 2.4 in a single portion to a solution of 3.122 and then 
introducing a solution of 1,2-DiMeIm slowly over several hours. Subjecting β-glycosides 
3.123  and 3.124 and β-thioglycosides 3.125 and 3.126 to the same conditions (adding a 
solution of 2.5 equiv of 1,2-DiMeIm in methylene chloride slowly to a solution of the 
carbohydrate and 2.0 equiv of reagent 2.4) led to the selective formation of the 3-O-
monosulfated products 3.129-3.131 in good to excellent yields (entries 3-5) with the 
exception being glucoside 3.123, which gave the 3-O-monosulfated product 3.128 in a 
60% yield and the corresponding disuflated product in an 18% yield (entry 2). In most 
cases the monosuflated products were readily separated from disulfated products by silica 
gel chromatography except when glucoside 3.123 was the substrate.  Attempts to increase 
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the yield of compound 3.128 by increasing the amount of sulfating agent and 1,2-
DiMeIm did not result in a significant increase in isolated yield mainly because multiple  
 














































































































a The imidazolium salt 2.4 and the (1,2-DiMeIm) were added in a single portion to a solution of the 
carbohydrate in CH2Cl2, and the reactions were stirred 24-40 h. b1,2-DiMeIm was added dropwise 
as a solution in CH2Cl2 over 4-6 h to a solution of carbohydrate and imidazolium salt 2.4 in 
CH2Cl2 then the reactions were stirred 24-30 h. 
 
columns were required to separate the mono- and disulfated products. Both the O- and S-
galactosides 3.124 and 3.126 exhibited better selectivity and higher yields than their 
glucoside counterparts 3.123 and 3.125, and S-glycosides 3.125 and 3.126 gave better 
selectivity than O-glycosides 3.123 and 3.124. Indeed, both galactosides 3.124 and 3.126 
as well as both S-glycosides 3.125 and 3.126 gave excellent yields of the 3-O-
monosulfated products even when subjected to a large excess of 2.4 and (1,2-DiMeIm) 
(entries 3-5), and only trace amounts of disulfated products or what appeared to be 2-O-
monosulfated products were formed. The regioselectivity of acylation or sulfonation 
reactions involving 2,3-diols of 4,6-O-benzylidene glucopyranoside and 
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galactopyranoside substrates under basic conditions is dependent upon the reagents, the 
precise reaction conditions, and the stereochemistry and nature of the anomeric 
substituent.65 However, in general, 4,6-O-benzylidene acetals of α-glucosides usually 
exhibit greater regioselectivity for the 2-OH,65-68 while 4,6-O-benzylidene acetals of β-
galactosides and, to a lesser extent, β-glucosides usually exhibit greater selectivity for the 
3-OH.69-71 4,6-O-Benzylidene galactopyranosides usually exhibit greater regioselectivity 
than 4,6-O-benzylidene glucopyranosides.65,66 The regioselectivity exhibited by 
carbohydrates 3.122-3.126 with reagent 2.4 is consistent with these general reactivity 
patterns. 4,6-O Benzylidene-β-glucopyranosides usually exhibit a lower degree of 
regioselectivity than 4,6-O-benzylidene-α-glucopyranosides65,66 and this is also 
consistent with our results (entries 1 and 2). However, β-thioglucoside 3.125 exhibits 
very good regioselectivity for the 3-OH and was considerably greater than that exhibited 
by β-glucoside 3.123 (entries 2 and 4). Some regioselective 3-OH acylations of 4,6-O-
benzylidene-β-thioglucopyranosides have been reported suggesting that this may be a 
general phenomenon with β-thioglucopyranosides.72 In 2000, Box and Evans-Lora, 
conducted molecular modeling study on the 4,6-O-benzylidene-2,3-diols of different 
hexopyranoses.73 The authors used the molecular mechanics module, QVBMM 
(quantized valence bond molecular mechanics) to simulate and evaluate the stereo-
electronic effects of these diols. In the case of 2,3-diols α-glucopyranoside, the 
calculation showed that, the highest energy lone pair is on O-2 and has 1.69 kcal of 
repulsive electronic energy and this reflects the nucleophilic reactivity of the OH-2. On 
the other hand, in case of the β-glucopyranoside, the highest energy lone pair on O-2 and 
O-3 are 0.85 and 0.63 kcal respectively, and this explains the low regioselectivity of the 
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β-anomer of glucopyranoside.73 In case of the β-galactopyranoside, the highest energy 
lone pair is on O-3, which explains the high regioselectivity found in the β-
galactopyranoside series.      
 Next we examined selective sulfation of carbohydrates 3.132-3.135 that contain 
free 3- and 4-OH groups (Table 3.2).  Adding solutions of reagent 2.4 (1.5 equiv) and 
(1,2-DiMeIm, 2.0 equiv) slowly to a solution of carbohydrate 3.132 resulted in the 
formation of mainly disulfated product. However, when a solution of 1,2-DiMeIm, (2.0 
equiv) was added slowly to a solution of the carbohydrate, during which reagent 2.4 was 
added in three equal portions, followed by stirring for an additional 24 h, selective 3-O-
sulfation of 3.132 was achieved in a 70% yield (entry 1, compound 3.136), and only a 
trace amount of disulfated product and what appeared to be the 4-O-monosulfated 
product were detected. Sulfation of galactosyl derivative 3.133 under the same conditions 
gave the 3-O-sulfated compound 3.137 in a 77% yield (entry 2). Selective 3-O-sulfation 
of S-glucoside and S-galactoside derivatives 3.134 and 3.135 could also be achieved in 
70% and 78% yields, respectively, using a similar approach (entries 3 and 4), though 
some disuflated product was obtained (approximately 10%). An 83% yield of the 3-O-
monosulfated S-galactoside compound 3.139 was obtained by adding reagent 2.4 (6 
equiv) in two portions over 8 h to a solution of 3.135 and 1,2-DiMeIm (7 equiv) followed 
by stirring for 20 h. Under these conditions the disulfated product was also formed in 


































































































a1,2-DiMeIm was added dropwise as a solution in CH2Cl2 over 6 h to a solution of the 
carbohydrate, while the imidazolium salt was added in 3 portions over 6 h. 
 
Direct regioselective protection of 3,4-diols of galactosides is common with reaction 
preferably occurring on the less sterically hindered 3-OH, and the reaction of galactoside 
3.128 with reagent 2.4 follows this pattern.74 We also presented several examples of this 
pertaining to sulfation with SO3 complexes in section 3.1.1. Several reports have 
appeared describing the regioselective protection (acylation, benzylation) of the 3-OH of 
3,4-diols of 2-deoxy-2-amino glucosides in which the amino group is protected with an 
acyl or phthalimido group.75,76 A report has appeared describing the selective benzylation 
of the 3-OH of a 3,4-diol of a 2-deoxy-2-azido glucosides.77 However, we have been 
unable to find reports describing the protection of the 3-OH in 3,4-diols of glucosides 
with good regioselectivity.78 Our results indicate that, at least for the sulfation reactions 
studied here, good selectivity can be achieved; however, further investigation will be 
required to determine if this level (or better) of selectivity can be achieved with other 
protecting groups and other 3,4-diols of glucosides.  
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 The ability of reagent 2.4 to selectively sulfate the primary 6-OH over a 
secondary hydroxyl group by the slow addition of a solution of (1,2-DiMeIm)  to a 
solution of the carbohydrate and reagent 2.4 was examined (Table 3.3). In most cases 
good selectivity was achieved (65-79% yield of 6-O-sulfated product) when one or two 
secondary OH’s were present, with compound 3.140 (entry 1) being an exception that 
gave the 6-O-sulfated product in a 60% yield. Disulfated products were isolated in 15% 
and 10% yields with carbohydrates 3.140 and 3.141, respectively. No products resulting 
from monosulfation of just the secondary hydroxyls were detected. For compounds 
bearing TCE sulfates at the 2- and 3-positions (entries 3 and 4), the 6-OH could be 
selectively sulfated over the 4-OH in good yield by direct addition of an excess of the 
base and sulfating agent in a single portion. Only trace amounts of what appeared to be 
tetrasulfated products were formed.  Attempts to selectively monosulfate methyl α- and 
β-D-glucopyranoside using 1.2 equiv of reagent 2.4 and 1.5 equiv of 1,2-DiMeIm led to a 















































































































































































































a The imidazolium salt and the 1,2-DiMeIm were added in a single portion to a solution of the 
carbohydrate in CH2Cl2, and the reactions were stirred 24-40 h. b 1,2-DiMeIm was added dropwise 
as a solution in CH2Cl2 over 4-6 h to a solution of carbohydrate and imidazolium salt in CH2Cl2 
then the reactions were stirred 24-30 h. c1,2-DiMeIm was added dropwise as a solution in CH2Cl2 
over 6 h to a solution of the carbohydrate, while the imidazolium salt was added in 3 portions over 
6 h. 
 
 Finally, we examined glucosamine 3.147 (Table 3.3, entry 8) as a candidate for 
selective sulfation. We had previously found that reagent 1.83 does not readily sulfate 
amines yet is capable of sulfating alcohols in good yield, whereas reagent 2.4 readily 
sulfates both amines and alcohols.40 Subjecting 3.147 to 1.5 equiv of 2.4 and 2.0 equiv of 
DMI gave the N-monosulfated product 3.155 in a 75% yield with a 10% yield of the 
disulfated product. Surprisingly, subjecting 3.147 to 1.5 equiv of reagent 1.83 and 2.0 
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equiv of 1-methylimidazole (1-MeIm) also gave the N-monosulfated product 3.155 in a 
70% yield and only a trace amount of the disulfated product. Increasing the amount of 
reagent 1.83 and (1-MeIm) did not result in an increase in the yield of the N-sulfated 
product 3.155, however, there was an increase in the amounts of unidentified byproducts 
formed as well as disulfated product as determined by TLC. 
3.3.2. Multiple Introduction of TCE-Protected Sulfate into Monosaccharides  
 Polysaccharides often contain residues that bear more than one sulfate groups. 
Since disulfated products were sometimes formed during the selective sulfation studies 
mentioned above, we anticipated that disulfation of certain carbohydrates could be 
achieved in good yield using reagent 2.4. As mentioned above, we were unable to obtain 
the disulfated products derived from 2,3-diols 3.124-3.126 and 3,4-diols 3.133 and 3.135. 
However, 2,3-diols 3.122 and 3.123 and 3,4-diol 3.132 were disulfated in good yield 
using 3.5-5.0 equiv of reagent 2.4 and 4.0-6.0 equiv of 1,2-DiMeIm (entries 1-3). 
Surprisingly, 3,4-diol 3.134 gave disuflated product 3.161 in only a 45% yield. A 
considerable number of unidentified byproducts were formed as determined by TLC.  
Compounds 3.140, 3.141, 3.144, 3.146, and 3.147 were also all disulfated in good yield 
(entries 5-9). Attempts to disulfate compound 3.156 led to a complex mixture of 
products. It is possible that upon sulfation of the 6-OH group an intramolecular reaction 
occurs between the sulfur at the anomeric position and C-6 resulting in loss of the sulfate 














































































































































































































































































 Although we could readily prepare trisulfated compounds 3.150 and 3.151 (Table 
3.3, entries 3 and 4) from their disulfated precursors 3.142 and 3.143, attempts to 
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trisulfate triols 3.145, 3.157, and 3.158 as well as to tetrasulfate methyl α- and β-D-
glucopyranoside under a variety of conditions were unsuccessful in that complex 
mixtures of sulfated products were obtained. However, trisulfated carbohydrates 3.172-
3.175 could be prepared from disulflated carbohydrates 3.168-3.171 as outlined in 
Scheme 3.30. Subjecting disulfated compounds 3.159 and 3.160 to either 
triethylsilane/TFA or BH3-THF/Cu(OTf)2 gave compounds 3.168- 3.171, which were 
then sulfated using 3 equiv of SIS 2.4 and 3.5 equiv of 1,2-DiMeIm to give compounds 
3.172-3.175 in yields ranging from 71% to 84%. Deprotection of the sulfate protecting 
groups in multisulfated carbohydrates can be readily achieved using Zn/ ammonium 
































3.159, R1 = H, R2= OMe








3.168, R1 = H, R2= OMe, 85%
3.169, R1 = OMP, R2= H, 83%
3.170, R1 = H, R2= OMe,76%




3.172, R1 = H, R2= OMe, 84%
3.173, R1 = OMP, R2= H, 80%
3.174, R1 = H, R2= OMe,77%





Scheme 3.30. Synthesis of trisulfated carbohydrates 
 
3.3.3 Deprotection of TCE-Protected Sulfate in Multisulfated Carbohydrates 
 Deprotection of the sulfate protecting groups in multisulfated carbohydrates was 
readily achieved under mild conditions using Zn/ammonium formate as illustrated for 































14 equiv Zn, MeOH, 6 h
12 equiv. HCOO-NH4
+
14 equiv Zn, MeOH, 6 h
3.163
3.159, R1 = H, R2= OMe
3.160, R1 = OMP, R2= H
3.176, R1 = H, R2= OMe (92%)
3.177, R1 = OMP, R2= H (89%)
 
Scheme 3.31. Deprotection of the sulfate group in multisulfated carbohydrates 
3.4 Summary and Future Work 
 In conclusion, we have shown that the direct regioselective incorporation of TCE-
protected sulfates into monosaccharides can be achieved using reagent 2.4. The sulfated 
compounds were easily purified by flash chromatography. We have also shown that 
reagent 2.4 can also be used for the direct disulfation of monosaccharides and that 
trisulfated monosaccharides can also be prepared from the disulfated compounds. The 
TCE-protected sulphate was deprotected from multisulfated monosaccharides under mild 
conditions in excellent yields. We expect that the procedures outlined here will prove to 
be very useful for the multiple and regioselective sulfation of complex sulfated 
carbohydrates. An important future direction of this work will be to examine tin-mediated 
sulfations with reagent 2.4.   
3.5 Experimental 
3.5.1 General Information 
For general information regarding solvents, NMR, MS, refer to section 2.4.1 in Chapter 
2. All commercially available reagents in chapter 3 were purchased from either Sigma 
Aldrich or Alfa Aesar. 
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3.5.2 Experimental Syntheses and Characterization 
 
General procedure for the Selective Sulfation of Compounds 3.122-3.126, 3.140-
3.143, 3.145, and 3.146. Method A: Reagent 2.4 (1.5 g, 3.32 mmol) and 1,2-DiMeIm 
(0.38 g, 3.98 mmol) were added in one portion to a solution of the appropriate 
monosaccharide (0.66 mmol, 1 equiv.) in CH2Cl2 (4 mL) at 0 oC (ice bath). The reaction 
was stirred, gradually allowed to warm to room temperature by allowing the ice bath to 
melt, and then stirred at room temperature until the reaction is complete (TLC, 1:2, 
EtOAc/hexanes),  24-40 h. The reaction was diluted with CH2Cl2, washed with brine, 
dried (MgSO4), and concentrated to crude brown oil. The crude residue was purified by 
flash chromatography (1:4, EtOAc/hexanes).  
Method B: To the appropriate monosaccharide (0.66 mmol, 1 equiv.) in dry CH2Cl2 (2.0 
mL) at 0 oC (ice bath) was added reagent 2.4 (0.61 g, 1.33 mmol) followed by the 
addition of a solution of 1,2-DiMeIm (0.16 g, 1.67 mmol) in CH2Cl2 (1 mL) over 6 h 
using a syringe pump. The ice bath was removed, and the reaction was allowed to warm 
to room temperature and left stirring until the reaction was complete by TLC 
(approximately 24 h). The reaction was diluted with CH2Cl2, washed with brine, dried 
(MgSO4), and concentrated to a crude brown oil. The crude residue was purified by flash 







 Methyl-2-O-trichloroethylsulfo-4:6-O-benzylidine-α-D-glucopyranoside (3.127):  
58% (method A) and 68% (method B) as a clear colorless syrup, (Table 3.1). 1H NMR 
(300 MHz, CDCl3) δ 2.41 (b, 1H, OH), 3.52-3.51 (m, 4H, OCH3 , H4), 3.84-3.90 (m, 2H, 
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H6`, H5), 4.22-4.31 (m, 2H, H3, H6), 4.50 (dd, 1H, J = 9.4, 3.7 Hz, H2), 4.71, 4.82 (AB 
system, 2H, J= 10.7 Hz, CH2CCl3), 5.12 (d, 1H, J = 3.6 Hz, H1), 5.53 (s, 1H, CHPh), 
7.41 (m, 3H, ArH), 7.43 (m, 2H, ArH); 13C NMR (75 MHz, CDCl3) δ 55.7, 61.7, 68.3, 
68.6, 79.7, 81.1, 81.9, 92.5, 97.2, 102.0, 126.1, 128.3, 129.4, 136.5; [α]D26 = -44.2 (c 1.0, 









(3.128):  55% (method A) and 60% (method B) as a white solid, (Table 3.1). Mp 130-132 
oC; 1H NMR (300 MHz, CDCl3) δ 2.81, (d, 1H, J = 3.1 Hz, OH ), 3.50 (ddd, 1H, J = 9.6, 
9.5, 4.8 Hz, H5), 3.71-3.82 (m, 5H, OCH3 , H6`, H4), 3.92 (dt, 1H, J = 8.9, 7.5, 3.1 Hz, 
H2), 4.31 (dd, 1H, J = 10.5, 9.9, 4.9 Hz, H6), 4.52-4.60 (AB system, 2H, J = 10.9 Hz, 
CH2CCl3), 4.81, 4.90 (m, 2H, H3, H1), 5.54 (s, 1H, CHPh), 6.82 (d, 2H, J = 8.9 Hz, 
ArH), 7.01(d, 2H, J = 9.0 Hz, ArH), 7.31 (m, 3H, ArH), 7.42 (m, 2H, ArH); 13C NMR 
(75 MHz, DMSO-d6) δ 55.8, 65.1, 68.0, 71.9, 77.5, 79.6, 86.8, 93.4, 100.9, 101.8, 115.0, 
118.5, 126.6, 128.6, 129.4, 137.4, 151.2, 155.3; [α]D26 = 76.4 (c 1.0, CHCl3); HRMS 








(3.129): 92% (method A) and 85% (method B) as a white solid, (Table 3.1). Mp 138-140 
oC; 1H NMR (300 MHz, CDCl3) δ 2.62, (d, 1H, J = 2.5 Hz, OH ), 3.51 (br, 1H, H5), 3.72 
(s, 3H, OCH3), 4.02 (dd, 1H, J = 12.5, 5.4 Hz, H6`), 4.21-4.32 (m, 2H, H2, H6), 4.63 (d, 
1H, J = 3.3 Hz, H4), 4.71-4.74 (m, 2H, H3, 1H of CH2CCl3), 4.81 (d, 1H, J = 7.7 Hz, H1 
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), 4.91 (d, 1H, J= 10.6 Hz, the second H of CH2CCl3), 5.52 (s, 1H, CHPh) 6.80 (d, 2H, J 
= 8.9 Hz, ArH ), 7.02 (d, 2H, J = 8.9 Hz, ArH), 7.31 (m, 3H, ArH), 7.52 (m, 2H, ArH); 
13C NMR (75 MHz, DMSO-d6) δ 55.8, 65.5, 67.5, 68.5, 73.4, 79.7, 85.2, 93.2, 100.0, 
101.1, 114.9, 118.3, 126.5, 128.6, 129.4, 138.3, 151.3, 155.1; [α]D26 = 81.6 (c 1.0, 









(3.130): 71% (method A) and 78% (method B) as a white solid, (Table 3.1). Mp 96-98 
oC; 1H NMR (300 MHz, CDCl3) δ 2.31 (s, 3H, CH3), 2.82 (s, 1H, OH ), 3.53-3.91 (m, 
4H, H5, H4, H2, H6`), 4.42 (dd, 1H, J = 10.3, 4.5 Hz, H6), 4.42-4.50 (m, 2H, CH2CCl3, 
H1), 4.82 (t, 1H, J = 8.9 Hz, H3), 5.42 (s, 1H, CHPh) 7.11-7.42 (m, 9H, ArH ); 13C NMR 
(125 MHz, CDCl3) δ 21.2, 68.4, 70.4, 70.7, 77.8, 79.7, 86.0, 88.7, 92.5, 102.2, 126.0, 
126.2, 128.6, 129.6, 130.1, 134.3, 136.1, 139.5; [α]D26 = 54.3 (c 1.0, CHCl3); HRMS 








(3.131): 94% (method A) and 88% (method B) as a white solid, (Table 3.1). Mp 92-94 
oC; 1H NMR (500 MHz, CDCl3) δ 2.36, (s, 3H, CH3), 2.68 (b, 1H, OH), 3.54 (s, 1H, H5), 
3.39 (t, 1H, J=9.4, H2), 4.02, 4.35 (AB, 2H, J=12.4 Hz, H6`, H6), 4.48 (d, 1H, J=9.3 Hz, 
H1), 4.56 (d, 1H, J=2.1 Hz, H4), 4.66, 4.86 (AB, 2H, J =10.8 Hz, CH2CCl3), 4.72 (dd, 
1H, J = 9.4, 2.7 Hz, H3), 5.52 (s, 1H, CHPh), 7.10 (d, 2H, J = 7.6 Hz, ArH), 7.41 (s, 5H, 
ArH), 7.57 (d, 2H, J = 7.6 Hz, ArH); 13C NMR(75 MHz, CDCl3) δ 21.8, 65.1, 68.8, 69.3, 
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73.3, 78.3, 79.7, 84.8, 86.8, 92.6, 100.9, 125.2, 126.2, 126.4, 128.1, 129.6, 129.9, 133.1, 
134.4, 134.6, 137.1, 139.0; [α]D26 = 49.4 (c 1.0, CHCl3); HRMS (ESI) m/z = 584.9987, 









(3.148): 60% (method B) as a colorless syrup (Table 3.3). 1H NMR (300 MHz, CDCl3) δ 
3.71 (s, 4H, OCH3 , OH), 4.02 (m, 2H, H5, H4), 4.62-4.81 (m, 4H, H6 , H6`, CH2CCl3 ), 
5.23 (d, 1H, J = 7.8 Hz, H1), 5.52 (t, 1H, J = 9.3 Hz , H3), 5.74 (t, 1H, J = 9.2 Hz , H2), 
6.73 (d, 2H, J = 8.8 Hz, ArH), 6.92 (d, 2H, J = 8.8 Hz, ArH), 7.47 (m, 6H, ArH), 7.91 (d, 
2H, J = 7.3 Hz, ArH) ; 13C NMR (75 MHz, CDCl3) δ 55.5, 68.9, 71.0, 71.8, 73.5, 76.7, 
79.6, 92.3, 100.3, 114.6, 118.5, 128.4, 128.5, 128.9, 129.6, 129.9, 133.4, 133.8, 150.7, 
155.8, 165., 167.6; [α]D26 = -36.2 (c 1.0, CHCl3); HRMS (ESI) m/z = 705.0370 (M+H)+ 








(3.149): 68% (method B) as a white solid, (Table 3.3). Mp 71-73 oC, 1H NMR (300 MHz, 
CDCl3) δ 2.7 (d, 1H, J = 4.5 Hz, OH at C2), 3.7 (s, 3H, OCH3), 4.21 (t, 1H, J = 6.6 Hz, 
H5), 4.43 (s, 1H, H4), 4.60-4.71 (m, 4H, H6, H6`, CH2CCl3), 5.12 (d, 1H, J = 7.9 Hz, 
H1), 5.31- 5.40 (dd, 1H, J = 10.2, 2.9 Hz , H3), 5.73 (t, 1H, J = 10.1, 8.2 Hz , H2), 6.72 
(d, 2H, J = 8.9 Hz, ArH), 6.91 (d, 2H, J = 8.9 Hz, ArH), 7.30 (m, 4H, ArH), 7.42 (t, 2H, 
ArH) 7.90 (m, 4H, ArH); 13C NMR (75 MHz, CDCl3) δ 55.6, 66.9, 69.0, 71.7, 71.9, 73.8, 
76.7, 79.7, 92.3, 100.7, 114.6, 118.6, 128.4, 128.6, 129.1, 129.7, 129.9, 133.4, 133.7, 
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150.8, 155.8, 165.4, 165.7; [α]D26 = 69.2 (c 1.0, CHCl3); HRMS (ESI) m/z = 705.0394 







Methyl-2,3,6-tri-O-trichloroethylsulfo-α-D-glucopyranoside (3.150): 75% (method A) 
and 60% (method B) as a colorless syrup (Table 3.3). 1H NMR (300 MHz, CDCl3) δ 3.21 
(s, 1H, OH), 3.42 (s, 3H, OCH3), 3.90 (br, 2H, H5, H4), 4.53- 4.81 (m, 9H, H6, H6`, H2, 
3CH2CCl3 ), 5.04 (br, 1H, H3), 5.21 (d, 1H, J = 2.8 Hz, H1); 13C NMR (75 MHz, CDCl3) 
δ 56.1, 68., 68.6, 71.4, 78.0, 79.7, 80.2, 80.4, 83.4, 92.2, 92.2, 92.3, 96.3; [α]D26 = 69 (c 








p-Methoxyphenyl-2,3,6-tri-O-trichloroethylsulfo-β-D-glucopyranoside (3.151): 72% 
(method A) as a colorless syrup (Table 3.3). 1H NMR (300 MHz, CDCl3) δ 3.09 (br, 1H, 
OH), 3.75 (s, 4H, OCH3, H5), 4.04 (t, 1H, J= 8.5 Hz, H4), 4.06-4.91 (m, 10H, H6, H6`, 
H2, 3CH2CCl3, H3 ), 5.12 (d, J = 8.5 Hz, 1H), 5.21 (d, 1H, J = 6.7 Hz, H1), 6.81 (d, 2H, 
J = 8.9 Hz, ArH), 6.98 (d, 2H, = 8.9 Hz, ArH); 13C NMR (75 MHz, CDCl3) δ 55.6, 68.2, 
70.7, 72.5, 79.8, 80.1, 80.5, 80.8, 85.5, 92.2, 92.2, 92.3, 98.6, 114.9, 118.7, 149.5, 156.4; 









Methyl-2-O-benzoyl-6-O-trichloroethylsulfo-α-D-glucopyranoside (3.153): 65% 
  (method B) as a colorless syrup (Table 3.3).  1H NMR (300 MHz, CDCl3) δ 3.31 (br, 
5H, OCH3 , 2OH), 3.62 (t, 1H, J = 9.4 Hz, H4), 3.80 (d, 1H, J = 9.6 Hz, H5), 4.01 (t, 1H, 
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J = 9.6 Hz, H3 ), 4.62 (b, 2H, H6, H6`), 4.71 (b, 2H, CH2CCl3), 4.92 (dd, 1H, J = 9.6, 2.3 
Hz , H2), 4.93 (d, 1H, J = 2.3 Hz , H1); 13C NMR (75 MHz, CDCl3) δ 55.6, 68.5, 69.9, 
71.8, 72.3, 73.4, 79.5, 92.4, 97.3, 128.4, 129.1, 129.8, 133.5, 166.4; [α]D26 = 84.1 (c 1.0, 









glucopyranoside (3.154): 79% (method B) as a colorless syrup (Table 3.3). 1H NMR 
(300 MHz, CDCl3) δ 3.12 (br, 1H, OH), 3.84 (t, 1H, J=9.3 Hz, H4), 4.05 (m, 2H, H5, H 
of allyl CH2), 4.22 (m, 2H, H of allyl CH2, H2), 4.46, 4.65 (AB system, 2H, J = 12.0 Hz, 
H6, H6`), 4.64 (s, 2H, CH2CCl3), 4.73 (s, 2H, Troc CH2), 4.97 (d, 1H, J= 3.5 Hz, H1), 
3.32 (m, 4H, oleifinic CH2 of allyl, H3, NH), 5.91 (m, 1H, olefinic H), 7.43 (t, 4H, J=7.6 
Hz, ArH), 7.56 (t, 1H, J= 7.5 Hz, ArH), 7.99 (d, 2H, J= 7.4 Hz, ArH); 13C NMR (75 
MHz, CDCl3) δ 53.3, 68.8, 69.0, 69.7, 72.1, 74.4, 75.2, 79.6, 92.5, 95.0, 96.4, 119.0, 
128.5, 128.6, 130.1, 132.7, 133.8, 154.2, 168.0; [α]D26 = 69.2 (c 1.0, CHCl3); HRMS 
(ESI) m/z = 707.9204, C21H24NCl6O11S (M+H)+ requires 707.9201. 
General procedure for the Selective Sulfation of Compounds 3.132-3.135, 3.143 and 
3.147. 
To the appropriate carbohydrate (0.23 mmol) in dry CH2Cl2 (2 mL) at 0 oC (ice bath) was 
added reagent 2.4 (0.053 g, 0.11 mmol), followed by the addition of a solution of 1,2-
DiMeIm (0.16 g, 1.67 mmol) in CH2Cl2 (2 mL) over 8 h using a syringe pump. During 
the addition of the 1,2-DiMeIm two portions of reagent 2.4 (0.053 g, 0.11 mmol for each 
portion) was added after 3 and 6 h and the ice batch was removed after the initial 1 h. The 
reaction was left stirring until the reaction was complete by TLC (approx 24 h). The 
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reaction was diluted with CH2Cl2, washed with brine, dried (MgSO4) and concentrated to 










Allyl-2,6-di-O-benzoyl-4-O-trichloroethylsulfo-α-D-glucopyranoside (3.136): 70% as 
a colorless syrup (Table, 3.2). 1H NMR (300 MHz, CDCl3) δ 3.63 (br, 1H, OH), 3.79 (t, 
1H, J=9.4 Hz, H4), 4.03 (m, 2H, H5, 1H of allyl CH2), 4.19 (AB, 1H, J=12.7 Hz, the 
second H of allyl CH2), 4.46, 4.92 (AB system, 2H, J= 12.4 Hz, H6, H6`), 4.72 (s, 2H, 
CH2CCl3), 5.07-5.14 (m, 2H, H2, 1H of olefinic CH2), 5.21-5.29 (m, 3H, 1H of olefinic 
CH2, H3, H1), 5.77 (m, 1H, olefinic H), 7.41-7.61 (m, 6H, ArH), 8.09 (m, 4H, ArH); 13C 
NMR (75 MHz, CDCl3) δ 63.01, 68.6, 69.0, 70.17, 70.91, 79.9, 84.73, 92.5, 95.23, 118.3, 
128.6, 128.7, 129.0, 129.9, 130.1, 132.8, 133.7, 133.71, 165.7, 167.7; [α]D26 =56.8 (c 1.0, 








Allyl-2,6-di-O-benzoyl-4-O-trichloroethylsulfo-α-D-galactopyranoside (3.137): 77% 
as colorless syrup (Table 3.2). 1H NMR (300 MHz, CDCl3) δ 2.91 (d, 1H, J= 4.0 Hz, 
OH), 3.99, 4.15 (dd of AB system, 2H, J = 13.1, 5.8 Hz, allyl CH2), 4.27 (t, 1H, J= 6.2 
HZ, H5), 4.42-4.73 (m, 5H, H6, CH2CCl3, H4, H6`), 5.01- 5.32 (m,4H, olefinic CH2, H1, 
H3), 5.56 (dd, 1H, J= 8.6, 3.3 Hz, H2), 5.79 (m, 1H, olefinic H), 7.44 (m, 4H, ArH), 7.58 
(m, 2H, ArH), 8.04 (m, 4H, ArH); 13C NMR (75 MHz, CDCl3) δ 62.5, 67.6, 67.6, 68.9, 
79.8, 81.6, 92.2, 95.5, 118.1, 127.5, 128.5, 128.7, 129.0, 129.2, 129.7, 129.9, 132.9, 
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133.5, 133.6, 165.6, 166.6; [α]D26 = 59.8 (c 1.0, CHCl3); HRMS (+ESI) m/z = 639.0261, 









70% as colorless syrup (Table 3.2). 1H NMR (300 MHz, CDCl3) δ 2.25 (s, 3H, CH3), 3.6-
3.81 (m, 3H, OH, H5, H4), 4.53-4.61 (m, 3H, CH2CCl3, H6), 4.76-4.84 (m, 2H, H6`, H1), 
4.97 (t, 1H, J = 9.5 Hz, H3 ), 5.19 (t, 1H, J = 9.5 Hz, H2 ), 6.95, 7.34 (AB system, 4H, J 
= 7.5 Hz, ArH), 7.41-7.60 (m, 6H, ArH), 8.01 (m, 4H, ArH); 13C NMR (75 MHz, CDCl3) 
δ 21.1, 62.9, 68.3, 69.5, 77.9, 79.9, 85.6, 88.0, 92.3, 126.8, 128.5, 129.06, 129.1, 129.6, 
130.01, 130.1, 133.66, 133.69, 134.3, 138.9, 165.1, 167.3; [α]D26 = 98.8 (c 1.0, CHCl3); 








galactopyranoside (3.139): 78 and 83% as colorless syrup (Table 3.2). 1H NMR (300 
MHz, CDCl3) δ 2.21 (s, 3H, CH3), 3.0 (br, 1H, OH), 3.62 (t, 1H, J = 8.9 Hz, H5), 3.74 
(m, 2H, H6, H6`), 4.51-4.62 (m, 6H, CH2Ph, H4,H1, H3,1H of CH2CCl3), 4.72 (d, 1H, J 
= 10.7 Hz, 1H of CH2CCl3 ), 5.11-5.23 (m, 3H, H2, CH2Ph), 7.01 (d, 2H, J = 7.8 Hz, 
ArH), 7.21-7.33 (m, 12H, ArH); 13C NMR (75 MHz, CDCl3) δ 21.1, 68.0, 69.4, 70.4, 
70.8, 73.9, 76.0, 79.9, 84.9, 86.4, 92.4, 127.5, 127.8, 128.1, 128.3, 128.6, 128.6, 128.7, 
129.7, 133.8, 134.7, 137.o, 138.8, 153.9; [α]D26 = 95.8 (c 1.0, CHCl3); HRMS (+ESI) m/z 











(3.152): 68% as colorless syrup (Table 3.3). 1H NMR (300 MHz, CDCl3) δ 2.42 (d, 1H, J 
= 3.8 Hz, OH), 3.31 (s, 3H, OCH3), 3.52 (t, 1H, J = 9.9 Hz, H4), 3.92 (m, 1H, H5) ), 4.31 
(dt, 1H, J = 9.4, 8.6, 3.7 Hz H3), 4.53 (m, 2H, H6, H6`), 4.61-4.70 (m, 3H, CH2CCl3, 1H 
of CH2Ph), 4.81-4.91 (m, 2H, H2, 1H of CH2Ph), 4.92 (d, 1H, J = 3.5 Hz, H1), 7.31-7.50 
(m, 8H, ArH), 8.01 (m, 2H, ArH); 13C NMR (75 MHz, CDCl3) δ 55.6, 67.9, 72.3, 72.3, 
73.7, 75.0, 76.9, 79.6, 92.5, 92.3, 97.0, 128.2, 128.2, 128.5, 1287, 129.3, 129.9, 133.5, 
137.5, 166.3; [α]D26 = 54.6 (c 1.0, CHCl3); HRMS (+ESI) m/z = 599.0295 (M+H)+ 









ranoside (3.155): 75% as colorless syrup (Table 3.3). 1H NMR (300 MHz, CDCl3) δ 1.71 
(t, 1H, J = 6.7 Hz, OH), 3.31 (s, 3H, OCH3), 3.62-3.83 (m, 6H, H5, H4, H3, H2, H6, 
H6`), 4.51-4.50 (AB, 2H, J = 10.8 Hz, CH2CCl3 ), 4.61, 4.83 (AB, 2H, J = 10.9 Hz, 
CH2Ph), 4.71-5.01 (m, 4H, CH2Ph, H1, NH); 13C NMR (75 MHz, CDCl3) δ 55.3, 58.2, 
61.4, 71.1, 75.0, 75.6, 77.8, 78.1, 79.2, 93.3, 97.9, 128.0, 128.0, 128.5, 128.6, 137.7; 
[α]D26 = 69.6 (c 1.0, CHCl3); HRMS (ESI) m/z = 601.0957 (M+NH4)+, C23H32Cl3NO8S 
requires 601.0945. 
 
General procedure for the preparation of multiply sulfated monosaccharides 3.159-
3.167 (Table 3.4). To the appropriate carbohydrate (0.85 mmol) in CH2Cl2 (3.4 mL) at 0 
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oC (ice bath) were added 1,2-DiMeIm (0.32 g, 3.4 mmol) and reagent 2.4 (1.16 g, 2.54 
mmol). The ice bath was removed, and the reaction was allowed to warm to room 
temperature and then stirred for 15 h. After 15 h, additional aliquots of 1,2-DiMeIm 
(0.163 g, 1.7 mmol) and reagent 2.4 (0.778 g, 1.69 mmol) were added at room 
temperature. Upon completion by TLC (approximately 30 h) the reaction was diluted 
with CH2Cl2, washed with brine, dried (MgSO4), and concentrated to crude brown oil. 










(3.159): 94% as a white solid (Table 3.4). Mp 128-130 oC. 1H NMR (300 MHz, CDCl3) δ 
3.51 (s, 3H, OCH3), 3.81-3.72 (m, 2H, H4, H6`), 3.79 (ddd, 1H, J=9.8, 9.7, 4.6 Hz, H5), 
4.35 (dd, 1H, J=10.4, 4.6 Hz, H6), 4.42, 4.51 (AB system, 2H, J = 11.1 Hz, CH2CCl3), 
5.68 (dd, 1H, J=9.3, 3.6 Hz, H2), 4.83, 4.91 (AB, 2H, J=11.0 Hz,CH2CCl3), 5.17 (t, 1H, 
J=9.6 Hz, H3), 5.25 (d, 1H, J=3.1 Hz, H1), 5.51 (s, 1H, CHPh), 7.35 (m, 3H, ArH), 7.46 
(m, 2H, ArH); 13C NMR (75 MHz, CDCl3) δ 56.1, 62.3, 68.6, 78.53, 78.8, 79.5, 80.1, 
80.4, 92.4, 92.4, 97.5, 102.8, 126.4, 128.7, 129.9, 135.8; [α]D26 = 44.0 (c 1.0, CHCl3); 












pyranoside (3.160). 85% as a white solid (Table 3.4). Mp 132-134 oC; 1H NMR (300 
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MHz, CDCl3) δ 3.61, (ddd, 1H, J = 9.4, 9.2, 4.8 Hz, H5), 3.70 (s, 3H, OCH3), 3.71-3.90 
(m, 2H, H4, H6`), 4.41-4.43 (m, 2H, H6, 1H of CH2CCl3), 4.42, 4.51 (AB, 2H, J = 11.1 
Hz, CH2CCl3), 4.81-4.82 (m, 2H, CH2CCl3), 4.91-5.02 (m, 2H, H2, H3), 5.11 (d, 1H, J = 
7.0 Hz, H1), 5.51 (s, 1H, CHPh), 6.8 (d, 2H, J = 9.0 Hz, ArH), 7.01 (d, 2H, J = 8.9 Hz, 
ArH),7.31 (m, 3H, ArH), 7.42 (m, 2H, ArH); 13C NMR (75 MHz, CDCl3) δ 55.6, 65.84, 
68.2, 77.6, 80.1, 80.5, 81.2, 92.4, 92.6, 100.0, 102.6, 144.7, 119.1, 126.4, 128.7, 129.9, 
135.6, 150.0, 156.3; [α]D26 = -48.6 (c 1.0, CHCl3); HRMS (+ESI) m/z = 794.8896, 











 (3.161). 80% as a colourless syrup (Table 3.4). 1H NMR (300 MHz, CDCl3) δ 3.99, 4.18 
(AB, dd, 2H, J = 12.9, 7.6 Hz, allylic CH2), 4.32 (d, 1H, J = 9.6 Hz, H5), 4.52-4.57 (dd , 
1H, J = 12.5, 3.9 Hz, H6`), 4.6-4.76 (AB, 2H, J = 11.1 Hz, CH2CCl3), 4.87 (m, 3H, H6, 
CH2CCl3), 5.06-5.12 (m, 2H, H4, H2), 5.19-5.25 (m, 3H, H1, olefinic CH2), 5.49 (t, 1H, J 
= 9.1 Hz, H3), 5.75-5.77 (ddd, 1H, J = 6 Hz, oleifinic H), 7.42-7.49 (m, 4H, ArH), 7.58 
(m, 2H, ArH), 8.06-8.13 (m, 4H, ArH);13C NMR (75 MHz, CDCl3) δ 61.7, 67.2, 69.4, 
70.8, 78.1, 80.4, 80.6, 81.4, 92.2, 92.3, 94.7, 118.8, 128.4, 128.5, 128.6, 129.4, 129.7, 
130.2, 132.3, 133.3, 133.9; [α]D25 = 56.8 (c 1.0, CHCl3); HRMS (+ESI) m/z = 848.8996, 












(3.162): 45% as a colourless syrup (Table 3.4). 1H NMR (500 MHz, CDCl3) δ 2.27 (s, 
3H, CH3), 4.02 (d, 1H, J= 8.1 Hz, H5), 4.53-4.57 (dd, 1H, J = 12.5, 4.3 Hz,H6), 4.11, 
4.80 (AB system, 3H, J= 11.2 Hz, CH2CCl3, H1 overlapped with one proton of the 
CH2CCl3 ), 4.91 (s, 2H, CH2CCl3), 5.01-5.05 (m, 2H, H4, H6`), 5.23 (t, 1H, J = 9.2 Hz, 
H3), 5.32 (t, 1H, J = 9.4 Hz, H2), 6.92, 7.31 (AB system, 4H, J= 7.6 Hz, ArH), 7.53 (m, 
4H, ArH), 7.65 (m, 2H, ArH), 8.01 (m, 4H, ArH); 13C NMR (125 MHz, CDCl3) δ 21.1, 
61.8, 69.7, 75.5, 77.6, 80.6, 80.7, 84.1, 85.5, 92.3, 125.8, 128.5, 128.6, 128.8, 129.4, 
129.7, 129.9, 130.2, 133.4, 133.9, 134.7, 139.3, 165.0, 165.7; [α]D26 = 67.8 (c 1.0, 











ranoside (3.163): 83% as a colourless syrup (Table 3.4). 1H NMR (300 MHz, CDCl3) δ 
3.70 (s, 3H,  OCH3), 4.11, (ddd, 1H, J = 6.9, 5.0, 2.2 Hz, H5 ), 4.51-4.62 (AB, 2H, J = 
11.0 Hz, CH2CCl3), 4.72 (m, 4H, H6, CH2CCl3, H6`), 5.11 (t, 1H, J = 9.3 Hz, H4,), 5.23 
(d, 1H, J = 7.6 Hz, H1), 5.61 (t, 1H, J =9.0, 8.0 Hz, H2), 5.65 (t, 1H, J = 9.3 Hz, H3), 
6.72 (d, 2H, J = 8.8 Hz, ArH), 6.91 (m, 2H, ArH), 7.32 (m, 4H, ArH), 7.53 (m, 2H, ArH), 
7.90 (m, 4H, ArH); 13C NMR (125 MHz, CDCl3) δ 55.6, 70.3, 71.1, 71.2, 71.6, 78.0, 
79.9, 80.4, 92.0, 92.3, 100.3, 114.7, 118.9, 128.2, 128.5, 128.6, 129.8, 130.1, 133.6, 
133.9, 150.4, 156.1, 164.8, 165.6; [α]D26 = 56.8 (c 1.0, CHCl3); HRMS (ESI) m/z = 











anoside (3.164). 80% as a colourless syrup (Table 3.4). 1H NMR (300 MHz, CDCl3) δ 
3.70 (s, 3H, OCH3), 4.12, (t, 1H, J = 6.3 Hz, H5 ), 4.61-4.72 (m, 5H, H6, H6`, CH2CCl3, 
1H of CH2CCl3 ), 4.82 (the second half of the AB system, 1H, J = 11.0 Hz, 1H of 
CH2CCl3), 5.21 (d, 1H, J = 8.0 Hz, H1,), 5.42-5.41 (m, 2H, H4, H3), 5.90 (t, 1H, J = 9.0, 
8.3 Hz, H2), 6.81 (d, 2H, J = 8.9 Hz, ArH), 6.92 (d, 2H, J = 8.9 Hz ArH), 7.31 (m, 4H, 
ArH), 7.51 (m, 2H, ArH), 7.92 (m, 4H, ArH); 13C NMR (125 MHz, CDCl3) δ 55.6, 68.3, 
70.2, 70.7, 71.1, 78.5, 79.9, 80.3, 92.1, 92.3, 100.8, 114.7, 118.8, 128.1, 128.5, 128.7, 
129.7, 129.8 130.0, 133.6, 134.0, 150.5, 156.1, 165.1, 165.7; [α]D26 =36.2 (c 1.0, CHCl3); 











(3.165): 77% as a colourless syrup (Table 3.4). 1H NMR (300 MHz, CDCl3) δ 3.31 (s, 
3H, OCH3), 3.80, (t, 1H, J = 9.5 Hz, H4 ), 3.93 (d, 1H, J = 10.0 Hz, H5), 4.41-4.62 (m, 
5H, H6, H6`, CH2CCl3, 1H of CH2Ph), 4.70 (s, 2H, CH2CCl3), 4.91-5.12 (m, 3H, 1H of 
CH2Ph, H1, H2), 5.43 (t, 1H, J = 9.3 Hz, H3), 7.31-7.42 (m, 7H, ArH), 7.50 (t, 1H, J = 
7.3 Hz, ArH), 8.12 (d, 2H, J = 7.4 Hz ArH); 13C NMR (125 MHz, CDCl3) δ 55.8, 68.0, 
70.9, 71.3, 74.8, 75.4, 79.6, 80.0, 85.1, 92.0, 92.3, 96.9, 128.1, 128.5, 128.6, 128.8, 130.2, 
130.3, 133.8, 136.2; [α]D26 = 34.6 (c 1.0, CHCl3); HRMS (+ESI) m/z = 808.9057, 












D-glucopyranoside (3.166). 84% as a colourless syrup (Table 3.4). 1H NMR (300 MHz, 
CDCl3) δ 4.09 (m, 1H, H of allyl CH2), 4.21-4.29 (m, 3H, H of allyl CH2, H5, H2), 4.41- 
4.47 (m, 2H, H6, 1H of CH2CCl3), 4.59-4.73 (m, 4H, 1H of CH2CCl3 , H6`, CH2CCl3), 
4.77 (s, 2H, Troc CH2), 4.92-5.0 (m, 2H, H4, H1), 5.28-5.37 (m, 3H, olefinic CH2 of 
allyl, NH), 5.69 (t, 1H, J = 9.6 Hz, H3), 5.91 (m, 1H, olefinic H), 7.41 (t, 4H, J=7.6 Hz, 
ArH), 7.56 (t, J= 7.5 Hz , 1H, ArH), 8.03 (d, 2H, J= 7.4 Hz, ArH); 13C NMR (75 MHz, 
CDCl3) δ 54.1, 67.1, 69.6, 70.2, 70.4, 74.4, 78.4, 79.8, 80.3, 92.0, 92.4, 94.9, 96.2, 119.7, 
128.3, 128.6, 130.2, 132.2, 134.0, 154.0, 166.2; [α]D26 = 89.2 (c 1.0, CHCl3); HRMS 










sulfamido-α-D-glucopyranoside (3.167): 88% as a colourless syrup (Table 3.4). 1H 
NMR (300 MHz, CDCl3) δ 3.40 (s, 3H, OCH3), 3.51-3.75 (m, 3H, H6, H4, H6`), 3.83-
3.87 (dd, 1H, J = 10, 2.4 Hz, H5), 4.39-4.48 (m, 2H, H3, H2), 4.65-4.64 (m, 3H, 
CH2CCl3, 1H CH2Ph), 4.69 (s, 2H, CH2CCl3), 4.85-4.91 (m, 3H, CH2Ph, 1H of the 
CH2Ph), 4.94 (d, 1H, J = 3.4 Hz, H1), 5.03 (br, 1H, NH), 7.24-7.38 (m, 10H, ArH); 13C 
NMR (125 MHz, CDCl3) δ 55.7, 58.1, 68.6, 72, 75.3, 75.8, 77.1, 78.2, 79.3, 79.6, 92.5, 
93.3, 97.9, 128.09, 128.12, 128.17, 128.3, 128.6, 137.0, 137.3; [α]D26 = 72.3 (c 1.0, 










Methyl-2,3-di-O-trichloroethylsulfo-α-D-glucopyranoside (3.141). A suspension of 
carbohydrate 3.159 (0.35 g, 0.5 mmol) in CH2Cl2:MeOH (1:2, 2.4 mL CH2Cl2, 4.8 mL 
MeOH) in a round bottom flask equipped with a reflux condenser was heated to 40 oC 
(oil bath) and stirred until all starting material had dissolved. p-TsOH (0.009 g, 0.05 
mmol) was added and the temperature was increased to 45 oC and the reaction was stirred 
until no starting material remained by TLC (24 h). The reaction was neutralized with 
NEt3 and concentrated to a yellow oil. Flash chromatography (1:3, EtOAc:hexanes) 
provided compound 3.141 as a white solid (0.26 g, 85%). Mp 48-50 oC; 1H NMR (300 
MHz, CDCl3) δ 1.90 (t, 1H, J = 5.9 Hz, OCH3 , OH), 3.21 (d, 1H, J = 4.5 Hz, OH), 3.41 
(s, 3H, OCH3), 3.72 (dd, 1H, J = 9.6, 5.5, 4.1 Hz, H5 ), 3.91-4.01 (m, 3H, H6, H6`, H4), 
4.62 (dd, 1H, J = 9.7, 3.2 Hz, H2), 4.72-4.81 (m, 4H, 2CH2CCl3), 5.01 (t, 1H, J = 9.4, 9.1 
Hz , H3), 5.12 (d, 1H, J =2.7 Hz , H1); 13C NMR (75 MHz, CDCl3) δ 55.7, 61.3, 68.9, 
70.6, 78.5, 80.2, 80.2, 84.0, 92.2, 92.4, 96.3; [α]D26 = 88.6 (c 1.0, CHCl3); HRMS (ESI) 










Compound 3.142 was prepared by the same procedure used for the preparation of 
compound 3.141. Flash chromatography (1:3, EtOAc:hexanes) provided 3.142 as a white 
solid. 80% yield. Mp 62-64 oC; 1H NMR (300 MHz, CDCl3) δ 2.11 (br, 1H, , OH), 3.52 
(b, 2H, OH, H5), 3.80 (s, 3H, OCH3), 3.91 (m, 2H, H6, H6`), 4.11 (m, 1H, J = 8.8, 8.4, 
4.1 Hz, H4), 4.82-4.91 (m, 6H, H3, H2, 2CH2CCl3), 5.11 (d, 1H, J = 7.0 Hz , H1), 6.81 
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(d, 2H, J = 8.9 Hz, ArH), 7.01 (d, 2H, J = 8.9 Hz, ArH); 13C NMR (75 MHz, CDCl3) δ 
55.5, 61.4, 68.9, 74.8, 80.3, 80.5, 80.5, 86.0, 92.3, 92.4, 98.7, 114.7, 118.5, 149.8, 156.1; 
[α]D26 = 64.3 (c 1.0, CHCl3); HRMS (ESI) m/z = 723.8809 (M+NH4)+ C17H24Cl6NO13S2 
requires 723.8820. 
General procedure for the selective opening of the benzylidene acetal in compounds 
3.159 and 3.160 using triethysilane/TFA (Scheme 3.30).79  
To the fully protected sugar (0.976 mmol) in CH2Cl2 (6 mL) was added dropwise 
triethysilane (0.779 mL, 4.88 mmol) followed by trifluoroacetic acid (0.37 mL, 4.88 
mmol). The reaction was stirred at room temperature for 9 h until there was no starting 
material remaining. The reaction was diluted with CH2Cl2, carefully quenched with 
triethylamine, and concentrated to crude syrup. The crude residue was purified with flash 









85% as a colourless syrup. 1H NMR (300 MHz, CDCl3) δ 3.21 (d, 1H, J=3.5 Hz, OH), 
3.40 (s, 3H,OCH3), 3.61 (ddd, 1H, J=10.9, 5.6, 5.2 Hz, H5), 3.81 (m, 2H, H6,H6`), 3.92 
(ddd, 1H, J=9.0, 8.9, 3.4 Hz, H4), 4.63 (m, 3H, H2,CH2Ph), 4.81 (m, 4H, 2CH2CCl3), 
5.01 (t, 1H, J=9.4 H3), 5.12 (d, 1H, J=3.0 Hz, H1), 7.32 (m, 5H, ArH); 13C NMR (75 
MHz, CDCl3) δ 55.8, 69.0, 69.1, 70.5, 73.9, 78.5, 80.2, 83.7, 92.3, 92.6, 96.3, 127.8, 
128.2, 128.6, 137.0; [α]D25 =96.2 (c 1.0, CHCl3); HRMS (+ESI) m/z=704.8768, 









(3.169): 83% as a colourless syrup. 1H NMR (300 MHz, CDCl3) δ 3.41 (br, 1H, OH), 
3.60 (dd, 1H, J = 10.9, 4.3 Hz, H5), 3.77 (m, 5H, OCH3, H6, H6`), 4.03 (br, 1H, H4), 
4.58 (dd, 2H, J = 11.3, 9.9 Hz, CH2Ph), 4.89 (m, 7H, 2CH2CCl3, H3, H2, H1), 6.81 (m, 
2H, ArH), 7.01 (m, 2H, ArH), 7.31 (m, 5H, ArH); 13C NMR (75 MHz, CDCl3) δ 55.6, 
69.2, 70.6, 73.2, 73.8, 80.3, 80.4, 80.6, 85.6, 92.5, 99.1, 114.7, 119.0, 127.9, 128.2, 128.6, 
137.0, 150.0, 156.2; [α]D26 = 38.6 (c 1.0, CHCl3); HRMS (ESI) m/z = 813.9177, 
C24H30Cl6 NO13S2 (M+NH4)+ requires 813.9289. 
 
General procedure for the selective opening of the benzylidene acetal in compounds 
3.159 and 3.160 using borane/tetrahydrofuran/copper(II) triflate (Scheme 3.30).80 To 
a solution of borane/tetrahydrofuran (1 M in THF, 1.41 mL, 1.41 mmol) was added the 
appropriate carbohydrate  (0.28 mmol) at room temperature under argon. The mixture 
was stirred for 10 min, and freshly dried copper (II) triflate (0.0051 g, 0.014 mmol) was 
added to the solution. After stirring for 24 h, the mixture was cooled to 0 oC (ice bath), 
and the reaction was quenched with triethylamine (0.1 mL, 0.7 mmol) and methanol (1 
mL, caution: hydrogen gas was evolved). The resulting mixture was concentrated at 
reduced pressure followed by co-evaporation with methanol. The crude residue was 








Methyl-2,3-di-O-trichloroethylsulfo-4-O-benzyl-β-D-glucopyrano-side (3.170): 76%  
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as a colorless syrup. 1H NMR (300 MHz, CDCl3) δ 1.72 (s, 1H, OH), 3.42 (s, 3H,OCH3), 
3.69-3.86 (m, 4H, H6, H60, H5, H4), 4.61-4.65 (m, 2H, 1H of CH2Ph, H2), 4.75-4.94 (m, 
5H, 1H of CH2Ph, 2CH2CCl3), 5.15-5.21 (m, 2H, H3, H1), 7.34 (m, 5H, ArH); 13C NMR 
(75 MHz, CDCl3) δ 55.56, 60.53, 70.78, 74.96, 75.21, 79.04, 80.24, 80.30, 83.38, 92.32, 
92.64, 96.21, 128.3, 128.4, 128.6, 136.6; [α]D26 = 68.6 (c 1.0, CHCl3); HRMS (ESI)m/z 









(3.171): 73% as colourless syrup. 1H NMR (300 MHz, CDCl3) δ 1.82 (br, 1H, OH), 3.41 
(d, 1H, J = 9.1 Hz, H5), 3.7-3.9 (m, 5H, H6`, OCH3, H6), 4.6 (d, 1H, J = 10.4 Hz, 1H of 
CH2Ph), 4.72-5.01 (m, 7H, 2CH2CCl3 , 1HCH2Ph, H2, H3), 5.04 (d, 1H, J = 7.3 Hz, H1), 
6.81 (d, 2H, J = 8.4 Hz, ArH), 6.92 (d, 2H, J = 8.4 Hz, ArH), 7.31 (m, 5H, ArH); 13C 
NMR (75 MHz, CDCl3) δ 55.6, 60.6, 74.8, 75.1, 75.2, 80.3, 80.5, 80.9, 84.8, 92.1, 92.6, 
98.5, 114.8, 118.4, 128.4, 128.6, 136.5, 149.7, 156.1; [α]D26 = 87.3 (c 1.0, CHCl3); 
HRMS 
(ESI) m/z = 813.9315, C24H30Cl6 NO13S2 (M+NH4)+ requires 813.9290. 
 
 
General procedure for the synthesis of trisulfated carbohydrates, compounds 3.172-
3.175 (Scheme 3.30). Prepared according to the general procedure described above for 
the multiple sulfations. The appropriate carbohydrate (0.14 mmol), CH2Cl2 (2 mL), (1,2-
DiMeIm) (0.07 g, 0.73 mmol), reagent 2.4 (0.3 g, 0.65 mmol), reaction time 30 h. The 








Methyl-2,3,4-tri-O-trichloroethylsulfo-6-O-benzyl-α-D-glucopyranoside (3.172): 84% 
as colourless syrup yield. 1H NMR (300 MHz, CDCl3) δ 3.48 (s, 3H, OCH3), 3.79-3.98 
(m, 3H, H6, H6`, H5), 4.51-4.62 (AB, 2H, J = 11.3 Hz, CH2Ph), 4.69 (m, 1H, H2), 4.81-
4.92 (m, 6H, 3CH2CCl3), 5.07-5.25 (m, 3H, H4, H3, H1), 7.34 (m, 5H, ArH); 13C NMR 
(75 MHz, CDCl3) δ 56.1, 66.7, 68.3, 73.7, 77.3, 78.0, 79.6, 79.7, 80.1, 80.3, 80.7, 80.8, 
92.2, 92.4, 92.5, 95.9, 127.9, 128.0, 128.4, 137.2; [α]D26 = 46.9 (c 1.0, CHCl3); HRMS 









(3.173): 80% as colourless syrup. 1H NMR (500 MHz, CDCl3) δ 3.74- 3.79 (m, 4H, H5, 
OCH3), 3.90 (t, 1H, J = 9.1 Hz, H4), 4.37 (dd, 1H, J = 10.8, 4.2 Hz, H6`), 4.49 (d, 1H, J 
= 10.9 Hz, H6), 4.58-4.64 (m, 3H, CH2Ph, 1H of CH2CCl3), 4.79-4.95 (m, 5H, 1H of 
CH2CCl3, 2CH2CCl3), 5.03-5.08 (m, 2H, H2, H3), 5.13 (d, 1H, J = 7.3 Hz, H1), 6.86 (d, 
2H, J = 8.9 Hz, ArH), 7.01 (d, 2H, J = 8.9 Hz, ArH), 7.41 (m, 5H, ArH); 13C NMR (125 
MHz, CDCl3) δ 55.6, 70.3, 72.2, 74.6, 75.81, 79.7, 80.3, 80.5, 80.7, 84.3, 92.2, 92.4, 
92.5, 98.5, 114.9, 118.7, 128.8, 128.9, 128.9, 135.7, 149.4, 156.4; [α]D26 = 86.2 (c 1.0, 











Methyl-2,3,6-tri-O-trichloroethylsulfo-4-O-benzyl-β-D-glucopyranoside (3.174): 77% 
as colorless syrup. 1H NMR (300 MHz, CDCl3) δ 3.44 (s, 3H, OCH3), 3.72 (t, 1H, J=9.5, 
9.1 Hz, H4), 3.94 (d, 1H, J=9.5 Hz, H5), 4.42-4.5 (m, 2H, H6, H6`), 4.55, 4.99 (AB 
system, 2H, J=10.5 Hz, CH2Ph), 4.63-4.89 (m, 7H, H2, 3CH2CCl3), 5.16-5.21 (m, 2H, 
H3, H1), 7.35 (m, 5H, ArH); 13C NMR (75 MHz, CDCl3) δ 56.0, 68.1, 70.8, 75.0, 75.6, 
78.4, 79.7, 80.3, 80.5, 82.9, 92.2, 92.4, 92.5, 96.2, 128.6, 128.8, 135.8 [α]D26 = 41.8 (c 










(3.177): 71% as colourless syrup. 1H NMR (300 MHz, CDCl3) δ 3.71- 3.88 (m, 5H, H5, 
OCH3, H4), 4.3-4.56 (m, 2H, H6, H6`), 4.57-4.73 (m, 3H, CH2Ph, 1H of CH2CCl3), 4.76-
4.9 (m, 5H, 1H of CH2CCl3, 2CH2CCl3), 4.97-5.09 (m, 2H, H3, H1), 6.8 (d, 2H, J = 8.8 
Hz, ArH), 6.96 (d, 2H, J = 8.7 Hz, ArH), 7.36 (m, 5H, ArH); 13C NMR (75 MHz, CDCl3) 
δ 55.6, 70.3, 72.1, 74.6, 75.8, 97.7, 80.3, 80.4, 80.7, 84.4, 84.5, 92.2, 92.4, 92.5, 98.4, 
114.9, 118.6, 128.8, 128.9, 135.7, 149.4, 156.4; [α]D26 = 75.1 (c 1.0, CHCl3); HRMS 
(+ESI) m/z =1006.7731, C26H28 Cl9 NO16S3 (M+H)+ requires 1006.7736. 
 
 
General procedure for the deprotection of the sulphate moiety in compounds 3.176, 
3.177, and 3.178 (Scheme 3.31). To a suspension of ammonium formate (0.105 g, 1.67 
mmol) in MeOH (1.4 mL) was added the appropriate carbohydrate (0.14 mmol) followed 
by zinc dust (0.13 g, 1.98 mmol). The reaction was stirred for 6 h at room temperature 
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after which no starting material was detected by TLC. The reaction was filtered through 
Celite, and the filtrate was concentrated. The crude residue was purified by flash 
chromatography (20:4:1CH2Cl2/MeOH/NH4OH) afforded a white solid that was 








 Methyl-2,3-di-O-sulfo-4:6-O-benzylidine-β-D-glucopyranoside (3.176): 92% as a 
white powder. 1H NMR (300 MHz, DMSO-d6) δ 3.29 (s, 3H, OCH3), 3.48-3.58 (m, 2H, 
H4, H5), 3.71 (t, 1H, J = 9.7 Hz, H6`), 3.94-3.99 (dd, 1H, J = 9.9, 3.1 Hz, H2), 4.12-4.16 
(dd, 1H, J=10.16, 5.9 Hz, H6), 4.45 (t, 1H, J=9.3 Hz, H3), 5.09 (d, 1H, J = 3.1 Hz, H1), 
5.54 (s, 1H, CHPh), 7.11 (br, 8H, 2NH4), 7.28 (m, 3H, ArH), 7.49 (m, 2H, ArH); 13C 
NMR (75 MHz, DMSO-d6) δ 54.6, 62.6, 68.4, 74.9, 75.7, 80.0, 98.9, 100.9, 126.0, 127.4, 










89% as a white powder. 1H NMR (300 MHz, DMSO-d6) δ 3.50 (t, 1H, J = 10.1, 9.26 Hz, 
H6`), 3.71 (m, 4H, OCH3, H5), 4.16-4.25 (m, 2H, H6, H4), 4.32 (d, 1H, J= 6.9 Hz, H3), 
4.41 (s, 1H, H2), 5.58 (s, 1H, CHPh), 5.76 (s, 1H, H1), 6.84, 6.92 (AB, 4H, J = 8.6 Hz, 
ArH), 7.12 (s, 8H, 2NH4), 7.36 (m, 5H, ArH); 13C NMR (75 MHz, DMSO-d6) δ 55.7, 
64.2, 69.5, 75.7, 76.6, 79.2, 98.0, 101.0, 115.0, 119.1, 126.8, 128.3, 129.1, 138.2, 150.8, 
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p-Methoxyphenyl-2,3-di-O-benzoyl-4,6-di-O-sulfo-β-D-glucopyranoside (3.178): 88% 
as a white powder. 1H NMR (500 MHz, DMSO-d6) δ 3.67 (s, 4H, OCH3, H6`), 4.01 (t, 
1H, J = 9.5 Hz, H5), 4.21 (t, 1H, J = 9.4 Hz, H4), 4.36 (d, 1H, J = 11.2 Hz, H6), 5.26 (t, 
1H, J = 9 Hz, H2), 5.45 (d , 1H, J = 7.8 Hz, H1), 5.66 (t, 1H, J = 9.3 Hz, H3), 6.75, 6.88 
(AA`BB`, 4H, J = 8.5, 8.4 Hz, ArH), 7.04 (s, 8H, 2NH4), 7.41 (m, 6H, ArH), 7.79 (d, 4H, 
J = 11.9 Hz, ArH); 13C NMR (125 MHz, DMSO-d6) δ 55.7, 66.4, 72.7, 73.2, 73.7, 74.3, 
99, 114.9, 118.2, 128.5, 129.2, 129.3, 129.5, 129.9, 130.5, 133.1, 134, 151.2, 155.2, 
165.1, 165.7; [α]D26 = 76.3 (c 1.0, H2O); HRMS (ESI) m/z = 653.0612, C27H25O15S2 






















Chapter 4 - Preparation of Trifluoroethyl- and Phenyl-Protected 
Sulfates using Sulfuryl Imidazolium Salts 
________________________________________________________________________ 
4.1 Introduction and Objectives 
 In previous chapters we demonstrated that trichloroethyl (TCE)-protected sulfates 
could be introduced into monosaccharides in good yield using sulfuryl imidazolium salts 
and that the TCE group has many of the characteristics that are required of a successful 
sulfate protecting group.  However, as we mentioned in chapter 1, other groups have also 
been examined as sulfate PG’s such as the phenyl, trifluoroethyl (TFE), neopentyl and 
isobutyl groups and some of these groups have useful properties, such as stability to 
certain hydrogenolysis conditions, which the TCE group lacks.  Unfortunately, in some 
instances the methodology that had been developed for incorporating these groups into 
carbohydrates was far from optimal.  For instance, the TFE group was installed by 
reacting the sulfate monoesters with trifluorodiazoethane, a reagent that must be prepared 
fresh and is a potentially explosive.  Also, the conditions that had been developed for 
removing this group, potassium tert-butoxide in refluxing tert-butanol, were not very 
compatible with complex carbohydrate syntheses. There are several objectives to the 
work presented in this chapter.  One is to determine what groups, in addition to the TCE 
group, are compatible with sulfuryl imidazolium salt formation.  The second is to 
demonstrate that, in addition to the TCE group, other protecting groups can be introduced 
into carbohydrates using sulfuryl imidazolium salts.  The third objective is to find better 
conditions for removing TFE groups from TFE-protected sulfated carbohydrates.   
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4.2. Results and Discussion 
4.2.1 Synthesis of sulfuryl imidazolium salts 
 We initially examined the preparation of SIS’s bearing moieties that have been 
studied as sulfate protecting groups such as the TFE, phenyl, isobutyl and neopentyl 
groups (Table 4.1).  Thus, sulfuryl chlorides 4.1-4.429,35,37,81 were reacted with imidazole 
or 2-methylimidazole to give compounds 4.5-4.12.  Compounds 4.5 and 4.6 formed by 
the reaction of imidazole with neopentyl and isobutylsulfuryl chloride were found to be 
very unstable and decomposed shortly after chromatographic purification. The 2-
methylimidazole derivatives of 4.5 and 4.6, compounds 4.7 and 4.8, were slightly more 
stable yet still decomposed within 6-12 h after chromatography. In contrast those bearing 
the trifluoroethyl or phenyl groups were readily obtained suggesting that electron 
withdrawing groups on the ester portion are important for stability and electron donating 
alkyl groups decrease stability.  However, sulfuryl imidazolides bearing electron donating 
aryl groups can be prepared as exemplified by the known compound 4.13 (Figure 4.1), 
which has an electron donating methoxy group at the 4-position of the phenyl ring and is 
readily prepared by reacting 4-methoxyphenol with sulfuryl diimidazole in the presence 
of a base.82 We also found that the 4-methylmercapto derivative 4.14 (Figure 4.1) could 



















THF, 0 oC, 1h 
then 1h rt
4.1, R1 = nPt
4.2, R1 = i-Bu
4.3, R1 = TFE
4.4, R1 = Ph
R2 = H or Me 4.5-4.12
 
product R1 R2 % Yield 
4.5 nPt H 0a 
4.6 i-Bu H 0a 
4.7 nPt CH3 0b 
4.8 i-Bu CH3 35b,c 
4.9 TFE H 84 
4.10 TFE CH3 87 
4.11 Ph H 75 
4.12 Ph CH3 85 
aDecomposed within 1 h of chromatography.  
bDecomposed within 6-12 h of chromatography.   






4.13, R = MeO
4.14, R = MeS  
Figure 4.1.  Sulfuryl imidizolates 4.13 and 4.14. 
 Attempts to convert 4.7 and 4.8 into SIS’s by treating them, immediately after 
purification by chromatography, with MeOTf in Et2O resulted in the precipitation of a 
white powder which rapidly decomposed after filtration and drying under high vacuum.  
In contrast, subjecting compounds 4.9-4.12 to methyl triflate in ether resulted in the 
precipitation of SIS’s 4.17-4.20 as white powders in high yield (Table 4.2) and these 
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compounds can be stored for at least two years at -20 oC with showing any detectable 
decomposition.  
 Although the p-methoxyphenyl and p-thiomethylphenyl groups have not been 
employed as sulfate protecting groups Prof. Scott Taylor subjected compounds 4.13 and 
4.14 to MeOTf to determine if SIS’s bearing an electron donating group on the phenyl 
ring could be prepared.  As with SIS’s 4.17-4.20, the resulting SIS’s 4.21 and 4.22 
readily precipitated out of solution and were found to be very stable and can be stored at -
20 oC for at least a year without any detectable decomposition.   
 
 

















4.9-4.14 4.15-4.22  
 
Product R1 R2 % Yield 
4.15 nPt CH3 0 
4.16 i-Bu CH3 0 
4.17 TFE H 92 
4.18 TFE CH3 91 
4.19 Ph H 92 
4.20 Ph CH3 93 
4.21 4-MeOPh H 90 
4.22 4-MeSPh H 86 
 
4.2.2 Sulfating Abilities of TFE/Phenyl Sulfuryl Imidazolium Salts 4.17-4.22  
 Introduction of TFE-protected sulfates into carbohydrates was examined using 
SIS’s 4.17 and 4.18. Subjecting carbohydrate 4.23 to 2 equiv 4.17 in the presence of 2.5 
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equiv N-methyl imidazole (1-MeIm) in THF gave sulfated carbohydrate 4.33 in a 45% 
yield.  However, switching to 2,6-lutidine as base and performing the reaction in CH2Cl2 
gave 4.33 in an 88% yield (entry 1).  Using 2 equiv of SIS 4.18 in the presence of 2.5 
equiv 1,2-dimethylimidazole, 1,2-DiMeIm in CH2Cl2 gave 4.33 in an 86% yield (entry 
2).  Carbohydrate 4.34 was obtained in an 80% yield using SIS 4.18 and 1,2-DiMeIm 
(entry 3).  In contrast, carbohydrates 4.33 and 4.34 were prepared by Proud et al in 60 % 
and 51 % yields respectively using the pyr/SO3/2,2,2-trifluorodiazoethane 
methodology.28 In general, sulfations using SIS 4.18 and 1,2-DiMeIm gave higher yields 
than those using SIS 4.17 and 2,6-lutidine (entries 3-8).  Further studies with SIS 4.18 
using 1,2-DiMeIm as base revealed that most of the sulfated carbohydrates could be 
obtained in good yield though in some instances yields were modest even when a 
considerable excess of SIS and base were used with prolonged reaction times (entries 8 
and 10). The TFE-protected sulfate group could be introduced selectively into 2,3-diols 
of benzylidene acetals in good yield by the slow addition of a solution of 1,2-DiMeIm to 
a solution of the carbohydrate and SIS 4.18 (entries 10-13). The selectivities are 
















Table 4.3. Synthesis of TFE-protected sulfocarbohydrates with sulfuryl 



















































































































































































































































































































a2.5 equiv 4.17, 2 equiv NMI, THF, 24h.  b2.0 equiv 4.17, 1.1 equiv 2,6-lutidine CH2Cl2, 24h.  c2 equiv 4.18, 2.5 equiv 
1,2-DiMeIm, CH2Cl2, 24-30 h.  d5 equiv 4.18, 6 equiv 1,2-DiMeIm, CH2Cl2, 72 h.  e1.2 equiv 4.18, 2 equiv 1,2-DiMeIm, 
CH2Cl2, 30 h.  f4 equiv 4.18, 5 equiv 1,2-DiMeIm, CH2Cl2, 30 h. 
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 Using estrone (4.43) and estradiol (4.44) as model aryl substrates it was found 
that the TFE-protected sulfate group can also be introduced into aryl substrates using SIS 
4.18 in good to excellent yields and relatively good selectivity could be achieved for the 




4.43, X = C=O
4.44, X = CHOH
X
TFEO3SO
4.45, X = C=O (92%)






Scheme 4.1.  Synthesis of TFE-protected estrone and estradiol 3-sulfates. 
 
The synthesis of phenyl-protected sulfated carbohydrates were examined using reagents 
4.19 and 4.20 and carbohydrates 4.25-4.28 (Table 4.4).  Using reagent 4.19/NMI (1-
MeIm)or 4.20/1,2-DiMeIm carbohydrates 4.47 and 4.48 were obtained in 90-95% yields.  
In contrast, carbohydrate 4.48 was prepared in a 75% yield by Penney and Perlin using 
NaH/PhOSO2Cl.29   Carbohydrates 4.49 and 4.50 which were obtained in a modest yield 









Table 4.4. Synthesis of phenyl-protected sulfocarbohydrates with sulfuryl 
























































































































































































a2-2.5 equiv 4.19, 2 equiv 1-MeIm, THF, 24 h. b2 equiv 4.20, 2.5 equiv  
1,2-DiMeIm, CH2Cl2, 24-30 h. 
 
4.2.3 Deprotection of TFE-protected Sulfate Esters 
 The conditions that are most commonly employed for deprotecting TFE-protected 
sulfates are refluxing KOt-Bu in t-BuOH.28,34 These harsh conditions have severely 
limited the use of the TFE moiety as a suflate protecting group as the deprotection yields 
are often low.34  As part of our efforts to find more suitable conditions for removing this 
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group we evaluated NaN3 in warm DMF since these conditions have been used for 
removing neopentyl groups from sulfates sometimes in very high yield.35  Subjecting 
fully protected carbohydrates bearing secondary suflate groups, 4.34, 4.37, 4.39 and 4.41 
to 1.4 equiv of NaN3 in warm DMF (65-70 oC) for 10-16 h resulted in removal of the 
TFE group in high yields (Table 4.5).  The crude products were passed through a small 
silica column using CH2Cl2/MeOH or CH2Cl2/MeOH/NH4OH as eluent which effectively 
removed any contaminating NaN3 and gave the desired deprotected sulfates as their 
sodium or ammonium salts.  












































































































































However, deprotections of substrates bearing a primary sulfate group, 4.99 and 4.101, 
proceeded in lower yields due to competing attack of the azide ion at C-6 followed by 
partial desulfation.  This side reaction was also noted by Karst et al during the attempted 
removal of a TFE group from the 6-position of a fully protected disaccharide substrate 
using KOt-Bu in refluxing HOt-Bu though it appears that this problem can be reduced or 
eliminated when free OH groups are present in the substrate.28,34 This side reaction was 
also found to occur during removal of the neopentyl group from neopentyl-protected 
glucose-3-sulfate though in this case complete loss of the sulfate group occurred.35  The 
phenolic sulfates 4.45 and 4.46 were deprotected in almost quantitative yield within 1-3 h 
using 1.4 equiv NaN3 in DMF at 65-70 oC.  
4.3 Summary and Future Work 
 In summary, we have shown that SIS’s bearing the TFE (compounds 4.17 and 
4.18) and phenyl (4.19 and 4.20) groups, two functionalities that have been used for the 
protection of suflate groups, can be readily prepared.  SIS’s bearing the electron donating 
neopentyl and isobutyl groups, two moieties that have also been used for the protection of 
sulfates, were found to be unstable and could not be isolated though SIS’s bearing an 
electron-donating p-methoxyphenyl or p-thiomethylphenyl group were readily prepared 
and are stable compounds.  In most instances, both TFE- and phenyl protected sulfates 
were easily prepared using reagents 4.17-4.20 though reagents 4.18 and 4.20 having a 
methyl group at the 2-position of the imidazole ring were, in general, superior sulfating 
agents in comparison to reagents 4.17 and 4.19 which lacked a methyl group at this 
position.  In general, the use of SIS’s 4.17-4.20 to prepare TFE- or phenyl-protected 
sulfates represent a significant improvement over the previous approaches to these 
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compounds.  Deprotection of carbohydrate substrates bearing a primary sulfate group 
using NaN3 in warm DMF proceeded in lower yields due to competing attack of the azide 
ion at C-6.  However the TFE group can be removed from secondary sulfates in 
carbohydrates and aryl sulfates in excellent yields using NaN3 in DMF, conditions that 
we believe are superior to the previous conditions using refluxing KOt-Bu in t-BuOH.  
Overall, these results make the TFE group a more viable alternative for sulfate protection 
which considered a viable approach to the synthesis of complex sulfated 
oligosaccharides. In addition, tin-mediated sulfations with reagent 4.18 could be 
examined in future. 
4.4. Experimental 
4.4.1 General Information 
For general information regarding solvents, NMR, MS, refer to section 2.4.1 in Chapter 
2. All commercially available reagents in chapter 4 were purchased from either Sigma  
Aldrich or Alfa Aesar. Compounds 4.13, 4.14, 4.21 and 4.22 were prepared by Prof. 
Taylor. 
4.4.2 Experimental Syntheses and Characterization 
General procedure for the preparation of compounds 4.8-4.12 (Table 4.1).  To a 
solution of the appropriate imidazole derivative (0.165 mol, 3.0 equiv) in dry THF (60 
mL) at 0 oC was added dropwise a solution of the appropriate sulfuryl chloride 4.1-4.4 
(0.055 mol, 1.0 equiv) in THF (40 mL). The reaction was stirred at 0 oC for 1 h, warmed 
to room temperature, and stirred for an additional 1 h. The reaction mixture was filtered, 
the residue was washed with THF, and the filtrate was concentrated under vacuum. The 
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crude residue was purified by flash chromatography (1:2 EtOAc/hexanes) to give 







Isobutoxysulfuryl-(2-methyl)imidazole (4.8). Prepared according to the general 
procedures. Purified by flash chromatography (33:67 EtOAc/hexanes) to provide 4.8, 
35%  as a clear, colorless oil containing approximately 13 % of 2-methylimidazole as 
impurity.   1H NMR (300 MHz, CDCl3) δ 0.86 (d, 6H, J = 6.8 Hz), 1.94 (dt, 1H, J = 7.5, 
6.8 Hz), 2.30 (s, 3H), 3.56 (d, 2H, J = 7.5 Hz), 6.73 (d, 1H, J = 1.3 Hz), 6.83 (d, 1H, J = 
1.3Hz); 13C NMR (75 MHz, CDCl3) δ 13.1, 19.9, 29.9, 53.5, 119.6, 121.2, 126.7, 144.5. 
We were unable to obtain a mass spectrum of this compound due to its rapid 






Trifluoroethoxysulfuryl imidazole (4.9).  Prepared according to the general procedures. 
Flash chromatography (1:2, EtOAc:hexanes),  84% yield as colorless oil. 1H NMR 
(300MHz, CDCl3) δ 4.53 (q, 2H, J = 7.55 Hz, CH2), 7.20 (s, 1H, Himi), 7.36 (s, 1H, 
Himi), 8.01 (s, 1H, Himi); 13C NMR (75 MHz, CDCl3) δ 68.9 (q, 1C, J = 150 Hz, 
CH2CF3), 117.8, 122 (q, 1C, J = 305.5 Hz, CF3), 131.8, 136.9; 19F-NMR (282 MHz, 










Trifluoroethoxysulfuryl–(2-methyl) imidazole (4.10). Prepared according to the 
general procedures. Flash chromatography (1:2, EtOAc:hexanes),  87% yield as colorless 
oil.1H NMR (300 MHz, CDCl3) δ 2.57 (s, 3H, CH3), 4.44 (q, 2H, J = 7.55 Hz, CH2), 6.90 
(s, 1H),7.24 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 14.5, 67.2 (q, 1C , J CF = 150 Hz, 
CH2CF3), 120.0, 121 (q, 1C , J CF = 316.5 Hz, CF3), 128.3, 146.4; 19F-NMR (282 MHz, 







Phenoxysulfuryl imidazole (4.11).  Prepared according to the general procedures. Flash 
chromatography (1:3, EtOAc:hexanes), 75% yield as  white solid. Mp 32-33 oC. 1H NMR 
(300 MHz, CDCl3) δ 6.92 (m, 2H), 7.14 (s, 1H, Himi),7.32 (m, 4H), 7.74 (s, 1H, Himi); 
13C NMR (75 MHz, CDCl3) δ 118.2, 121.9 (2C), 128.5, 130.19 (2C), 131.2, 137.3, 148.8; 








Phenoxysulfuryl-(2-methyl) imidazole (4.12).  Prepared according to the general 
procedures. Flash chromatography (1:3, EtOAc:hexanes), 85% yield as  white solid. Mp 
32-33 oC. 1H NMR (300MHz, CDCl3) δ 2.20 (s, 3H), 6.71 (m, 3H), 6.93 (s, 1H, Himi), 
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7.15 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 14.5, 120.3, 121.5, 127.9, 128.5, 130.2, 
146.7, 148.9; HRMS (EI) , 238.0412, C10H10N2O3S (M)+, require 238.0412.  
 
General procedure for the preparation of sulfuryl imidazolium salts, compounds 
4.17-4.22  (Table 4.2).  To a solution of the appropriate sulfuryl imidazole (0.04 mol, 1.0 
equiv) in dry Et2O (70 mL) at 0 oC was added methyl triflate (4.6 mL, 0.04 mol, 1.0 
equiv) dropwise over 30 min. The reaction was stirred for 3 h at 0 oC during which time a 
white precipitate formed. The mixture was filtered. The filter cake was washed with cold 










Trifluoroethoxysulfuryl-N-methylimidazolium triflate (4.17).  Prepared according to 
the general procedures. White solid, 92%. Mp 103-104 oC; 1H NMR (300 MHz, CD3OD) 
δ 4.02 (s, 3H, CH3), 5.25 (q, 2H, J = 7.8 Hz, CH2), 9.95 (s,1H, Himi), 8.28 (s, 1H, 
Himi),7.36 (s, 1H, Himi), 8.01 (s, 1H, Himi); 13C NMR (75 MHz, CD3OD) δ 36.6, 69.8 
(q, 1C, J = 150 Hz, CH2CF3), 121.0 (2q, 2C, 2CF3, J CF = 305.5, 316.5 Hz, CF3), 120.8, 
126.1, 139.9; 19F NMR (282 MHz, CD3OD) δ −75.1, −79.9; HRMS (ESI), 245.0208, 














Trifluoroethoxysulfuryl -(2-methyl)-N-methylimidazolium triflate (4.18).  Prepared 
according to the general procedures. White solid, 91% yield. Mp 98-100 oC; 1H NMR 
(300MHz, CD3OD) δ 2.87 (s, 3H, CH3-imi), 3.90 (s, 3H, CH3), 5.16 (q, 2H, J = 7.55 Hz, 
CH2), 7.70 (d, 1H, J = 2.3 Hz, Himi), 8.02 (d, 1H, J = 2.3 Hz, Himi),; 13C NMR (75 
MHz, CD3OD) δ 10.4, 35.3, 69.3 (q, 1C , J CF = 150 Hz, CH2CF3), 120.7, 121.0 (2q, 2C, 
2CF3, J CF = 303, 316.5 Hz, CF3), 123.6, 148.8; 19F-NMR (300 MHz, CD3OD) 







Phenoxysulfuryl-N-methylimidazolium triflate (4.19).  Prepared according to the 
general procedures. White solid, 92% yield. Mp 87-88 oC; 1H NMR (300MHz, CD3OD) δ 
4.05 (s, 3H), 7.26 (d, 2H, J = 6.7 Hz), 7.51 (m, 3H), 7.80 (s, 1H), 8.05 (s, 1H), 9.76 (s, 
1H); 13C NMR (75 MHz, CD3OD) δ 36.5, 120.5 (q, J = 316.5 Hz, CF3), 120.9, 126, 
129.3, 130.8, 139.5, 149.3; 19F-NMR (282 MHz, CD3OD) δ  −79.5; HRMS(ESI), 









Phenoxysulfuryl-(2-methyl)-N-methylimidazolium triflate (4.20).  Prepared according 
to the general procedure. White solid, 93% yield. Mp 79-80 oC; 1H NMR (300 MHz, 
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CD3OD) δ 2.81 (s, 3H), 3.94 (s, 3H), 7.26 (d, 2H, J = 7.5 Hz), 7.49 (d, 3H, J = 7.5 Hz), 
7.68 (s, 1H), 7.77 (s, 1H); 13C NMR (75 MHz, CD3OD) δ 10.5, δ 35.5, 120.0 (q, 1C, J = 
316.5 Hz, CF3), 120.9, 122.5, 123.6, 129.3, 130.7, 148.7, 149.3; 19F-NMR (282 MHz, 
CD3OD) δ  −79.5; HRMS (ESI), 253.0640, C11H13N2O3S (M-OTf)+, require 253.0647.  
 
General procedure for the synthesis of TFE-protected sulfocarbohydrates using 
reagent 4.17 and 2,6-lutidine, compounds 4.33-4.36 (Table 4.3).  To a solution of the 
appropriate carbohydrate (0.95 mmol) in CH2Cl2 (4.2 mL) at 0 oC (ice bath) was added 
2,6-lutidine (0.123 ml, 1.05 mmol, 1.1 equiv) followed by reagent 4.17 (0.19 g, 0.48 
mmol, 0.5 equiv). The reaction was stirred for 1 h at 0 oC and gradually allowed to warm 
to room temperature.  After every two hours another 0.19 g of reagent 4.17 was added 
until the total was equal to 2 equiv and the reaction was stirred over night for a total of 24 
h. The reaction was quenched with water, extracted with EtOAc, washed with brine, 
dried (MgSO4) and concentrated to a crude brown oil.  Flash chromatography (1:4, 










Prepared from carbohydrate 4.23 according to the general procedures. Flash 
chromatography (1:5, EtOAc:hexanes), 88% yield as white solid. Mp 34-35 oC; 1H NMR 
(300 MHz, CDCl3) δ 1.30, (s, 6H, 2CH3), 1.41 (s, 3H, CH3 ), 1.49 (s, 3H, CH3), 4.09 (bd, 
1H, J = 5.6 Hz, H5), 4.15 (dd, 1H, J = 7.7, 1.8 Hz, H4), 4.32 (t, 1H, J = 4.8 Hz, H2), 4.41 
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(dd, 2H,  J = 5.8, 2.5 Hz, H6, H6`), 4.52- 4.63 (m, 3H,  CH2CF3, H3), 5.49 (d, 1H, J = 4.6 
Hz, H1);  13C NMR (75 MHz, CDCl3) δ 24.3, 24.72, 25.73, 25.55, 65.6, 66.6 (q, 1C, J CF 
= 150 Hz, CH2CF3), 70.1, 70.4, 70.6, 72.5, 96.1, 109.1, 110.05, 121.6 (q, 1C, J CF = 303 
Hz, CF3); 19F-NMR (282 MHz, CDCl3) δ −73.8; HRMS (ESI) m/z = 423.0952, 
C14H22F3O9S (M+H)+ requires 423.0937.  
 
 
1,2:5,6-di-O-isopropylidene-3-O-trifluroroethylsulfo-α-D-glucopyranoside (4.34).  
Prepared from carbohydrate 4.24 according to the general procedures. Flash 
chromatography (1:5, EtOAc:hexanes), 70% yield as white solid.  Mp 67-68 oC; 1H NMR 
(300 MHz, CDCl3) δ 1.30, (s, 6H, 2CH3), 1.39 (s, 3H, CH3 ), 1.47 (s, 3H, CH3), 4.18 (m, 
4H, H6, H6`, H4, H5), 4.52 (m, 1H, 1H of CH2CF3), 4.82 (m, 1H, 1H of CH2CF3), 4.89 
(bs, 1H,  H2), 4.95 (bs, 1H, H3), 5.91 (bs, 1H, H1); 13C NMR (75 MHz, CDCl3) δ 24.4, 
26.1, 26.5, 26.8, 67 (q, J = 150 Hz, CH2CF3), 67.5, 71.7, 79.4, 82.5, 85.6, 105, 110.1, 
112.8, 121 (q, J = 305.5 Hz, CF3); 19F-NMR (282 MHz, CDCl3) δ −73.8; HRMS (ESI) 









Benzyl 2,3,4-tri-O-benzyl-6-O-trifluoroethylsulfo-β-D-glucopyranoside (4.35).  
Prepared from carbohydrate 4.2584 according to the general procedures. Flash 






NMR (300 MHz, CDCl3) δ 3.52 (m, 3H, H4,H2, H5), 3.71 (t, 1H, J = 8.6 Hz, H3), 4.41, 
4.57 (AB system, 2H, J = 10.2 Hz, H6, H6`), 4.51-4.82 (m, 7H,  CH2CF3, H1, 2CH2), 
4.91-5.01 (m, 4H, 2CH2), 7.32 (m, 20H, ArH); 13C NMR (75 MHz, CDCl3) δ 66.6 (q, 1C, 
J = 150 Hz, CH2CF3), 71.5, 72.2, 73.3, 74.9, 75.1, 75.7, 76.3, 82.0, 84.3, 102.4, 121 (q, 
1C, J = 305.6 Hz, CF3), 126.1, 127.1, 127.6, 127.7, 127.8, 127.85, 128.02, 128.05, 128.1, 
128.2, 128.4, 128.47, 128.5, 128.6, 128.7, 136.8, 137.3, 138.1, 138.2; 19F-NMR (282 








Benzyl 2,4,6-tri-O-benzyl-3-O-trifluoroethylsulfo-β-D-galactopyranoside (4.36).  
Prepared from carbohydrate 4.2685 according to the general procedures. Flash 
chromatography (1:5, EtOAc:hexanes), 26% yield as  colorless syrup. 1H NMR (300 
MHz, CDCl3) δ 3.48-3.62, (m, 3H, H6,H6`, H5), 3.94 (t, 1H, J = 8.6 Hz, H2), 4.06 (m, 
2H, CF3), 4.24 (d, 1H, J = 2.4 Hz, H4), 4.51 (m, 7H, H1, H3, CH2, 1H of CH2), 4.83, 
5.02 (AB system, 2H, J = 10.7 Hz, CH2), 4.94 (d, 1H, J = 10.7 Hz, the other H of CH2), 
7.29 (m, 20H, ArH); 13C NMR (75 MHz, DMSO-d6) δ 66.6 (q, 1C, J = 150 Hz, CH2CF3), 
76.9, 71.1, 72.7, 73.5, 73.8, 75.3, 76.6, 85.7, 102.1, 122 (q, 1C, J = 305.6 Hz CF3), 126.7, 
127.4, 127.8, 127.9, 127.9, 128, 128.1, 128.2, 128.3, 128.3, 128.4, 128.5, 128.5, 136.8, 
137.3, 137.5, 137.6; 19F-NMR (282 MHz, CDCl3) δ −73.8;  HRMS (ESI) m/z = 
709.2281, C36H37F3O9S Li(M+Li)+ requires 709.2270. 
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General procedure for the synthesis of TFE-protected sulfocarbohydrates using 
reagent 4.18 and (1,2-DiMeIm), compounds 4.33-4.38 (Table 4.3).  To a solution of 
the appropriate carbohydrate (0.62 mmol) in CH2Cl2 (5 mL) at 0oC (ice bath) was added 
1,2-DiMeIm (0.15 g, 1.56 mmol) and reagent 4.18 (0.51 g, 1.25 mmol).  The ice bath was 
removed and the reaction allowed to warm to room temperature and then stirred for 30 h.  
The reaction was diluted with CH2Cl2, washed with brine, dried (MgSO4) and 
concentrated to crude brown oil.  Flash chromatography (1:4, EtOAc:hexanes) gave 










topyranoside (4.37). Prepared from carbohydrate 4.2786 according to the general 
procedures. Flash chromatography (1:4, EtOAc:hexanes), 80% yield as a white solid.  Mp 
128-130 oC; 1H NMR (300 MHz, CDCl3) δ 3.6o (bs, 1H,  H5), 3.71 (s, 3H, OCH3), 4.13, 
4.41 (AB system, 2H, J = 12.5 Hz, H6, H6`), 4.23-4.34 (m, 2H, CH2CF3), 4.64 (d, 1H, J 
= 3.3 Hz, H4), 4.99 (dd, 1H, J = 10.2, 3.2 Hz, H3), 5.04 (d, 1H, J = 7.9 Hz, H1), 5.56 (s, 
1H, CHPh), 5.88 (t, 1H, J = 9.6 Hz, H2), 6.73, 6.92 (AA`BB` system, 4H, J = 8.7, 8.5 
Hz, ArH), 7.47 (m, 8H, ArH), 8.04 (d, 2H, J = 7.8 Hz ArH);  13C NMR (75 MHz, CDCl3) 
δ 55.5, 65.9, 67.2 (q, J CF = 150 Hz, CH2CF3), 68.3, 68.7, 73.0, 82.1, 101.11, 101.5, 
114.4, 119.4, 134 (q, J CF = 304.5 Hz, CF3)126.4, 128.4, 128.6, 129.6, 129.8, 133.6, 
136.7, 150.9, 155.9, 164.9; 19F-NMR (282 MHz, CDCl3) δ −73.5; HRMS (ESI) m/z = 










oyranoside (4.38).  Prepared from carbohydrate 4.2887 according to the general 
procedures. Flash chromatography (1:4, EtOAc:hexanes), 52% yield as  White solid.  Mp 
112-114 oC; 1H NMR (300 MHz, CDCl3) δ 3.40 (s, 3H, OCH3), 3.71 (m, 2H, H6, H6`), 
3.92 (m, 1H, H5), 4.32 (dd, 3H, H4, CH2CF3), 4.92 (dd, 1H, J = 9.1, 7.8 Hz, H3), 5.04 (d, 
1H, J = 3.4, H1), 5.18 (t, 1H, J = 9.3, Hz, H2), 5.23 (s, 2H, CH2Ph), 5.55 (s, 1H, CHPh), 
7.49 (m, 10H, ArH); 13C NMR (75 MHz, CDCl3) δ 55.5, 62.1, 66.8 (q, 1C, J CF = 150 Hz, 
CH2CF3 ), 68.4, 70.4, 73.7, 78.2, 80.9, 97.5, 101.9, 117 (q, J CF = 305.6 Hz, CF3), 123, 
126.0, 126.7, 128.1, 128.2, 128.4, 128.5, 129.4, 134.4, 136.0, 153.9; 19F-NMR (282 
MHz, CDCl3) δ −73.5; HRMS (ESI) m/z = 579.1156, C24H26F3O11S, (M+H)+ requires 
579.1148. 
General procedure for the selective sulfation of compounds 4.39-4.42 (Table 4.3).  To 
the appropriate carbohydrate (0.55 mmol) in dry CH2Cl2 (4 mL) at 0 oC (ice bath) was 
added reagent 4.18 (0.45 g, 1.1 mmol), followed by the addition of a solution of 1,2-
DiMeIm (0.26 g, 2.77 mmol) in CH2Cl2 (2 mL) over 8 h using a syringe pump.  During 
the addition of the 1,2-DiMeIm another portion of reagent 4.18 (0.45 g, 1.1 mmol) was 
added after 6 h and the ice bath was removed after the initial 1 h.   The mixture was left 
stirring until the reaction was complete by TLC (approx 30 h).  The reaction mixture was 
diluted with CH2Cl2, washed with brine, dried (MgSO4) and concentrated to brown crude 












(4.39).  Prepared from carbohydrate 4.2988 according to general procedures. Flash 
chromatography (1:4, EtOAc:hexanes), 89% yield as  colourless syrup. 1H NMR (300 
MHz, CDCl3) δ 2.90 (b, 1H, OH), 3.41 (bs, 1H, H5), 3.72 (s, 3H, OCH3), 4.03, 4.2 (AB 
system, 2H, J = 12.5 Hz, H6, H6`), 4.28 (t, J = 8.2 Hz, H2), 4.49 (m, 2H, H4, 1H of 
CH2CF3), 4.66 (m, 3H, J1,2 = 7.7 Hz, 1H of CH2CF3, H3, H1), 5.40 (s, 1H, CHPh), 6.9, 
7.0 (AA`BB` system, 4H, J = 8.7, 8.5 Hz,  ArH), 7.41 (m, 5H, ArH); 13C NMR (75 MHz, 
CDCl3) δ 55.6, 65.9, 67.2 (q, J CF = 150 Hz, CH2CF3), 68.09, 68.6, 73.1, 83.4, 101.0, 
102.2, 114.6, 119.0, 123 (q, J = 305.6 Hz, CF3), 126.2, 128.2, 129.3, 137.0, 150.7, 155.8; 
19F NMR (282 MHz, CDCl3) δ −73.8; HRMS (ESI) m/z = 537.1044 C22H24F3O10S, 










(4.40).  Prepared from carbohydrate 4.3089 according to general procedures. Flash 
chromatography (1:4, EtOAc:hexanes), 89% yield as  white solid. Mp 71-73 oC; 1H NMR 
(500 MHz, CDCl3) δ 2.90 (b, 1H, OH at C2), 3.61 (m, 1H, J = 9.3, 4.8 Hz, H5), 3.82 (m, 
5H, OCH3, H4, H6`), 4.01 (t, J = 7.8 Hz, H2), 4.42 (m, 3H, H6, CH2CF3), 4.81 (t, 1H, J = 
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9.3 Hz, H3), 4.95 (d, 1H, J = 7.5 Hz, H1), 5.5 (s, 1H, CHPh), 6.80, 7.01 (AA`BB` system, 
4H, J = 8.9, 8.7 Hz,  ArH), 7.41 (m, 5H, ArH); 13C NMR (125 MHz, CDCl3) δ 55.6, 66.0, 
67.0 (q, 1C, J CF = 150 Hz, CH2CF3), 68.4, 72.7, 77.7, 84.8, 102.0, 102.6, 114.7, 118.9, 
122 (q, 1C, J = 305.6 Hz, CF3), 126.0, 128.5, 129.6, 136.0, 150.5, 156.1; 19F-NMR (282 







TFEO3SO OMe  
Methyl 2-O-trifluoroethylsulfo-4:6-O-benzylidene-α-D-glucopyranoside (4.41).  
Prepared from carbohydrate 4.3190 according to the general procedures. Flash 
chromatography (1:4, EtOAc:hexanes), 85% yield as colorless syrup; 1H NMR (300 
MHz, CDCl3) δ 2.81 (b, 1H, OH at C3), 3.40 (s, 3H, OCH3), 3.46 (t, 5H, J = 9.3 Hz, H4), 
3.68 (dd, 1H, J = 10.2, 4.3 Hz, H6`), 3.81 (dd, 1H, J = 9.7, 4.3 Hz, H5), 4.16 (t, 1H, J = 
9.1 Hz, H3), 4.28 (dd, 1H, J = 9.7, 4.3 Hz, H6), 4.46 (dd, 1H, J = 9.4, 3.4 Hz, H2), 4.51-
4.72 (m, 2H, CH2CF3), 5.41 (d, 1H, J = 3.5 Hz, H1), 5.50 (s, 1H, CHPh), 7.42 (m, 5H, 
ArH); 13C NMR (75 MHz, CDCl3) δ 55.7, 61.7, 67.0 (q, J CF = 150 Hz, CH2CF3), 68.2, 
68.6, 81.1, 82.1, 97.2, 102.1, 122 (q, J = 305.6 Hz, CF3), 126.2, 128.4, 129.5, 136.6; 19F 















(4.42).  Prepared from carbohydrate 4.3291 according to general procedures. Flash 
chromatography (1:4, EtOAc:hexanes), 91% yield as  colorless syrup; 1H NMR (300 
MHz, CDCl3) δ 2.57 (br, 1H, OH), 3.57 (bs, 1H, H5), 3.93 (t, 1H, J = 9.5 Hz, H2), 4.03, 
4.39 (AB system, 2H, J= 12.4 Hz, H6, H6`), 4.4-4.68 (m, 5H, H4, H1, CH2CF3, H3), 5.51 
(s, 1H, CHPh), 7.29 (m, 8H, ArH), 7.65 (d, 2H, J = 7.3 Hz, ArH); 13C NMR (75 MHz, 
CDCl3) δ 65.2, 67 (q, J CF = 150 Hz, CH2CF3), 68.9, 69.6, 73.4, 84.8, 87.0, 101.1, 123 (q, 
J CF = 305.5 Hz, CF3),126.3, 128.2, 128.8, 129.1, 129.2, 129.4, 134.0, 137.0; 19F-NMR 




Synthesis of 3-TFE-protected estrone (Scheme 4.12, compound 4.45).  
To a solution of estrone 4.43 (0.29 g, 1.1 mmol) in dry CH2Cl2 (4 mL) at 0 0C (ice bath) 
was added reagent 4.18 (0.86 g, 2.2 mmol) followed by the addition 1,2-DiMeIm (0.26 g, 
2.75 mmol).  The ice bath was removed after the initial 1h.   The reaction was left stirring 
until the reaction was complete by TLC (approx 24 h).  The reaction was diluted with 
CH2Cl2, washed with brine, dried (MgSO4) and concentrated to brown crude oil. Flash 
chromatography (1:4, EtOAc:hexanes) gave compound 4.45 (0.42 g, 91%) as colorless 
syrup.1HNMR (300 MHz, CDCl3) δ 0.81 (s, 3H, CH3), 1.41-1.56 (m, 6H), 1.92-2.11 (m, 
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4H), 2.26 (m, 1H), 2.38 (m, 1H), 2.49 (m, 1H), 2.92 (dd, 2H, J= 8.6, 4.0 Hz), 4.58 (q, 2H, 
J= 7.6.0 Hz, CH2CF3), 7.01 (m, 2H, ArH), 7.29 (d, 1H, J= 8.5 Hz, ArH); 13C NMR (125 
MHz, CDCl3) δ 13.7, 21.5, 25.6, 26.0, 29.3, 31.4, 35.7, 37.7, 44.0, 47.8, 50.3, 67.5 (q,     
J CF = 150 Hz, CH2CF3), 119.6, 120.8, 121.2 (q, J CF = 306.4 Hz, CF3), 127.1, 139.1, 
139.8, 147.9; 19F NMR (282 MHz, CDCl3) δ −73.3; HRMS (EI) m/z = 432.1229, 
C20H23F3O5S (M)+ requires 432.1218. 
OH
TFEO3SO  
Synthesis of 3-TFE-protected estradiol (Scheme 4.12, compound 4.46). 
 
To a solution of estradiol 4.44, (0.3 g, 1.1 mmol) in dry CH2Cl2 (4 mL) at 0 0C (ice bath) 
was added reagent 4.18 (0.43 g, 1.1 mmol) followed by the addition of a solution of 1,2-
DiMeIm (0.26 g, 2.75 mmol) in CH2Cl2 (2 mL) over 6 h using a syringe pump.  During 
the addition of the DMI another portions of reagent 4.18 (0.43 g, 1.1 mmol) was added 
after 4 h and the ice bath was removed after the initial 1h.   The reaction was left stirring 
until the reaction was complete by TLC (approx 24 h).  The reaction was diluted with 
CH2Cl2, washed with brine, dried (MgSO4) and concentrated to brown crude oil. Flash 
chromatography (1:4, EtOAc:hexanes) gave compound 4.46 as a colorless syrup (0.373 
g, 78% of the monosulfated estradiol + 0.065 g, 10% of the disulfated derivative).  1H 
NMR (500 MHz, CDCl3) δ 0.81 (s, 3H, CH3), 1.21-1.52 (m, 7H), 1.60 (s, 1H), 1.73 (m, 
1H), 1.91 (m, 2H), 1.98 (m, 1H), 2.14 (m, 1H), 2.33 (d, 1H, J= 13.0 Hz), 2.92 (t, 1H, J= 
3.6 Hz ), 3.71 (t, 1H, J= 8.4 Hz, H17), 4.64 (q, 2H, J= 7.6 Hz, CH2CF3), 7.01 (s, 1H, 
ArH), 7.06 (d, 1H, J= 8.5 Hz, ArH), 7.32 (d, 1H, J= 8.5 Hz, ArH); 13C NMR (125 MHz, 
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CDCl3) δ 11.0, 23.1, 26.1, 26.8, 29.5, 30.5, 36.6, 38.1, 38.2, 43.1, 44.1, 50.0, 67.5 (q, J CF 
= 150 Hz, CH2CF3), 81.7, 117.7, 120.8, 121.2 (q, J CF = 308 Hz, CF3), 127.1, 139.4, 
140.4, 147.8; 19F-NMR (282 MHz, CDCl3) δ −73.3; HRMS (EI+) m/z = 434.1364, 
C20H25F3O5S (M)+ requires 434.1375.   
 
General procedure for synthesis of phenyl-protected sulfocarbohydrates using 
sulfuryl imidazolium salt 4.20 (Table 4.4, compounds 4.47-4.50).  To a solution of the 
appropriate carbohydrate (0.96 mmol) in CH2Cl2 (4.2 mL) at 0 oC (ice bath) was added 2-
methylimidazole (0.23 ml, 2.4 mmol) followed by reagent 4.20 (0.77 g, 1.92 mmol). The 
reaction was stirred for 1 h at 0 oC and gradually allowed to warm to room temperature. 
The reaction was stirred overnight (24 h), then diluted with CH2Cl2, washed with brine, 
dried (MgSO4) and concentrated to a crude brown oil.  Flash chromatography (1:4, 









1,2:3,4-di-O-isopropylidene-6-O-phenylsulfo-α-D-galactopyranoside (4.47).  Prepared 
from carbohydrate 4.23 according to the general procedures. Flash chromatography (1:5, 
EtOAc:hexanes), 95% yield as a white solid, Mp 77-79 oC; 1H NMR (300 MHz, CDCl3) 
δ 1.30 (2s, 6H, 2CH3), 1.42 (s, 3H, CH3 ), 1.51 (s, 3H, CH3), 4.15 (t, 1H, J = 6.6 Hz, H5), 
4.21 (dd, 1H, J = 7.8, 1.8 Hz, H4), 4.32 (dd, 1H, J = 4.8, 2.4 Hz, H2), 4.47-4.56 (dd, 2H,  
J = 5.8, 2.5 Hz, H6, H6`), 4.62 (dd, 1H, J = 7.7, 2.2 Hz , H3), 5.51 (d, 1H, J = 4.9 Hz, 
H1), 7.32 (m, 5H, ArH);  13C NMR (75 MHz, CDCl3) δ 24.3, 24.8, 25.91, 25.94, 65.7, 
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70.2, 70.52, 70.59, 72.3, 96.1, 109.0, 109.8, 121.4, 127.4, 129.8, 150.3; HRMS (EI) m/z 
= 401.0905, C17H21O9S (M-CH3)+ requires 401.0906.  
   
 
1,2:5,6-di-O-isopropylidene-3-O-phenylsulfo-α-D-glucopyranoside (4.48). Prepared 
from carbohydrate 4.24 according to the general procedures. Flash chromatography (1:5, 
EtOAc:hexanes), 93% yield as colorless syrup.  1H NMR (300 MHz, CDCl3) δ 1.27, (s, 
3H, CH3), 1.28 (s, 3H, CH3 ), 1.39 (s, 3H, CH3), 1.48 (s, 3H, CH3), 4.18 (m, 4H, H6, H6`, 
H4, H5), 4.84 (d, 1H, J = 3.6 Hz, H2), 5.12 (d, 1H,  J = 3.6 Hz, H3), 5.88 (d, 1H, J = 3.6 
Hz, H1), 7.33 (m, 5H, ArH); 13C NMR (75 MHz, CDCl3) δ 25.0, 26.1, 26.5, 26.8, 67.1, 
71.5, 79.7, 82.5, 85.8, 104.8, 109.6, 112.7, 121.0, 121.1, 127.5, 127.6, 129.9, 130.0, 







Benzyl 2,3,4-tri-O-benzyl-6-O-phenylsulfo-β-D-glucopyranoside (4.49).  Prepared 
from carbohydrate 4.25 according to the general procedures. Flash chromatography (1:5, 
EtOAc:hexanes), 80% yield as colorless syrup. 1H NMR (300 MHz, CDCl3) δ 3.61 (m, 
4H, H4,H2, H5, H3), 4.47-5.01 (m, 11H, H6, H6`, H1, 4CH2), 7.32 (m, 25H, ArH); 13C 
NMR (75 MHz, CDCl3) δ 71.2, 72.4, 72.5, 74.9, 75.1, 75.7, 76.7, 82.0, 84.4, 102.3, 






128.6, 130.0, 137.06, 138.23, 150.3; HRMS (ESI) m/z = 714.2742, C40H44NO9S 







Benzyl 2,4,6-tri-O-benzyl-3-O-phenylsulfo-β-D-galactopyranoside (4.50).  Prepared 
from carbohydrate 4.26 according to the general procedures. Flash chromatography (1:5, 
EtOAc:hexanes), 75% yield as colorless syrup. 1H NMR (300 MHz, CDCl3) δ 3.62 (m, 
3H, H6,H6`, H5), 4.01 (t, 1H, J = 8.6 Hz, H2), 4.31 (bs, 1H, H4), 4.42 (bs, 2H, CH2), 
4.62 (m, 2H, H1, H3), 4.71- 5.01 (m, 6H, 3CH2), 7.32 (m, 25H, ArH); 13C NMR (75 
MHz, CDCl3) δ 68.18, 71.2, 72.8, 73.5, 74.2, 74.9, 75.2 76.5, 86.3, 102.4, 121.2, 127.3, 
127.6, 127.9, 127.94, 127.96, 128, 128.1, 128.2, 128.3, 128.37, 128.4, 128.5, 128.5, 
129.8, 130.1, 137.0, 137.7, 137.8, 137.89, 150; HRMS (ESI) m/z = 714.2728, 
C40H44NO9S (M+NH4)+ requires 714.2737. 
 
General procedure for the deprotection of TFE-protected sulfates with sodium azide 
(Table 4.5, compounds 4.51-4.58).  To a solution of the TFE-protected carbohydrate  
(0.156 mmol) in DMF (1 mL) was added sodium azide (0.014 g, 0.21 mmol) and the 
reaction was heated at 70 oC (oil bath) until no starting material was detected by TLC (1-
10 h). The solvent was removed by rotary evaporation.  Flash chromatography of the 
residue (20:4:1 CH2Cl2/MeOH/NH4OH) afforded the deprotected sulphate as a white 











1,2:3,4-di-O-isopropylidene-6-O-sulfo-α-D-galactopyranoside (4.51).  
Prepared according to the general procedures.Flash chromatography (10:2:0.5, CH2Cl2: 
MeOH:NH4OH), 65% yield as a white solid in addition to 20% of the glucose 6-azido 
derivative. 1H NMR (300 MHz, CD3OD) δ 1.30, (s, 6H, 2CH3), 1.37 (s, 3H, CH3 ), 1.48 
(s, 3H, CH3), 4.09 (m, 3H, H5,H6, H6`), 4.27 (m, 2H, H4, H3), 4.62 (dd, 1H, J = 7.3, 4.6 
Hz, H2), 5.47 (d, 1H, J = 4.6 Hz, H1);  13C NMR (75 MHz, CD3OD) δ 23.2, 23.9, 24.9, 
24.99, 66.5, 66.5, 70.4, 70.5, 70.8, 96.2, 108.7, 109.1; HRMS (ESI) m/z = 339.0753, 








1,2:5,6-di-O-isopropylidene-3-O-sulfo-α-D-glucopyranoside (4.52).  
Prepared according to the general procedures. Flash chromatography (10:2, CH2Cl2: 
MeOH),  90% yield as a white solid. 1H NMR (300 MHz, DMSO-d6) δ 1.19, (s, 3H, 
CH3), 1.21, (s, 3H, CH3), 1.26 (s, 3H, CH3 ), 1.35 (s, 3H, CH3), 3.75 (t, 1H, J = 8.1 Hz, 
H6`), 3.89 (t, 1H, J = 8.1 Hz, H6), 4.19 (m, 2H, H5, H4), 4.39 (d, 1H, J = 2.2 Hz, H3 ), 
4.72 (d, 1H, J = 3.6 Hz, H2 ), 5.91 (d, 1H,  J = 3.6 Hz, H1); 13C NMR (75 MHz, DMSO-
d6) δ 25.7, 26.5, 28.8, 27, 65.1, 73.4, 78.5, 79.7, 83.1, 104.8, 107.8, 111.1; HRMS (ESI) 










Benzyl 2,3,4-tri-O-benzyl-6-O- sulfo-α-D-glucopyranoside (4.53).   
Prepared according to the general procedures. Flash chromatography (10:2:0.5, CH2Cl2: 
MeOH:NH4OH), 50% yield as white solid in addition to 30% of the glucose 6-azido 
derivative.   1H NMR (300 MHz, CD3OD) δ 3.62 (t, 1H, J = 7.4 Hz, H4), 3.53 (m, 3H, 
H2, H5, H3), 4.32 (m, 2H, H6, H6`),  4.61 (d, 1H, J = 7.6 Hz, H1),  4.62-4.93 (m, 8H, 
4CH2), 7.32 (m, 20H, ArH); 13C NMR (75 MHz, CD3OD) δ 51.4, 70.6, 72.7, 74.2, 74.3, 
74.5, 74.9, 78.9, 82.1, 83.9, 102.0, 127.7, 127.9, 127.92, 128.0, 128.1, 128.16, 128.2, 
128.29, 128.3, 128.6, 128.63, 128.72, 128.79, 129, 137.8, 138.4, 139.5; HRMS (ESI) m/z 










(4.54). Prepared according to the general procedures. Flash chromatography (20:4:1 
CH2Cl2/MeOH/NH4OH), 95% yield as a white solid. 1H NMR (300 MHz, DMSO-d6) δ 
3.60 (s, 3H,  OCH3), 3.91 (bs, 1H, H5), 4.08 (AB system, 2H, J = 12.4 Hz, H6, H6`), 4.61 
(m, 2H, H4, H3), 5.35 (m, 2H, H1, H2), 5.61 (s, 1H, CHPh), 6.76, 6.86 (AA`BB` system, 
4H, J = 8.8, 8.6 Hz, ArH), 7.04 (b, 4H, NH4), 7.47 (m, 6H, ArH), 7.59 (t, 1H, J= 7 Hz, 
ArH), 7.95 (d, 2H, J = 7.8 Hz ArH); 13C NMR (75 MHz, CDCl3) δ 55.8, 66.5, 68.6, 70.0, 
73.8, 74.6, 99.6, 100.3, 115.0, 118.1, 126.7, 128.4, 128.9, 129.2, 129.9, 130.5, 133.5, 
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p-Methoxyphenyl 3-O-sulfo-4:6-O-benzylidene-β-D-galactopyranoside (4.55).  
Prepared according to the general procedures. Flash chromatography (10:2:0.5, CH2Cl2: 
MeOH:NH4OH), 88% as a white solid. 1H NMR (300 MHz, DMSO-d6) δ 3.72 (m, 5H, 
OH, OCH3, H5), 4.05 (m, 2H, H6, H6`), 4.35 (m, 2H, H4, H2), 5.03 (d, 1H, J = 7.6 Hz, 
H1), 5.26 (bs, 1H, H3), 5.50 (s, 1H, CHPh), 6.81, 7.02 (AA`BB` system, 4H, J = 8.7, 8.5 
Hz,  ArH), 7.15 (b, 4H, NH4), 7.42 (m, 5H, ArH); 13C NMR (125 MHz, DMSO-d6) δ 
55.8, 66.2, 68.7, 68.8, 74.7, 76.9, 100.1, 101.4, 114.8, 118.0, 126.7, 128.4, 129.1, 138.9, 







Methyl 2-O-sulfo-4:6-O-benzylidene-α-D-glucopyranoside (4.56). Prepared according 
to the general procedures. Flash chromatography (10:2, CH2Cl2: MeOH), 95% yield as a 
white solid. 1H NMR (300 MHz, DMSO-d6) δ 3.27 (s, 3H, OCH3), 3.43 (m, 1H, H5), 
3.57 (dt, 1H, J = 9.6, 4.2 Hz, H3), 3.66 (m, 2H, H6, H6`), 3.95 (dd, 1H, J = 9.6, 3.4 Hz, 
H2), 4.13 (dd, 1H, J = 9.6, 4.2 Hz, H4), 4.85 (d, 1H, J = 3.4 Hz, H1), 5.12 (b, 1H, OH), 
5.50 (s, 1H, CHPh), 7.36 (m, 5H, ArH); 13C NMR (75 MHz, DMSO-d6) δ 55.3, 62.5, 
68.5, 68.6, 76.8, 81.8, 99.1, 101.3, 126.8, 128.4, 129.3, 138.1; HRMS (ESI) m/z = 





Estrone-3-sulfate (4.57). Prepared according to the general procedures. Flash 
chromatography (10:2:0.5, CH2Cl2 : MeOH : NH4OH), 94% yield as a white solid. 1H 
NMR (300 MHz, DMSO-d6) δ 0.81 (s, 3H, CH3), 1.31-1.50 (m, 6H), 1.72 (m, 1H), 1.89-
2.01 (m, 3H), 2.12 (b, 1H), 2.38 (m, 2H), 2.75 (t, 2H, J= 8.6Hz), 6.85 (m, 2H, ArH), 7.01 
(b, 4H, NH4), 7.11 (d, 1H, J= 8.5 Hz, ArH); 13C NMR (75 MHz, DMSO-d6) δ 13.9, 21.6, 
25.9, 26.5, 29.5, 31.8, 35.8, 38.2, 44.0, 47.8, 50.0, 118.5, 120.9, 125.9, 134.7, 137.0, 




Estradiol-3-sulfate (4.58).  Prepared according to the general procedures. Flash 
chromatography (10:2, CH2Cl2:MeOH), 96% yield as a white solid. 1H NMR (500 MHz, 
CD3OD) δ 0.82 (s, 3H, CH3), 1.21-1.52 (m, 7H), 1.63 (m, 1H), 1.91 (m, 1H), 2.01 (m, 
2H), 2.18 (m, 1H), 2.33 (d, 1H, J= 13.0 Hz), 2.88 (t, 1H, J= 3.6 Hz ), 3.67 (t, 1H, J= 8.4 
Hz, H17), 7.04 (m, 2H, ArH), 7.25 (d, 1H, J= 8.5 Hz, ArH); 13C NMR (125 MHz, 
CD3OD) δ 10.2, 22.6, 26.1, 26.9, 29.1, 29.3, 36.6, 38.8, 42.9, 44.1, 49.9, 81.06, 118.3, 
121.0, 125.5, 136.7, 137.4, 150.2; HRMS (ESI) m/z = 351.1272, C18H23O5S (M-H)- 
requires 351.1266.  
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Chapter 5.  Towards the Total Synthesis of the Disulfated 
Tetrasaccharide Portion of SB1a, a Carbohydrate Antigen Associated 
with Human Hepatocellular Carcinoma  
______________________________________________________ 
5.1 Introduction 
 As we mentioned in Chapter 2, a series of modified sulfuryl imidazolium salts 
(SIS’s) were prepared and their sulfating abilities were studied.  The most efficient 
sulfating agent, 2.4, was obtained by incorporating a methyl group at the 2-position of the 
imidazolium ring of the original reagent 1.83. The trichloroethyl-protected sulfates could 
be introduced into monosaccharides in excellent yields using reagent 2.4.  The TCE 
group withstands many of the conditions that are commonly encountered in carbohydrate 
chemistry and a simple disaccharide containing TCE-protected sulfates was prepared and 
the suflate groups deprotected in high yield (see chapter 1 section 1.3.4).38   In Chapter 3, 
we showed that the direct regioselective incorporation of TCE-protected sulfates into 
monosaccharides can be achieved using reagent 2.4 and that the TCE group can be 
removed from di- and trisulfated monosaccharides under mild conditions in excellent 
yields.  Our next objective is to demonstrate that our sulfate-protecting group strategy can 
be applied to the synthesis of a complex multisulfated oligosacharide.  In this chapter we 
present our studies on the application of our sulfate protecting group strategy towards the 
synthesis of the tetrasaccharide portion of a disulfated glycosphingolipid called SB1a.  
 In 1982, Tadano and coworkers isolated a novel disulfated tetraglycosylceramide 
from the lipid extract of rat kidney.92  After extensive structural studies, Tadano and 
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coworkers proposed the structure of this glycolipid to be (HSO3-3)Galβl-3GalNAcβ1-
























Figure 5.1.  The structure of SB1a (5.1). 
  
In 1988, Hiraiwa and coworkers raised two mouse monoclonal antibodies against 
human hepatocellular carcinoma (HCC) cells and an acidic glycolipid mixture prepared 
from the same cells.93  The antigen recognized by both monoclonals was determined to 
be SB1a. SB1a was found to be strongly expressed on the surface of human HCC’s but 
was not detectable in the acidic glycolipid fractions obtained from normal livers 
indicating that the SB1a antigen is associated with human HCC.  
 Little is known about the function of SB1a.  In order to clarify the functions of 
SB1a in detail, especially its involvement in the metastasis of human HCC and hence 
pursue carbohydrate-based anticancer vaccines for HCC, Li and coworkers undertook the 
first synthesis of the disulfated tetrasaccharide moiety of SB1a (5.2, Figure 5.2).  The 
ceramide moiety was replaced by a 2-aminoethyl spacer arm which could be used to 




















Figure 5.2.  The tetrasaccharide portion of SB1a.with a tether attached to the reducing 
end, prepared by Li et al. 
 Li et al. used a [2+1+1] approach to form the fully protected tetrasaccharide back 
bone.  The orthogonal protecting group strategy was used where the hydroxyls that would 
ultimately contain the sulfate groups were orthogonally protected using p-methoxybenzyl 
(PMB) and monochloroacetate (MCA) moieties.  2-N-Phthalimido and 2-O-benzoyl 
protected donors were used to direct the required β-glycosidic linkages. Finally, benzyl 
ethers were used for permanent protection of the rest of the hydroxyl groups.  
 The authors started the synthesis of the SB1a tetrasaccharide with the preparation 
of lactosyl acceptor 5.6 which had been previously prepared by Chernyak et al (Scheme 
5.1).94 No details were given for the synthesis of this compound by Li et al.  Chernyak et 
al’s synthesis along with the yields they obtained is shown Scheme 5.1.  Treating lactose 
acetate derivative 5.3 with hydrogen bromide in acetic acid followed by 2-azidoethanol in 
the presence of mercuric cyanide and mercuric bromide afforded the 2-azidoethyl lactose 
derivative 5.4 in 44 % yield.  Deacetylation of 5.4 with sodium methoxide gave the 2-
azidoethyl lactose in 95% yield.  The resulting material was subjected to p-TsOH in 
acetone then the crude product was treated with benzyl bromide and sodium hydride in 
DMF to afford the fully protected disaccharide in 55% yield (over the two steps).  
Removal of the acetal group was achieved in 92% yield by treating the fully protected 
disaccharide with 70% TFA in methylene chloride.  The lactosyl diol 5.5 was prepared in 
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21% overall yield from 5.3. Tin mediated selective alkylation of 5.5 afforded the 3`-p-
methoxybenzyl ether derivative 5.6 in 90% yield (the overall yield of 5.6 is 19% over the 
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    (55% for steps 2 and 3)
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Scheme 5.1 Synthesis of the lactosyl acceptor 5.6 
 Standard glycosylation of acceptor 5.6 and the glycosyl donor 3,4,6-tri-O-acetyl-
2-deoxy-2-phthalimido-β-D-galactopyranosyl trichloroacetimidate 5.7 (prepared in 5 











































Prepared in 5 steps
5.8
 
Scheme 5.2.  Synthesis of the trisaccharide 5.8. 
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 Trisaccharide 5.8 was subjected to a series of protecting group manipulations 
including dephthaloylation using 1,2-diaminoethane in n-butanol at 75 oC followed by N-
acetylation to give 5.9 in 91% yield. O-Deacetylation of 5.9 followed by installation of 
the 4,6-O-benzylidene acetal provided the trisaccharide acceptor 5.10 in 90% yield 
(compound 5.10 was obtained on 67% overall yield starting from disaccharide 5.6) 



















































    CSA, CH3CN
1. 1,2-diaminoethane, 75 oC






Scheme 5.3  Synthesis of the trisaccharide acceptor 5.10 
 
 With the trisaccharide acceptor 5.10 in hand, the authors first examined ethyl 
2,4,6-tri-O-acetyl-3-O-p-methoxybenzyl-1-thio-β-D-galactopyranoside 5.11 and the 
corresponding glycosyl bromide 5.12 (Figure 5.3) as the glycosyl donor for the assembly 
of the tetrasaccharide backbone.  No reaction occurred when 5.11 and 5.10 were reacted 
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at room temperature employing Bu4NBr–CuBr2 as the promoter in nitromethane or DMF 
or when using methyl triflate as promotor in dichloromethane or diethyl ether. The 
authors then tried the glycosylation of the donor 5.12 with the trisaccharide acceptor 5.10 
in the presence of silver triflate as a promoter, but again no desired tetrasaccharide was 























Figure 5.3.  Glycosyl donors 5.11, 5.12 and the disaccharide by-product 5.13 
  
After the above failures the authors then turned to glycosyl donor 5.16.  This 
donor was prepared by chloroacetylation of the known ethyl 4-O-acetyl-2,6-di-O-
benzoyl-1-thio-β-D-galactopyranoside 5.1498 (Compound 5.14 was prepared in 6 steps in 
28% overall yield starting from galactose pentaacetate)98 followed by the in situ 
transformation to the bromide using bromine in methylene chloride at -20 oC (Scheme 




















Scheme 5.4  Synthesis of the glycosyl bromide 5.16 
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galactose pentaacetate. Surprisingly, when glycosyl bromide 5.16 was treated with the 
trisaccharide acceptor 5.10 in CH2Cl2 at -20 oC in the presence of silver triflate as 


















































Prepared in 7 steps 
from its precursor
 
Scheme 5.5  Synthesis of the protected tetrasaccharide 5.17 
 The protected tetrasaccharide 5.17 was subjected to several transformations to 
give the target tetrasaccharide 5.2.  First, selective removal of the chloroacetyl group at 
the 3```-OH position was achieved in 76% yield by treating 5.17 with thiourea in CH2Cl2-
EtOH at 58 oC in the presence of 2,6-lutidine. In the next step, the p-methoxybenzyl 
group at 3`-OH position was removed selectively with cerium(IV) ammonium nitrate 
(CAN), to give diol 5.18 in 92% yield (Scheme 5.6).  Treatment of the diol 5.18 with 
sulfur trioxide·pyridine complex in pyridine furnished the disulfated tetrasaccharide 5.19 
in 94% yield. Subjecting the disulfated tetrasaccharide 5.19 to catalytic hydrogenolysis, 
using Pd/C in different solvents (AcOH, 2:1 MeOH–AcOH) proceeded very slowly and 
gave low yields. The authors attributed this problem to some undefined inhibitory 
interaction of the catalyst with the aminoethyl fragment formed during the reaction.99,100 
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To over come this apparent inhibitory effect, the authors converted the amino group  to 
its hydrochloride salt and then did the hydrogenolysis reaction which gave the target in 






































































































    58 oC, 76 %
2. CAN, CH3CN-H2O,
    rt, 92%
SO3.Pyr, Pyr
1. H2,10% Pd/C, 
    MeOH-H2O, 0.1 M HCl, 60 h, 88%
2. 0.012M NaOMe-









 0.5 M NaOMe-MeOH, 
     0 oC, 6 h
 
Scheme 5.6  Completed synthesis of the SB1a tetrasaccharide 
Some difficulties were faced during the saponification of the ester groups on the left hand 
galactose moiety. Saponification with 0.012 M sodium methoxide in MeOH at room 
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temperature gave the 2```-O-benzoyl 5.20 where only the ester groups at 4```-OH and 
6```-OH were hydrolysed. Increasing the base concentration and prolonging the reaction 
time only led to decomposition of the product. On the other hand, using ammonia in 
MeOH led to O-desulfation, and no O-deacylation was observed.  The saponification of 
5.20 was eventually achieved using 0.5 M sodium methoxide in MeOH at 0 °C for 6 h 
which gave  compound 5.2 in 90% yield (Scheme 5.6). 
5.2 Objectives 
 Although Li et al.25 achieved the synthesis of 5.2 their approach did have some 
shortcomings.  Although good yields were eventually obtained for most steps some 
significant problems were encountered at various stages especially during the 
deprotection of the benzoyl groups at the end of the synthesis.  Because the sulfate group 
was introduced using the traditional approach at the end of the synthesis, protecting group 
manipulations had to be performed in the latter stages of the synthesis to accommodate 
them.  The objective of the work described in this chapter is to determine if a superior 
synthesis of SB1a can be achieved using the sulfate protecting group strategy.   
5.3 Results and Discussion 
 We chose the SB1a tetrasaccharide as a target to test our sulfate protecting group 
approach to the synthesis of complex multisulfated oligosaccharides for several reasons.  
First, as we discussed in the introduction, it had been made before using traditional 
sulfation strategies.  This was important since we wished to compare the synthesis of a 
complex sulfated oligosaccharide using the sulfate protecting group approach to the 
traditional approach.  The second reason had to do with our selective sulfation studies 
described in Chapter 3.  We had recently discovered that we were able to incorporate a 
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TCE-protected sulfate group selectively into the 3-OH of thiogalactosyl derivative 3.131 





















Scheme 5.7.  Selective sulfation of carbohydrate 3.126. 
reaction would be very useful in the synthesis of sulfated oligosaccharides containing one 
or more galactosyl residues with a sulfate at the 3-position.  SB1a contains two galactosyl 
residues with a sulfate at the 3-position and so was a very good target for testing this.  
The third reason has to do with the N-acetyl group in residue 3.  The N-acetyl group is 
found in many in oligo- and polysaccharides.  However, carbohydrates bearing N-acetyl 
groups at the 2-position are usually not used as donors in glycosidation reactions since 
very stable oxazoline compounds can readily form upon donor activation (such as 5.22 in 













Scheme 5.8. Stable oxazoline formation 
 
This is why Li et al used a phthalimido group to protect the amino group in residue 3 in 
their synthesis of SB1a (Scheme 5.2).  The phthalimido group participates during 
glycosidic bond formation between 5.6 and 5.7 but does not form stable oxazoline 
compounds.  Hence, the glycosidic bond is formed and with the required β-
 151
stereochemistry.  The disadvantage of the phthalimido group is that it has to be removed 
and the resulting free amino group acetylated which increases the number of steps (as in 
Scheme 5.3). Other amino protecting groups besides the phthalimido group have also 
been used.  One is the trichloroacetyl (TCA) group (Scheme 5.9).101 This group also 
participates during glycosidic bond formation but does not form stable oxazoline 
compounds.  The advantage of using this protecting group is that it can be directly 
converted to the N-acetyl group using tributylstannane and AIBN or by hydrogenolysis 



















































Scheme 5.9.  2-Trichloroacetamido-2-deoxyglucopyranosyl glycosyl donors. 
Laura Ingram, a former graduate student in the Taylor group has shown that a 
monosaccharide containing a TCE-protected sulfate and a TCA-protected amide group 
















10% Pd/C (25 wt%)




   Scheme 5.10. Co-reduction and deprotection of trichloroacetamide and TCE groups 
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an excess of Et3N (Scheme 5.10).  We wanted to try this methodology on a more complex 
carbohydrate such as SB1a.  Indeed, we ultimately wanted to design a synthesis of SB1a 
such that all of the protecting groups could be removed at the end of the synthesis in a 
single step by hydrogenolysis.  By doing so we would avoid the difficulties encountered 
by Li et al during the removal of the benzoyl groups at the end of their synthesis.  The 
obvious group for protecting the hydroxyl moieties that would not bear a sulfate group 
was the benzyl group either in the form of a benzyl ether or benzylidene acetal as it can 
be readily removed by hydrogenation.  However, we could not use a benzyl ether at the 
2-position of residues 2 and 4 since we required a participating group at these positions to 
get the desired β-stereochemistry.  The carbobenzyloxy (Cbz) group offered itself as a 
possible alternative.  Although the Cbz group is rarely used in carbohydrate chemistry  it 
has been shown that it can be readily introduced into carbohydrates, can participate to 
give exclusively trans-1,2 linkages and can be removed by catalytic hydrogenolysis.103-105  
The only potential problem in using the Cbz group is that under certain glycosidation 
conditions the benzyl group (derived from a Cbz group at the 2- position of the donor) 
can be transferred to the acceptor.106  This issue will be discussed in more detail in a 
subsequent section in this chapter. 
 Our first synthetic strategy for the synthesis of SB1a is shown in Scheme 5.11.  
We anticipated that the target tetrasaccharide 5.29 could be prepared from the fully 
protected precursor 5.30 (Scheme 5.11). The protecting groups in 5.30 (the benzyl ethers 
and benzylidene acetals, Cbz, TCE-protected sulfate and TCA-protected amide group) 
were chosen such that they could be removed in one step by catalytic 
hydrogenation/hydrogenolysis in the last step of the synthesis. Tetrasaccharide 5.30 
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would ultimately be assembled from the disaccharides 5.31 and 5.32 which in turn would 
be synthesised from monomers 5.33, 5.34 and 5.35 (Scheme 5.11). Monomer 5.33 would 
be easily prepared via our selective sulfation methodology and two of the residues would 
















































































5.34 5.355.33  
 
Scheme 5.11. Retrosynthesis of the tetrasaccharide of SB1a  
 
 The formation of 5.32 involves the coupling of donor 5.33 and acceptor 5.34 both 
of which are thioglycosides. They clearly have different groups attached to the 2- and 3-
positions and one is a phenyl thioglycosides while the other is a tolyl thioglycoside.  
 154
Thioglycoside reactivity can be manipulated by the introduction of different thiol 
aglycons.107c  In 2002, Lahmann and Oscarson reported a study on the reactivity of 
thioglycosides with different aglycon moieties using competitive glycosylations. The 
authors used methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside 5.41 as an acceptor and 
DMTST ((dimethylthio) methylsulfonium trifluoromethanesulfonate) as a promoter. 107c 
Lahmann and Oscarson found that the reactivity depends on the electron donating 
properties of the aglycon (Scheme 5.12). 107c The donor bearing the more electron 
donating group attached to the sulfur was more readily activated by the promotor and so 
was a better donor. On the basis of these results one would expect that carbohydrate 5.33 



































R= Me, n-Bu, n-Hex, c-Hex, 
      i-Pr, t-Bu, Ph, Tol, m-ClPh,
     p-ClPh, m-BrPh, p-BrPh
 
Scheme 5.12. A competitive glycosylation of thioglycosides with different aglycon 
 
 Protecting groups can also affect the reactivity of donors (and acceptors).  In 
1988, Fraser-Reid and coworkers, introduced the armed–disarmed concept to denote the 
influence of the protecting groups on the reactivity of the anomeric n-pentenyl group. The 
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authors reported that, n-pentenyl glycoside 5.36, “armed” with the electron-donating 
benzyl groups, was selectively activated with IDCP (iodonium dicollidine perchlorate) to 
couple with n-pentenyl glycoside 5.37, which is “disarmed” with the electron-
withdrawing acetyl groups, where disaccharide 5.38 was formed in 62% yield without 




























Scheme 5.13. A prototypical “armed-disarmed” glycosylation. 
 
 It is not known whether a trichloroacetamide (TCA) group at the 2-position in a 
donor (as in 5.34) arms or disarms a donor.  The chlorines are electron withdrawing 
which may decrease the reactivity of 5.34 relative to 5.33.  However, no studies have 
ever been conducted on the effect of a TCE-protected sulfate on the reactivity on a donor 
nor has the effect of a Cbz group been examined.  The TCE-protected suflate in 5.33 will 
certainly be electron-withdrawing and deactivate it but is further away for the anomeric 
position than the TCA group in 5.34. No matter what their respective reactivities, 5.33 
will have to be activated in preference to 5.34 in order to obtain 5.32.   Should we witness 
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products resulting from the self-coupling of 5.34 during the formation of 5.32, then 
modifications will have to be made to donor 5.33.   
5.3.1 Synthesis of the Glucosyl acceptor 5.35 
 Glucosyl acceptor 5.35 was prepared according to the reported literature 
procedures starting from methyl α-D-glucopyranoside (Scheme 5.14).108 Methyl α-D-
glucopyranoside 5.43 was stirred with a mixture of benzaldehyde and anhydrous zinc 
chloride at room temperature to afford the corresponding benzylidene acetal in 78% 
yield.  Treatment of the diol with benzyl bromide and sodium hydride in DMF for 24 
hour gives the fully protected methyl glucopyranoside 5.44 in 85% yield. Acceptor 5.35 
was obtained in 89% yield by reductive opening of the benzylidene acetal 5.44 with 



















TFA, 5 eq, 
CH2Cl2, rt, 6 h
89 %
2. BnBr, 5 eq
NaH, 7 eq, DMF, 85%
1. PhCHO, ZnCl2, 78%
5.43 5.44 5.35
 
Scheme 5.14. Synthesis of glucosyl acceptor. 
 
5.3.2 Synthesis of the GalNTCA Acceptor 5.34 
 The synthesis of acceptor 5.34 was straight forward starting from the 
commercially available galactose amine hydrochloride 5.45 using the known literature 
procedures.109  Condensation of the amino group in 5.45  with p-anisaldehyde in presence 
of 1 M NaOH afforded 5.46 in 75% yield.  Acetylation of 5.46 followed by the 
deprotection of the amino group give the free amino galactose amine 5.48 almost in 
quantitative yield. Protection of the amino functionality with TCA-group was achieved in 
96% yield using trichloroacetyl chloride and pyridine in methylene chloride (Scheme 
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5.13). The fully protected galactose amine 5.49 was treated with BF3OEt2 in the presence 
of benzenethiol to give compound 5.50 in 90% yield.  Removal of the remaining acetate 
protecting groups gave triol 5.51 in near quantitative yield. Treatment of the triol with 
benzaldehyde dimethyl acetal in the presence of catalytic amount of CSA in acetonitrile 
afforded the benylidene acetal acceptor 5.34 in 80% yield (Scheme 5.15). The overall 




















CH2Cl2, 20 h, rt
C6H5CH(OMe)2, 2 eq















































Scheme 5.15.  Synthesis of galactose amine acceptor 5.34. 
5.3.3 Synthesis of the galactose donor 5.33 
 As we mentioned in the beginning of this chapter and chapter 3 we were able to 
introduce the TCE-protected sulfate selectively into the 3-OH of the galactose in the 
presence of 2-OH free in excellent yield (Scheme 5.7).  The thiogalactose diol 3.126 was 
prepared in good yield starting from the commercially available galactose pentaacetate in 
three steps.110 The TCE-protected sulfate was selectively introduced into the 3-OH in 
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94% yield by treating the diol 3.126 with the imidazolium salt 2.4 in methylene chloride 





OAcOAc 4-MePhSH,2.5 eq 






















1. NaOMe/MeOH, rt, 












Scheme 5.16.  Selective sulfation of galactose diol. 
 With the TCE-protected sulfate 3.131 in hand, we started looking for conditions 
for introducing the Cbz group into the 2-OH.  Unfortunately, once the TCESO3 moiety 
had been installed, the 2-OH of 3.131 appeared to be extremely unreactive.  Under 
different conditions including different bases, solvents, and temperatures and after many 
trials, we were not able to introduce the Cbz-group into the desired donor and the starting 
material was isolated each time without observing the product. To insure that the problem 
was not due to the Cbz-group, we tried other acylating agents under the same conditions 














Acylating agents: Benzoyl chloride
                            Carbobenzyloxy chloride
                            Benzoic anhydride
                            Chloroacetyl chloride
                            Chloroacetic anhydride
Bases: DMAP-  Et3N
            DABCO
            DMAP-Pyridine
            Pyridine
3.131 5.33
Acylating agent , base
solvent
 
Scheme 5.17  Different acylating conditions 
 Since we were unable to introduce the Cbz-group into compound 3.131, we 
decided to find an alternative route for the synthesis of the galactose donor 5.33.  In 2004, 
Shan Ye et al. reported that 2,3-diols of benzylidene acetal-protected galactosides could 
be selectively acylated at the 2-position using freshly prepared silver oxide and KI 























KI, 0.2 eq, CH2Cl2, rt +




Scheme 5.18.  Selective incorporation of benzoyl group 
 
to introduce the Cbz-group into the 2-OH of diol 3.126.  If successful we would then 
install the TCE-SO3 group at the 3-OH to complete the synthesis of 5.33.  When diol 
3.126 was treated with CbzCl under the same condition described by Xin-Shan Ye,111 the 
desired product 5.56 was isolated in relatively low yield (15%) after a tedious separation 
from the 3-O-Cbz derivative 5.57 which was isolated in a 20% yield.  Compound 5.56 
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was treated with imidazolium salt 2.4 and 1,2-dimethylimidazole (1,2-DiMeIm) in 








































 Ag2O, 1.5 eq
KI, 0.2 eq, CH2Cl2, rt +









Scheme 5.19.  Selective incorporation of Cbz- group. 
 Due to the low yield and the difficult purification of thiogalactoside 5.56, we 
decided to search for a better route to 5.33.  In 2004, Jacquinet was able to selectively 
introduce a benzoyl protecting group at the 3-position of 2, 3-diol-4,6-O-benzylidene- 
galactose protected with OMP group at the anomeric position. The author was able to 
migrate the benzoyl group to the 2-position in good yield by subjecting it to a solution of 
NaOH in acetone-water (Scheme 5.20).112 The migration took 3 minutes and the product 
precipitated during the reaction which probably helped in pushing the equilibrium 
































CH2Cl2, 5 h, rt
75 %
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Scheme 5.20.  Selective benzoylation and benzoyl migration. 
 On the basis of the Jacquinet’s work, another route for the synthesis of donor 5.33 
was proposed in which the Cbz group would be selectively introduced into the 3-position 
of 3.126 and then migrated to the 2-position to provide 5.56. Compound 5.56 would then 


































Scheme 5.21. Proposed route to donor 5.33 
 
This work was done by Laura Ingram a former colleague in the Taylor laboratory while 
she was performing studies on migration of Cbz-group in carbohydrates. Migration of a 
Cbz group from 3-OH to 2-OH (or vice versa) in a carbohydrate had never been 
demonstrated before.  After trying many conditions, she was able to selectively introduce 
the Cbz group into the 3-OH of diol 3.126 by adding a solution of Cbz-Cl (2 equiv) in 
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methylene chloride dropwise over 1.5 hour to a solution of 3.126 and 2 eq. of pyridine. 
After stirring the reaction for 3 hour at room temperature, another equivalent of CbzCl 
was added dropwise over 30 minutes and the reaction was stirred for an additional hour.  
Compound 5.61 was isolated in 84% yield (Scheme 5.22).  Compound 5.61 was 
subjected to a variety of conditions including those of Jaquinet condition but 
unfortunately, a mixture of the 3-OCbz 5.61 and 2-OCbz 5.56 isomers was obtained.  The 
















pyridine, 5 eq., CH2Cl2
84%  
 Scheme 5.22.  Selective installation of the Cbz protecting group into 3.126. 
  
The benzoyl migration reaction reported by Jacquinet was performed on the same 
galactose derivative but he used an OMP group for the protection of the anomeric 
position instead of STol group in our case.  In order to determine if the thiol moiety at the 
anomeric position was hindering the migration of the Cbz-group, Laura Ingram tried the 
migration reaction on the galactose derivative protected at the anomeric position with 
OMP-group using Jacquinet’s migration conditions (Scheme 5.23). The Cbz-group was 
selectively introduced to the 3-OH of diol 5.58 using the same condition for the 
preparation of compound 5.61.  The desired product was isolated in 94% yield (Scheme 
5.23). Subjecting compound 5.62 to the condition used by Jaquinet, the 2-OCbz galactose 
derivative 5.63 precipitated out from the reaction mixture and was isolated by filtration in 
89% yield (Scheme 5.23).   
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 After this achievement, our strategy for the synthesis of the TCE-protected sulfate 
galactose donor was changed. Compound 5.63 was sulfated in 86% yield using 
imidazolium salt 2.4 followed by removal of the OMP- group using CAN and acetonitrile 
at 30 oC to afford the hemiacetal 5.65 in 76% yield (Scheme 5.24).  Treatment of the 
hemiacetal 5.65 with Cl3CCN and DBU in dry methylene chloride at -35 oC give the 
trichloroactimidate donor 5.66 in 86% yield (Scheme 5.24).  The synthesis of compounds 






















acetone, 0 oC, 5 min
0.05 M
5.58 5.62






































Reagent 2.4, 2 eq.
1,2-DiMeIm, 2.5 eq
CH2Cl2, rt, 24 h
CH3CN, (0.02 M)









Scheme 5.24.  Synthesis of trichloroacetimidate donor 5.66. 
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Although the synthesis of donor 5.66 was achieved in good yield, there were 
some drawbacks to this route.  First, we missed the advantage of selectively incorporating 
the TCE-protected sulfate into diol 3.126.  Conseqently, the synthesis of donor 5.66 
requires 5 steps starting from diol 5.58, while the synthesis of 5.33 - if we were able to 
achieve it - requires two steps only (Scheme 2.25).  Finally, we found that the yields for 
removal of the OMP from 5.64 were not consistent especially when the reaction was run 




































Scheme 5.25.  Comparison between the number of steps required 
for synthesis of donors 5.66 and 5.33. 
 Due to the above limitations, we decided to try again the synthesis of the 
thiogalactoside donor 5.33 by finding a suitable method for the installation of the Cbz-
group at the 2-OH of the sulfated thiogalactoside 3.131.  After many attempts under a 
variety of conditions we eventually found that the Cbz-group could be successfully 
introduced into our target by adding 3 eq. of Cbz-Cl portionwise over 15 minutes to a 
solution of compound 3.131 and 5 eq. of DMAP in methylene chloride at room 
temperature (Scheme 5.24). The starting compound 3.131 was completely consumed 
within 4 hours, where the desired product 5.33 was isolated in 92% yield.  In our 
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previous attempts we only used DMAP in catalytic quantities and in the presence of other 
bases.  It is possible that when using a high concentration of DMAP the Cbz-Cl is 











Cbz-Cl, 3 eq, 
DMAP, 5 eq




Scheme 5.26.  Incorporation of Cbz-group into the galactose donor 
 All of the building blocks required to prepare disaccharides 5.31 and 5.32 were 
now in hand (Figure 5.4).  Only 15 steps were required for their preparation.  We then 
started looking for glycosylation conditions that would enable us to build the desired 

















OCH35.34 5.355.33  
Figure 5.4.  Building blocks for the tetrasaccharide of SB1a 
5.3.4. Synthesis of disaccharide 5.32  
 Among the wide variety of promoters that can be used for the activation of 
thioglycoside donors, we selected the conditions developed by Crich et al. which employ 
a combination of 1-benzenesulfinyl piperidine (BSP) and trifluoromethanesulfonic 
anhydride (Tf2O) as promoters. These were chosen since they have been shown to be 
very successful with both armed and disarmed thioglycosides.113,114 For the synthesis of 
the left hand disaccharide, a mixture of thioglycoside donor 5.33, BSP, and 2,4,6-tri-tert-
butylpyrimidine (TTBP) in anhydrous methylene chloride in the presence of 3Å 
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molecular sieves were activated at low temperatures with Tf2O. A few minutes after the 
addition of the Tf2O, the galactose amine acceptor 5.34 was added (Scheme 5.27a). 
However, after analysis of the major isolated product, the spectroscopic data indicated 
that target disaccharide 5.32 was not formed. Instead, the major products isolated from 
the reaction were the cyclic carbonate 5.67 and benzylated acceptor 5.68 (Scheme 5.27b).  






















































BSP, 1 eq, TTBP, 2 eq
















 Scheme 5.27. Unsuccessful glycosylation using donor 5.33 
This was not entirely unexpected as Montero et al. reported the same type of benzyl 
group transfer reaction during the coupling of donor 5.69 with acceptor 5.70 in presence 
of AgOTf as a promoter.  The benzylated acceptor 5.71 was formed as the only isolated 
product (Scheme 5.28a).106  However, the authors mentioned that the target disaccharide 
was obtained in 65% yield by using trichloroacetimidate donor 5.72 instead of the 
bromide donor 5. 69 (Scheme 5.28b).  Only the β-isomer was formed indicating that the 
Cbz group directed the formation of the trans-1,2 linkage.  Thioglycoside donors bearing 





























































Scheme 5.28. Benzyl migration during the synthesis of disaccharide 5.73106 
 Montero et al. suggested a mechanism for the formation of the side product in that 
upon activation, the 2-O-Cbz group of the donor participates in the formation of the 
oxazolium ion 5.74. The subsequent nucleophilic attack by the acceptor, however, did not 
occur at the anomeric position as required, but at the benzylic carbon in the Cbz 








































5.74 5.75  
 
Scheme 5.29. Mechanism for cyclic carbonate formation as proposed by Montero and 
coworkers106 
 
 On the basis of Montereo and coworkers’ results we decided to switch to the 
trichloroacetimidate glycosyl donor 5.66.  We had already prepared 5.66 from the OMP-
glycoside 5.64 (Scheme 5.24).  However, as we mentioned above, there were drawbacks 
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to that route.  Therefore, we decided to see if we could prepare 5.66 more efficiently from 
thioglycoside 5.33.  Thioglycoside 5.33 was treated with NBS/H2O to afford the 
corresponding hemiacetal 5.65 in an 89% yield. Subsequent treatment of hemiacetal 5.65 
with a catalytic amount of DBU in the presence of trichloroacetonitrile in methylene 
chloride at -40 oC afforded imidate 5.66 in a 90 % yield (Scheme 5.30).  This procedure 
was superior to our previous approach as the overall yield was higher and was 
reproducible upon scale-up. The overall yield of 5.66 starting from 3.126 was 50 % (7 































oC to rt 5.665.65
 
Scheme 5.30. Synthesis of trichloroacetimidate donor 5.66 
Trichloroacetimidate 5.66 and glycosyl acceptor 5.34 were treated with TMSOTf at -40 
°C in anhydrous methylene chloride in presence of 4oA molecular sieves to afford the 

























4A  MS, -40 0C, 1 h




Scheme 5.31. Synthesis of disaccharide 5.32. 
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5.3.5. Synthesis of right hand disaccharide acceptor of SB1a   
 For the synthesis of disaccharide 5.76, the trichloroacetimidate glycosyl donor 
5.66 and the glucose acceptor 5.35 were subjected to a variety of glycosylation conditions 
including different promoters such as BF3.OEt2, TMSOTf, HClO4-SiO4, under a range of 
reaction temperature (-40 oC to room temperature) in different solvents such as methylene 
chloride and acetonitrile in presence of 4oA molecular sieves. After many trials, the 
synthesis of target disaccharide 5.76 was achieved in 68% yield with the required β-
linkage by treating a mixture of donor 5.66 and acceptor 5.35 in dry methylene chloride 
with 0.2 equivalent of TMSOTf at -40 oC. The glycosyl donor 5.66 was used in excess 
(1.6 eq.). Again, no benzyl migration or formation of cyclic carbonate were observed 

























 -40 0C, 1 h




Scheme 5.32. Synthesis of disaccharide 5.76 
 For selective ring opening/reduction of the benzylidene acetal, disaccharide 5.76 
was subjected to a variety of conditions commonly used in carbohydrate chemistry for 
opening of the benzylidene acetals.  Treatment of disaccharide 5.76 with Et3SiH in 
methylene chloride in the presence of TFA at room temperature or TfOH at -78 oC led to 
the cleavage of the acetal, where the 4,6-diol was obtained as the major product (Scheme 
5.33a). On the other hand, by treating disaccharide 5.76 with Et3SiH/TFA at lower 
temperature, no significant reaction was observed and the starting material was isolated.  
A thorough literature search revealed that the majority of benzylidene acetals in galactose 
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derivatives were selectively opened and reduced (to give the free 4-OH) by passing dry 
HCl gas into a solution of the galactose derivative in the presence of NaCNBH3.115  
Applying these conditions to disaccharide 5.76, led to the regioselective opening of the 
benzylidene acetal where the desired disaccharide acceptor 5.31 was isolated in 75% 





























TES /TFA /CH2Cl2 
MS,  rt, 0, -40 oC
or TES /TfOH /CH2Cl2




















Scheme 5.33. Synthesis of disaccharide acceptor 5.31 
 Some of the selective sulfation studies reported in Chapter 3 were being done 
concurrently with our SB1a synthesis.  While we were tackling the synthesis of SB1a, we 
discovered that we were able to incorporate the TCE-protected sulfate selectively into the 
3-OH of galactose derivative 3.135 in good yield (Scheme 5.34).  It then occurred to us 
that we might be able to perform a selective sulfation on the 3-OH of the galactosyl 
portion of a lactose derivative and so have a potentially more efficient route (we will call 
this route # 2) to the right-hand disaccharide portion of the SB1a tetrasaccharide.  More 
specifically, the idea was to start with peracetylated lactose and convert it into protected 
disaccharide diol 5.78 using chemistry similar to that developed for the preparation of 5.5 
(Scheme 5.1).95,96  A selective sulfation would then give the desired disaccharide 5.79 






























































Scheme 5.35.  Alternative route to the synthesis of the right-hand disaccharide acceptor 
5.3.6. Synthesis of lactosyl acceptor 5.79   
 The lactose diol 5.78 was prepared in six steps starting from commercially 








































2. MeOH, 1 N HCl
















Scheme 5.36. Synthesis of lactose diol 5.78 
Treatment of lactose diol 5.78 with 1.5 equivalent of imidazoliun salt 2.4 in methylene 
chloride followed by the dropwise addition of 2 equivalent of 1,2-DiMeIm afforded the 
desired lactosyl acceptor 5.79 in 78% yield in addition to 10% of the disulfated derivative 










 Imidazolium salt 2.4,1.5 eq. 














Scheme 5.37.  Selective sulfation of lactose diol 5.78 
  
We now had two very good routes to the protected right-hand disaccharide 
portion of our target.  In route # 2 disaccharide 5.79 was prepared in just 7 steps in an 
overall 31% yield which is very respectable.  In route # 1, disaccharide 5.31 required 12 
steps.  The overall yield of 5.31 is difficult to compute since it is a convergent synthesis 
where donor 5.66 was prepared in an overall 50% yield over 7 steps and acceptor 5.35 in 
an overall 60% yield over 3 steps.  The coupling of these two monomers (Scheme 5.32) 
and the subsequent ring opening of the resulting disaccharide (Scheme 5.33) proceeded in 
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yields of 68 % and 75 % respectively.  So route # 2 is the superior route for the synthesis 
of this disaccharide. However, it is not the best approach for the synthesis of the target 
tetrasaccharide since donor 5.66 has to be prepared no matter what route we chose for 
the synthesis of the right-hand disaccharide since it is required for the synthesis of the 
left-hand disaccharide 5.32 (Scheme 5.31).  So although route # 2 is a very efficient route 
to the protected right-hand disaccharide, it actually adds two additional steps onto the 
overall synthesis of the target tetrasaccharide.   
5.3.7 Synthesis of the protected tetrasaccharide 
 The next step is the formation of the protected tetrasaccharide using disaccharide 
donor 5.32 and disaccharide acceptors 5.31 or 5.79 (Scheme 5.38).  We attempted to 
couple 5.32 to 5.31 under the conditions developed by Crich et al. which employ a 
combination of 1-benzenesulfinyl piperidine (BSP) and trifluoromethanesulfonic 
anhydride (Tf2O) as promoters. 113 However, so far we have not been able to obtain any 
product.  The donor disappeared (by TLC) within few minutes, while the acceptor 5.31 
remained.   The promoter used in this method is a very powerful activator.  Our donor is 
being rapidly activated but we believe that our acceptor is relatively unreactive.  So the 
activated donor is decomposing before it reacts with the acceptor.  We believe that a less 







































































R = Bn or Cbz R' = α-OMe
or β-OMP
R' = α-OMe
or β-OMP  
Scheme 5.38.  Remaining steps for the synthesis of the SB1a tetrasaccharide. 
 
 While these studies were in progress, we came across a paper by Belot and 
Jaquinet who performed an extensive study on the glycosylation of galactose donors 5.83 
and 5.87 (Scheme 5.39).  These two donors are in some ways similar to the reducing end 
of donor disaccharide 5.34 (Scheme 5.38).117 The authors found that the coupling of these 
donors to acceptor 5.84 (a relatively unreactive acceptor) gave the disaccharide products 
as α and β mixtures (Scheme 5.39a and b).  The authors attributed this to steric factors 
induced by the rigid 4,6- dioxolane ring in the 4,6-O-benzylidene-D-galactose derivatives 
which results in the formation of  an incompatible pair in the transition state. In order to 
confirm that the loss of stereocontrol in the coupling reactions was not due to the lack of 
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participation of the trichloroacetamido group, the authors treated thioglycosides 5.83 and 
5.88 with NIS–trimethylsilyl triflate for a short period in the absence of acceptor, where 
the corresponding silylated oxazoline 5.91 and the acetylated oxazoline 5.92 were 
isolated, respectively, as the major product, which indicating that participation of the 2-
trichloroacetamido group is quite effective in both cases (Figure 5.5).  On the other hand, 
when donors 5.88 and 5.99 were used the disaccharide 5.89 was obtained in good yield 

































































































5.85, R= MCA      65%, α:β; 1:3
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Figure 5.5.  Oxazoline intermediates  
Belot and Jaquinet’s results suggest that it is possible that even if we get the 
coupling of 5.79 or 5.31 to 5.32 to proceed, we may end up with an α, β mixture of the 
protected tetrasaccharide 5.30.  Nevertheless, we will still attempt to couple 5.79 or 5.31 
to 5.32 using other promoters though if we get an α-β mixture then we will probably 
have to remove the benzylidene acetals from 5.32 and replace them with other groups 
such as a Cbz group.   
 
5.4 Summary and Future Work 
 Although we have not yet achieved the synthesis of the target tetrasaccharide 
several significant results have come from these studies so far.  Efficient routes were 
developed for the construction of the left- and right-hand protected disaccharide portions 
of the SB1a tetrasaccharide.  In the case of the right-hand disaccharide two efficient routes 
were developed.  Selective sulfations using reagent 2.4 were key reactions in both 
syntheses.  The conditions we developed for installing the Cbz group in the relatively 
unreactive carbohydrate 3.131 may prove to be useful for installing the Cbz group in 
carbohydrates in general.  Consistent with Montero’s work, we found that the Cbz group 
installed at the 2-position of a donor can direct the formation of trans-1,2 linkages so long 
as a trichloroacetimidate donor is used.  The thioglycoside donor 5.33 gave the cyclic 
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carbonate and benzyl-transfer products at least when Crich’s conditions were used for 
forming the glycosidic bond.  Whether this is always going to be the case for 
thioglycosides donors and/or whether it depends upon the conditions used to promote the 
glycosidation reaction are issues that are currently under study by the Taylor group.  The 
synthesis of the target tetrasaccharide is currently being completed in the Taylor group.  
Only two steps remain.  Should this synthesis be successful then it will have been 
accomplished in just 22 steps (using disaccharide 5.31), eleven less than the synthesis 
described by Li et al.  This will be a potent demonstration of the value of the sulfate-
protecting group approach in the synthesis of complex, multisulfated oligosaccharides.  
5.5 Experimental 
5.5.1 General Considerations 
 For all general considerations, see section 2.4.1 in Chapter 2. 











Methyl 2,3-di-O-benzyl-4,6-O-benzylidene –β-D-glucopyranoside (5.44). Prepared 
according to literature procedure.107 Anhydrous ZnCl2 (3.5 g, 25.8 mmol) was added to 
(15 mL, 147 mmol) of pure benzaldehyde and the solution was stirred for 10 minutes at 
room temperature. Methyl α-D-glucopyranoside (5.0 g, 25.7 mmol) was added to the 
reaction mixture and the reaction was stirred for 5 h at room temperature. The reaction 
was diluted with ethyl acetate (200 mL) and washed with water. The organic layer was 
dried over anhydrous Na2SO4. The solvent was removed under vacuum and the residue 
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was crystallized from ethyl acetate/hexane to give (5.7 g, 78%) of the desired compound. 
All spectra are in agreement with literature data for this compound. The crystallized diol 
(5.0 g, 0.02 mol) was stirred with 60% NaH (1.8 g, 0.1 mol) in DMF at 0 oC for 30 
minutes. Benzyl bromide (10 mL, 0.08 mol) was added dropwise to the reaction mixture 
and the reaction was stirred at room temperature for 24 hour. The reaction was quenched 
with methanol, and the solvent was removed under vacuum. The residue was dissolved in 
ethyl acetate and washed with water and brine then dried over anhydrous sodium sulfate. 
Flash chromatography (EtOAc/Hexanes; 1: 3) afforded (6.95 g, 85%) of compound 5.44. 








Methyl 2,3,6-tri-O-benzyl-β-D-glucopyranoside (5.35). To the fully protected sugar 
5.44 (5.0 g, 0.01 mol) in CH2Cl2 (100 mL) was added dropwise triethysilane (7.9 mL, 
0.05 mol) followed by trifluoroacetic acid (3.85 mL, 0.05 mol). The reaction was stirred 
at room temperature for 9 h until there was no starting material remaining. The reaction 
was diluted with CH2Cl2, carefully quenched with triethylamine, and concentrated to 
crude syrup. Flash chromatography (1:4, EtOAc/hexanes) gave compound 5.35 as a 















noside (5.50). To tetraacetate 5.49 (15.0 g, 30.4 mmol) in freshly distilled CH2Cl2 at 0 °C 
was added benzene thiol (15.0 mL, 136 mmol), follwed by a dropwise addition of 
BF3OEt2 (15.0 mL, 118.0 mmol).The reaction was allowed to gradually warm to room 
temperature and stir overnight for 16 h. The solution was then cooled, diluted with 
CH2Cl2 and carefully quenched with sat. aq.NaHCO3. The resulting layers were 
separated, and the organic layer was washed with cold 1 M NaOH, and H2O, dried over 
MgSO4 and concentrated to a yellow solid. Recrystallization (EtOAc/Hexanes) afforded 





Phenyl 2-deoxy-2-trichloroacetamido-1-thio-β-D-galactopyranoside (5.51). Na0 metal 
(0.3 eq.) was added to 5.50 in reagent grade MeOH (0.12 M solution). The reaction was 
stirred for 12 h, neutralized with Dowex H+ resin, filtered and concentrated to a white 
solid. The resulting crude triols were used directly in the next step without any 



















Phenyl 4.6-O-2-deoxy- 2-trichloroacetimido-1-thio -β-D-galactopyranoside (5.34). To 
a solution of 5.51 (4.0 g, 9.6 mmol) in acetonitrile (80 mL) was added benzaldehyde 
dimethyl acetal (5.0 mL, 28.8 mmol) and DL-10-camphorsulfonic acid (10 mol %) and 
the mixture stirred 16 h at room temperature. The solution was neutralized by addition of 
triethylamine, and concentrated to a crude yellow solid. The crude solid was purified by 
flash chromatography (1:1 EtOAc/Hexanes) to afford 5.34 (3.9 g, 80%). All spectra for 










p-Tolyl 4,6-O-benzylidene-2-O- -carbobenzyloxy-1-thio-β-Dgalactopyranoside (5.56). 
To carbohydrate 3.126 (0.5 g, 1.33 mmol) in CH2Cl2 (10 mL) was added freshly prepared 
Ag2O (0.46 g, 2 mmol), KI (0.044 g, 0.27 mmol) followed by a dropwise addition of 
benzyl chloroformate (0.2 mL, 1.5 mmol). The reaction was stirred in dark for 24 h. The 
reaction mixture was filtered over cellite, and then the solvent was washed with water, 
brine and dried over anhydrous sodium sulfate. The solvent was removed under vacuum 
and the residue was purified by flash chromatography (EtOAc/Hexanes; 1:4) provided 
5.56 as a white foam (0.1 g, 15%) in addition to (0.125 g, 20%) of the 3-O-Cbz derivative 
5.57. 1H NMR (300 MHz, CDCl3) δ 2.32 (s, 3H, CH3), 2.44 (br-s, 1H, OH), 3.55 (s, 1H, 
H5), 3.89 (dd, 1H, J3,2 = 9.7 Hz, J3,4 =3.1 Hz, H3), 3.99 (d, 1H, J6,6` = 12.4 Hz, H6), 4.34 
(d, 1H, J6`,6 = 12.4 Hz, H6`), 4.40 (d, 1H, J4,3 = 2.9 Hz, H4), 4.51 (d, 1H, J1,2 = 9.5 Hz, 
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H1), 4.76 (dd, 1H, J2,3 = J2,1 = 9.6 Hz,  H2), 5.14 (s, 2H, CO2CH2Ph), 5.44 (s, 1H, CHPh), 
7.03 (d, 2H, J=7.9 Hz, ArH), 7.24-7.33 (m, 10H, ArH), 7.54 (d, 2H, J= 7.9 Hz, ArH). 13C 
NMR (75 MHz, CDCl3) δ 21.3, 69.0, 69.8, 70.0, 72.4, 74.1, 75.5, 84.5, 101.4, 126.6, 
127.0, 128.2, 128.3, 128.5, 128.6, 129.4, 129.5, 134.5, 135.2, 137.4, 138.4, 154.6. HRMS 










galactopyranoside (5.33). To a solution of 3.131 (0.3 g, 0.51 mmol) and DMAP (0.3 g, 
2.56 mmol) in CH2Cl2 (6 mL) at room temperature was added benzyl chloroformate (0.2 
mL, 1.5 mmol) dropwise over 15 min. The reaction was stirred for 4 h, where no starting 
material remained by TLC. The reaction was quenched with cold MeOH, diluted with 
CH2Cl2 and washed with water. The organic layers were collected, dried over MgSO4 and 
concentrated to a crude yellowish solid. Purification by flash chromatography 
(EtOAc/Hexanes; 1:4) afforded 5.33 as a white solid (0.34 g, 92%). 1H NMR (300 MHz, 
CDCl3) δ 2.32 (s, 3H, CH3), 3.57 (s, 1H, H5), 4.08 (d, 1H, J6,6` =12.4 Hz, H6). 4.35 (d, 
1H, J6`,6 =12.4 Hz, H6`), 4.57-4.67 (m, 3H, H4, CH2CCl3), 4.84 (dd, 1H, J3,2 =10.3 Hz, 
J3,4 =3.6Hz, H3), 4.88 (d, 1H, J1,2 =7.9 Hz, H1), 5.19, 5.26 (AB, 2H, J= 12.1 Hz, 
CH2CO2Ph), 5.44 (dd, J2,3= 10.3 Hz, J2,1 =8.1 Hz, H2), 5.57 (s, 1H, CHPh), 6.74 (d, 2H, 
J=9.0 Hz, ArH), 6.85 (d, 2H, J=9.0 Hz, ArH), 7.24-7.51 (m, 10H, ArH); 13C NMR (75 
MHz, CDCl3) δ 21.2, 65.9, 68.6, 70.5, 71.9, 72.9, 80.0, 81.3, 92.4, 100.8, 101.4, 114.5, 
119.3, 126.5, 128.4, 128.5, 128.69, 128.74, 129.6, 134.8, 136.7, 150.9, 153.9, 155.9. 









(5.65). NBS (0.39 g, 2.22 mmol) was added to 5.33 (0.4 g, 0.550 mmol) in acetone/ H2O 
(9:1, 15 mL) at 0 °C. The reaction was stirred for 4 h at 0 °C then concentrated until 
turbidity developed. The remaining residue was dissolved in EtOAc, washed with H2O, 
dried over MgSO4 and concentrated to a yellow foam. Purification by flash 
chromatography (EtOAc/Hexanes; 1:1) afforded 5.65 as a white foam (0.3, 89%). The 












To hemiacetal 5.65 (0.4 g, 0.64 mmol) in CH2Cl2 (5.0 mL) at –40 °C was added 
trichloroacetonitrile (1.4 mL, 10.32 mmol) followed by a 1.0 M solution of DBU in 
CH2Cl2 (0.12 mL, 0.12 mmol). The reaction was stirred for 2 h and gradually warmed to 
room temperature. The solvent was evaporated and the residue was applied to a silica gel 
column (EtOAc/Hexanes; 1:4) where 5.66 was isolated as white foam (0.44 g, 90%). 1H 
NMR (500 MHz, CDCl3) δ 4.04 (s, 1H, H5), 4.13 (d, 1H, J6,6` =11.8 Hz, H6), 4.35 (d, 
1H, J6`,6 =11.8 Hz, H6`), 4.68, 4.81 (AB, 2H, J= 10.7 Hz, CH2CCl3), 4.84 (d, 1H, J4,3 
=3.0 Hz, H4), 5.18-5.24 (m, 3H, H2, CO2CH2Ph), 5.43 (dd, 1H, J3,2 =10.5 Hz, J3,4 =3.0 
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Hz, H3), 5.66 (s, 1H, CHPh), 6.89 (d, 1H, J1,2 =3.2 Hz, H1), 7.28-7.45 (m, 2H, ArH), 
7.54-7.57 (m, 2H, ArH), 8.61 (s, 1H, NH); 13C NMR (75 MHz, CDCl3) δ 64.7, 68.5, 70.2, 
70.6, 73.3, 78.1, 79.9, 92.4, 94.1, 101.1, 126.2, 128.4, 128.6, 128.7, 128.8, 128.9, 129.5, 














(5.32). A mixture of imidate 5.66 (0.18 g, 0.25 mmol) and acceptor 5.34 (0.10 g, 0.2 
mmol) and 4oA molecular sieves were stirred in dry CH2Cl2 (3.0 mL) under argon for 1 h 
at room temperature. The solution was then cooled to -40 oC. A solution of 0.1 M 
TMSOTf (0.040 mL) was added, and the reaction was allowed to stir at -40 oC for 1 h 
and at rt for 3 h. The reaction mixture was then treated with triethylamine (0.08 mL), 
filtered through celite and concentrated. Purification by flash chromatography 
(EtOAc/Hexanes; 1:1) afforded (0.164 g, 73%) of the desired disaccharide 5.32. 1H NMR 
(300 MHz, CDCl3) δ 3.27(b, 1H, H5`), 3.46-3.59 (m, 2H, H5, H2), 3.92, 4.31 (AB, 2H, 
J6`,6`` =12.3 Hz, H6Gal, H6`Gal),  4.01, 4.22 (AB, 2H, J6,6` =12.3 Hz, H6GalN, 
H6`GalN), 4.28 (m, 1H, H4), 4.51-4.61(m, 5H, H3, CH2CCl3, H3`, H4`), 4.72 (d, 1H, J1,2 
=7.8 Hz, H1`), 4.94, 5.10 (AB, 2H, J= 11.8 Hz, CH2Ph), 5.15 (m, 1H, H2`under the CH 
of the CH2Ph, ),5.45 (d, 1H, J1,2 =10 Hz, H1), 5.51 (s, 1H, CHPh), 5.52 (s, 1H, CHPh), 
6.94 (d, 1H, JNH,H2 =6.7 Hz, NH),  7.19-7.37 (m, 14H, ArH), 7.42 (m, 2H, ArH), 7.52 (m, 
2H, ArH), 7.62 (d, 2H, J=6.7 Hz, ArH); 13C NMR (75 MHz, CDCl3) δ 53.1, 65.8, 68.5, 
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69.0, 70.1, 70.3, 72.3, 72.8, 74.4, 75.8, 79.9, 81.1, 83.2, 92.1, 92.3, 100.21, 100.27, 101.1, 
126.27, 126.29, 128.11, 128.2, 128.4, 128.8, 129, 129.1, 129.5, 131.7, 133.5, 134.7, 
136.6, 137.9, 153.8, 162.0.HRMS (+ESI) m/z = 1115.0393 C44H45 Cl6N2O15S2, 














galactosyl)-2,3,6-tri-O-benzyl-α-D-glucopyranoside  (5.76). A mixture of imidate 5.66 
(0.186 g, 0.25 mmol) and acceptor 5.35 (0.1 g, 0.22 mmol) and 4oA molecular sieves 
were stirred in dry CH2Cl2 (3.0 mL) under argon for 1 h at room temperature. The 
solution was then cooled to -40 oC. A solution of 0.1 M TMSOTf (0.040 mL) was added, 
and the reaction was allowed to stir at -40 oC for 1 h and at rt for 2 h. The system was 
then treated with triethylamine (0.08 mL), filtered through celite and concentrated. 
Purification by flash chromatography (EtOAc/Hexanes; 1:1) afforded (0.155 g, 68%) of 
the desired disaccharide 5.76. 1H NMR (300 MHz, CDCl3) δ 2.91(b, 1H, H5`), 3.35 (s, 
3H, OCH3), 3.47 (m, 3H, H5, H2, H4`), 3.88 (m, 4H, H6Gl, H6Gal, H3, H6`Gal) 4.16 (d, 
1H, J6,6`= 12.5 Hz, H6`Gl), 4.34 (d, 1H, J=8.7 Hz, H1`-Gal), 4.41 (m, 3H, CH2CCl3, H4), 
4.55 (d, 1H, J= 3.5 Hz, H1), 4.58-4.84 (m, 7H, H2`, 3CH2Ph), 5.13 (dd, 1H, H3`under the 
CH2Ph), 5.14, 5.24(AB, 2H, J =12.3 Hz CH2Ph), 5.52 (s, 1H, CHPh), 7.19 (m, 3H, ArH), 
7.34 (m, 18H, ArH), 7.46 (d, 4H, J=3.7 Hz, ArH); 13C NMR (75 MHz, CDCl3) δ 55.5, 
65.5, 67.6, 68.3, 69.6, 70.3, 72.5, 72.9, 73.3, 73.7, 76, 78.1, 79.2, 79.9, 80, 81.6, 92.5, 
98.4, 100.3, 101.4, 126.5, 127.9, 128, 128.1, 128.2, 128.2, 128.3, 128.4, 128.5, 128.6, 
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128.7, 128.8, 129.4, 134.9, 136.9, 138.1, 138.3, 138.9, 153.9.HRMS (+ESI) m/z = 














O-benzyl-α-D-glucopyranoside  (5.77). To the fully protected disaccharide 5.76 (0.1 g, 
0.09 mmol) in CH2Cl2 (2 mL) was added dropwise triethysilane (0.08 mL, 0.47 mmol) 
followed by trifluoroacetic acid (0.04 mL, 0.47 mmol). The reaction was stirred at room 
temperature for 6 h until there was no starting material remaining. The reaction was 
diluted with CH2Cl2, carefully quenched with triethylamine, and concentrated to crude 
syrup. Flash chromatography (1:1, EtOAc/hexanes) gave compound 5.77 as a white solid 
(0.073 g, 80%). 1H NMR (300 MHz, CDCl3) δ 2.21 (b, 1H, OH), 2.72 (b, 1H, OH), 
2.91(b, 1H, H5`), 3.35 (s, 3H, OCH3), 3.47 (m, 3H, H5, H2, H4`), 3.88 (m, 4H, H6Gl, 
H6Gal, H3, H6`Gal) 4.16 (d, 1H, J6,6`= 12.5 Hz, H6`Gl), 4.34 (d, 1H, J=8.7 Hz, H1`-
Gal), 4.41 (m, 3H, CH2CCl3, H4), 4.55 (d, 1H, J= 3.5 Hz, H1), 4.58-4.84 (m, 5H, H3`, 
2CH2Ph), 5.13 (t, 1H, J= 7.8 Hz, H2`), 5.14, 5.24(AB, 2H, J =12.3 Hz CH2Ph), 7.19 (m, 
3H, ArH), 7.34 (m, 18H, ArH), 7.46 (d, 4H, J=3.7 Hz, ArH); 13C NMR (75 MHz, CDCl3) 
δ 55.5, 63.1, 67.3, 68.6, 69.6, 70.1, 71.8, 72.7, 73.4, 73.5, 75, 77.2, 78.7, 79.7, 79.9, 83.5, 
92.5, 98.4, 100.2, 126.8, 127.4, 127.8, 128, 128.1, 128.2, 128.4, 128.5, 128.59, 128.66, 















ctosyl)-2,3,6-tri-O-benzyl-α-D-glucopyranoside  (5.31). To the disaccharide 5.76 (0.1 
g, 0.09 mmol) in dry diethyl ether (2 mL) was added NaCNBH3 (0.05 g, 0.75 mmol) 
followed by dropwise addition of diethyl ether saturated with HCl until no effervescence.  
The reaction was stirred at room temperature for 4 h until there was no starting material 
remaining. The reaction was diluted with CH2Cl2, carefully quenched with triethylamine, 
and concentrated to crude syrup. Flash chromatography (1:1, EtOAc/hexanes) gave 
compound 5.31 as a white foam (0.075 g, 75%). 1H NMR (300 MHz, CDCl3) δ 2.61 (b, 
1H, OH), 2.91(b, 1H, H5`), 3.35 (s, 3H, OCH3), 3.47 (m, 3H, H4`, H5, H2), 3.88 (m, 4H, 
H6Gl, H6Gal, H3, H6`Gal) 4.16 (d, 1H, J6,6`= 12.5 Hz, H6`Gl), 4.34 (d, 1H, J=8.7 Hz, 
H1`-Gal), 4.41 (m, 3H, CH2CCl3, H4), 4.55 (d, 1H, J= 3.5 Hz, H1), 4.58-4.84 (m, 7H, 
H2`, 3CH2Ph), 5.14 (dd, 1H, H3`under the CH2Ph), 5.14- 5.24(m, 4H, 2CH2Ph), 7.2 (m, 
3H, ArH), 7.36 (m, 18H, ArH), 7.46 (d, 4H, J=3.7 Hz, ArH); 13C NMR (75 MHz, CDCl3) 
δ 55.5, 65.5, 67.6, 68.3, 69.6, 70.3, 72.5, 72.8, 72.9, 73.3, 73.7, 76, 78.1, 79.2, 79.9, 80, 
81.6, 92.5, 98.4, 100.3, 126.5, 127.9, 128, 128.1, 128.2, 128.2, 128.3, 128.4, 128.5, 128.6, 
128.7, 128.8, 129.4, 134.9, 136.9, 138.1, 138.3, 138.9, 153.9.HRMS (+ESI) m/z = 


















4-Methoxyphenyl β-D-galactopyranosyl-(1-4)-β-D-glucopyranoside (5.81).  
To a solution of peracetylated lactose 5.3 (30.0 g, 44.1 mmol) in freshly distilled CH2Cl2  
(250 mL) at 0 °C was added 4-methoxyphenol (7.13 g, 57.5 mmol), follwed by a 
dropwise addition of BF3OEt2 (9.50 mL, 75.2 mmol).The reaction was allowed to 
gradually warm to room temperature and stirred overnight for 16 h. The solution was 
then cooled, diluted with CH2Cl2 and carefully quenched with sat. aq.NaHCO3. The 
resulting layers were separated, and the organic layer was washed with cold H2O, dried 
over MgSO4 and concentrated to a yellow solid. Recrystallization (EtOAc/Hexanes) 
afforded desired product as fine white crystalls (36.3 g, 83%). All spectra agree with 
literature data for this compound.115 To a solution of the lactose heptaacetate-OMP (30 g, 
40.4 mmol) in methanol-CH2Cl2; 1:1 (300 mL) was added Na° metal (0.35 g, 15 mmol). 
The reaction was stirred for 6 h, neutralized with Dowex H+ resin, filtered and 
concentrated to a white solid (17.4 g, 96%). The resulting crude was used directly in the 
















oside (5.82). To a solution of 4-methoxyphenyl β-D-galactopyranosyl-(1-4)-β-D-
glucopyranoside 5.81 (15 g, 33.4 mmol) in DMF (80mL) 2,2-dimethoxypropane (10 mL) 
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and p-toluenesulfonic acid (200 mg) were added and the mixture was stirred for 4 hr at 80 
oC, then neutralized with triethyl amine. The solvent was removed under vacuum and the 















β-D-glucopyranoside (5.78). Prepared according to a modified literature procedure.115 To 
a solution of 5.82 (8.0 g, 16.3 mmol) in dry DMF 80% NaH (3 g, 0.10 mol) was added in 
small portions at 0 0C. The reaction mixture was stirred for 30 min and benzyl bromide 
(12 mL, 0.10 mol) was added. After 6 hr, another portion of NaH (1.5 g, 0.05 mol) and  
benzyl bromide (6 mL, 0.05 mol) were added. The reaction was stirred at rt for another 
10 h, then MeOH was added in order to decompose the excess of hydride. The solvent 
was evaporated, the residue was dissolved in DCM (300 mL), washed with distilled water 
(3 x 100 mL), dried over anhydrous Na2SO4, filtered, and evaporated. The sirupy crude 
product (15 g) was used for the next step without purification. A stirred mixture of the 
fully protected isopropylidene lactose (15 g, 16 mmol) in methanol (200 mL) and 1M 
HCl (20 mL) was heated for 50 oC. After 2 hr, t.l.c. showed complete conversion, the 
solution was evaporated and the solid residue was crystallized from methanol to give 5.78 
















(1-4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside (5.79).  
To the diol 5.78 (0.5 g, 0.55 mmol) in dry CH2Cl2 (5 mL) at 0 oC (ice bath) was added 
reagent 2.4 (0.2 g, 0.41 mmol), followed by the addition of a solution of DiMeIm (0.1 g, 
1.1 mmol) in CH2Cl2 (2 mL) over 6 h using a syringe pump. During the addition of the 
DiMeIm another portion of reagent 2.4 (0.2 g, 0.41 mmol) was added after 4 h and the ice 
batch was removed after the initial 1 h. The reaction was left stirring until the reaction 
was complete by TLC (approx 24 h). The reaction was diluted with CH2Cl2, washed with 
brine, dried (MgSO4) and concentrated to brown crude oil. The crude residue was 
purified with flash chromatography (1:4, EtOAc/hexanes) to give the sulfated lactose 
5.79 (0.48 g, 78%) in addition to (0.07 g, 10%) of the disulfated derivative. 1H NMR (300 
MHz, CDCl3) δ 2.91 (b, 1H, OH at C4`), 3.22 (b, 1H, H5`),  3.45-3.8 (m, 11H, H5, H4`, 
H3, H2`, H6Gl, H6`Gl, OCH3, H6 Gal, H6`Gal), 4.10 (t, 1H, J=9 Hz, H2), 3.41 (m, 6H, 
H1`, CH2CCl3, H4, CH2Ph), 4.71 (m, 8H, 3CH2, H1, 1H of CH2Ph), 5.01 (m, 2H, 1H of 
CH2Ph, H3`), 6.81, 7.01 (AB, 2H, J= 12 Hz, ArH), 7.31 (m, 25 H, ArH); 13C NMR (75 
MHz, CDCl3) δ 55.6, 67.5, 67.9, 68.7, 71.5, 73.3, 73.6, 75, 75.1, 75.4, 75.5, 76.4, 79.6, 
82.6, 86.1, 92.6, 102.2, 102.8, 114.5, 118.5, 127.4, 127.7, 127.9, 128, 128.1, 128.2, 128.4, 
128.41, 128.6, 137.3, 137.4, 138, 138.3, 139, 151.5, 155.3. HRMS (+ESI) m/z = 
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